TW591056B - Polyamide-imide, liquid crystal orientating ingredient varnish and liquid crystal display - Google Patents
Polyamide-imide, liquid crystal orientating ingredient varnish and liquid crystal display Download PDFInfo
- Publication number
- TW591056B TW591056B TW091117861A TW91117861A TW591056B TW 591056 B TW591056 B TW 591056B TW 091117861 A TW091117861 A TW 091117861A TW 91117861 A TW91117861 A TW 91117861A TW 591056 B TW591056 B TW 591056B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- liquid crystal
- ch2ch2
- polyamidoamine
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G73/00—Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
- C08G73/06—Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
- C08G73/10—Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
- C08G73/14—Polyamide-imides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K19/00—Liquid crystal materials
- C09K19/52—Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
- C09K19/54—Additives having no specific mesophase characterised by their chemical composition
- C09K19/56—Aligning agents
-
- G—PHYSICS
- G02—OPTICS
- G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
- G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
- G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour
- G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour based on liquid crystals, e.g. single liquid crystal display cells
- G02F1/133—Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
- G02F1/1333—Constructional arrangements; Manufacturing methods
- G02F1/1337—Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
Landscapes
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Nonlinear Science (AREA)
- Organic Chemistry (AREA)
- Crystallography & Structural Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Mathematical Physics (AREA)
- Materials Engineering (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Liquid Crystal (AREA)
Abstract
Description
591056 9825 pif 1 玖、發明說明: 發明頜域 本發明關於一種使用於電子材料領域的新型聚醯胺-亞醯胺(polyamide-imide)。使用此聚醯胺-亞醯胺,可得到 具有較佳之液晶配向性的液晶配向膜。使用使液晶配向膜 可以給予液晶顯示元件較佳之電特性。 發明背景 液晶顯示元件係以使用向列型(nematic)液晶的顯示元 件爲主流,關於此方面,習知包括液晶爲40度螺旋之TN型 ® 液晶顯示元件、液晶爲180度以上螺旋之STN型液晶顯示元 件、以及使用薄膜電晶體(transistor)的所謂TFT型液晶顯示 元件。近來,更有改良視覺特性之橫向電場方式的內平面 轉移(In-Plane Switching,簡稱IPS)型液晶顯示元件、利用 垂直配向狀態之垂直調準(Vertical Alignment,簡稱VA)型 液晶顯示元件、或使用彎曲配向狀態的光學補償雙折射 (Optically Compensated Birefringence,簡稱OCB)型液晶顯 示元件等的硏究,其中前述之一部份甚至已實用化。液晶 籲 顯示元件之進展不僅以上述之方式進展,也活躍的朝向以 提高液晶顯示元件之特性爲目的的周邊材料的改良進展。 由於液晶配向劑對液晶顯示元件之顯示品質而言係爲一個 · 重要的因素,且當要求液晶顯示元件之高品質化之際,液 晶配向劑之比例係變爲更重要的因素。 現在,主要使用之液晶配向劑係爲用以使聚醯胺酸亞 醯胺化的聚醯胺酸以及可溶性聚亞醯胺等的聚亞醯胺系。 8 9825 pifl 除了聚亞醯胺系配向劑之外,種種的液晶配向劑也被探 討,並以之對耐熱性、耐藥品性(耐液晶性)、塗布性、液晶 配向性、電特性、顯示特性等是否不合適進行考量。在聚 亞醯胺系配向劑之中,聚醯胺酸對溶劑之溶解性較高因而 其基板塗布性良好。然而,在配向膜之形成時’由於加熱 對稱爲亞醯胺化的燒結製程而言係爲必要的,因而會有因 低溫燒結而造成特性惡化之問題產生。另一方面、在可溶 性聚醯胺中,其所具有之可溶性對溶劑而言會有溶解性比 較差的問題,甚至當未使用所限定之溶劑時,也會有印刷 性變差的缺點。 除了聚亞醯胺系配向劑之外,聚醯胺及N置換聚醯胺 (將醯胺鍵結(-CONH-)之氫原子置換成其他基團的聚醯 胺)等的高分子化合物也被硏究。聚醯胺係具有良好的液 晶配向性,但具有些許關於溶解性及印刷性的缺點,並有 關於電特性方面的問題。N置換聚醯胺係具有良好的溶解 性、印刷性及電特性等性能,然具有些許關於液晶配向性 的缺點。另外也存在有混合有多種高分子化合物的液晶配 向劑、使用嵌段共聚合高分子化合物的液晶配向劑等。然 在現今之情況下,前述仍具有些許關於消耗電流、殘留電 荷、電壓保持率、燒結等電氣特性、以及液晶配向性等缺 點,在被要求的課題中僅可有特定性質較佳,因而作爲液 晶配向劑之實用化仍有所因難。液晶配向劑必須具有總合 的平衡特性。 當液晶顯示元件之使用領域變得較廣時,對液晶顯示 591056 9825 pifl 元件之特性的要求也相對提高。對此之要求包括對以液晶 前傾角爲代表的液晶配向性的要求、對消耗電流値、電壓 保持率、殘留電荷等的液晶顯示元件之電特性的要求、對 前述各種特性之長期使用時之可靠度的要求、對液晶顯示 元件之殘影現象、顯示不均等顯示品質的要求等。 在前述特性中,液晶之前傾角可利用液晶顯示元件之 驅動方式對其所需之數値進行變動。例如,液晶爲90度螺 旋之TN型液晶顯示元件及TFT型液晶顯示元件係爲1〜6度 $ 左右。在螺旋角較大之STN型液晶顯示元件中,必需要有3 〜8度左右之前傾角。然而,此所要求之前傾角之値會隨著 用途而有所變化,近來,在STN型液晶顯示元件中也出現 要求2〜3度或8度以上之情形。另一方面,在IPS型液晶顯 示元件中,爲了使液晶在水平方向上對基板進行變動,因 此前傾角不需要變大,前傾角係變化大約1〜3度左右。反 之,在VA型液晶顯示元件中,必需使用90度左右之較大的 前傾角,而在OCB液晶顯示元件中,爲使其彎曲配向狀態 穩定化,因而必需有5〜20度之較大的前傾角。 籲 再者,不僅是前傾角,關於配向均一性、配向穩定性 或液晶-配向膜界面之固定能(anchoing energy)等的液晶配 向性的特性也對液晶顯示元件之性能有較重要之影響。在 液晶顯示元件之製造流程中,此特性之製程界限(process margin)也很重要。塗佈配向劑之後的乾燥條件、液晶注入 後之退火(annealing)處理條件等必然也會使前傾角或配向 性發生變化。 10 591056 9825 pifl STN型液晶顯示元件,特別是用於攜帶型機器領域的 低電壓型的顯示元件,由於驅動電壓較低,因而消耗電流 之大小係爲重要的。即,液晶顯示元件之消耗電流變大時, 由於會相對的降低施加於液晶上之電壓,因而,液晶之起 立會變得不穩定,進而降低其對比。再者,在低電壓型的 液晶顯示元件中,液晶顯示元件之長期使用中之消耗電流 値的變化(可靠度)也變得重要。由於STN型顯示元件之 顯示開-關僅藉由電位差而進行,因此當元件之消耗電流値 與施加於液晶上之電壓一同變化時,則無法進行正常的驅 動。在較極端之情形下,長時間驅動之結果,液晶顯示元 件之影像會發生無法完全顯示之現象。 另一方面,在TFT型液晶顯示元件中,關於電壓保持 率及殘留電荷之性能係爲特別重要的。當電壓保持率較低 時,且於構圖期間,液晶上所施加之電壓降低,則易發生 對比降低的問題。再者,當殘留電荷較大之際,施加電壓 後,由於會呈現殘留作爲「關」的電荷之狀態,因而被消 去之影像會有殘影殘留。在TFT型液晶顯示元件中,此殘影 現象(燒結)係爲相當重要的問題。 近年來,隨著驅動電壓之低電壓化,係採用具有較大 之異方向性之介電常數的液晶。然而,隨著此傾向,而於 顯示面內發生顯示不均(明亮度不均)的問題。由於經過 硏磨處理之配向膜會發生削渣之情形,因而未去除此現象 而進行水洗。此時,會發生因殘留水洗痕跡而造成之顯示 不均的現象,且此現象係爲較大之問題。 11 591056 9825 pif 1 本發明係提供一種液晶配向劑,係用以得到在前述液 晶顯示元件所要求之各種特性中,特別是具有較佳之前傾 角、液晶配向性及電特性(消耗電流値、電壓保持率、殘 留電荷、燒結)等較佳平衡性的液晶顯示元件。 發明槪述 本發明者爲了解決上述問題而進行硏究,其結果係藉 由在液晶配向劑淸漆(varnish)中,使用下述結構中之聚醯胺 -亞醯胺,即可達到上述目的。 即,本發明係具有下述之結構。 < [1]具有式(1-1)中所表示之結構單位、或具有由式 (1-2)及式(1-3)所分別表示之結構單位的聚醯胺-亞醯胺。591056 9825 pif 1 发明 Description of the invention: Inventive jaw field The present invention relates to a new type of polyamide-imide used in the field of electronic materials. By using this polyamidoamine-iminomine, a liquid crystal alignment film having better liquid crystal alignment can be obtained. The use of the liquid crystal alignment film can give the liquid crystal display element better electrical characteristics. BACKGROUND OF THE INVENTION Liquid crystal display elements are mainly display elements using nematic liquid crystals. In this regard, it is known to include TN type liquid crystal display elements with a liquid crystal having a 40 degree spiral, and STN types with a liquid crystal having a spiral of 180 degrees or more A liquid crystal display element and a so-called TFT-type liquid crystal display element using a thin film transistor. Recently, In-Plane Switching (IPS) type liquid crystal display elements with improved horizontal visual field characteristics, vertical alignment (Vertical Alignment (VA) type liquid crystal display elements using vertical alignment state), or Research on optically compensated birefringence (OCB) type liquid crystal display elements using curved alignment states, among which one of the aforementioned parts has even been put into practical use. The progress of liquid crystal display devices has not only progressed in the above-mentioned manner, but also has been actively moving toward the improvement of peripheral materials for the purpose of improving the characteristics of liquid crystal display devices. Since the liquid crystal alignment agent is an important factor for the display quality of the liquid crystal display element, and when the high quality of the liquid crystal display element is required, the ratio of the liquid crystal alignment agent becomes a more important factor. At present, the liquid crystal alignment agents that are mainly used are polyamidoamines that are used to aminate polyamidoamines, and polyamidoamines such as soluble polyamidoamines. 8 9825 pifl In addition to polyimide-based alignment agents, various liquid crystal alignment agents have also been explored. They are used for heat resistance, chemical resistance (liquid crystal resistance), coating properties, liquid crystal alignment properties, electrical properties, and display. Whether characteristics, etc. are inappropriate. Among the polyimide-based alignment agents, polyamic acid has a high solubility in a solvent, and thus has good substrate coating properties. However, when forming the alignment film, since heating is necessary for a sintering process called imidization, there is a problem that characteristics are deteriorated due to low-temperature sintering. On the other hand, the soluble polyamidoamine has a problem of poor solubility in solvents, and even when a limited solvent is not used, there is a disadvantage of poor printability. In addition to polyamidine-based alignment agents, polymer compounds such as polyamidamine and N-substituted polyamidine (polyamidine in which a hydrogen atom of (amidron-bonded (-CONH-)) is replaced with another group), etc. Be investigated. Polyamides have good liquid crystal alignment, but they have some disadvantages regarding solubility and printability, and they have problems with electrical characteristics. N-substituted polyamides have good solubility, printability, and electrical properties, but they have some shortcomings about the alignment of the liquid crystal. There are also liquid crystal alignment agents mixed with a plurality of polymer compounds, and liquid crystal alignment agents using block copolymerized polymer compounds. However, in the present situation, the foregoing still has some shortcomings about electrical characteristics such as current consumption, residual charge, voltage retention, sintering, and liquid crystal alignment. Among the required topics, only certain properties are better, so as The practical application of liquid crystal alignment agents is still difficult. The liquid crystal alignment agent must have a combined balance characteristic. When the field of use of liquid crystal display elements becomes wider, the requirements for the characteristics of liquid crystal display 591056 9825 pifl elements are also relatively increased. The requirements include requirements for liquid crystal alignment represented by the forward tilt of the liquid crystal, requirements for electrical characteristics of liquid crystal display elements such as current consumption, voltage retention, and residual charge, and long-term use of the aforementioned characteristics. Reliability requirements, afterimage phenomenon of liquid crystal display elements, and display quality requirements such as uneven display. Among the aforementioned characteristics, the front tilt angle of the liquid crystal can be changed by the driving method of the liquid crystal display element to the required number. For example, the TN-type liquid crystal display element and the TFT-type liquid crystal display element whose liquid crystal is 90-degree spiral are about 1 to 6 degrees. In the STN type liquid crystal display element with a large helix angle, it is necessary to have a front tilt angle of about 3 to 8 degrees. However, the angle of inclination before this requirement may vary depending on the application. Recently, STN type liquid crystal display elements have also been required to be 2 to 3 degrees or 8 degrees or more. On the other hand, in the IPS-type liquid crystal display element, in order to change the liquid crystal to the substrate in the horizontal direction, the tilt angle does not need to be large before, and the forward tilt angle is changed by about 1 to 3 degrees. On the other hand, in the VA type liquid crystal display element, a large forward tilt angle of about 90 degrees must be used, and in the OCB liquid crystal display element, in order to stabilize the bending alignment state, a large value of 5 to 20 degrees must be used. Lean forward. Furthermore, not only the forward tilt angle, but also the liquid crystal alignment characteristics such as alignment uniformity, alignment stability, or anchoring energy at the liquid crystal-alignment film interface have a more important influence on the performance of the liquid crystal display element. In the manufacturing process of a liquid crystal display device, the process margin of this characteristic is also important. The drying conditions after the alignment agent is applied, and the annealing treatment conditions after the liquid crystal is injected will inevitably change the rake angle or the alignment. 10 591056 9825 pifl STN liquid crystal display elements, especially low-voltage type display elements used in the field of portable devices, have low driving voltages, so the magnitude of current consumption is important. That is, when the current consumption of the liquid crystal display element becomes larger, the voltage applied to the liquid crystal is relatively reduced, so that the rise of the liquid crystal becomes unstable, thereby reducing the contrast. Furthermore, in a low-voltage type liquid crystal display element, a change in current consumption 可靠 (reliability) during long-term use of the liquid crystal display element becomes important. Since the display on-off of the STN type display element is performed only by the potential difference, when the element's current consumption 値 changes with the voltage applied to the liquid crystal, normal driving cannot be performed. In more extreme cases, as a result of driving for a long time, the image of the liquid crystal display element may not be completely displayed. On the other hand, in a TFT-type liquid crystal display element, the performance regarding voltage retention and residual charge is particularly important. When the voltage holding ratio is low and the voltage applied to the liquid crystal decreases during the patterning period, the problem of lowered contrast tends to occur. Furthermore, when the residual charge is large, after the voltage is applied, it will remain as an "off" charge, so the image after being erased will have an afterimage. In the TFT-type liquid crystal display element, this afterimage phenomenon (sintering) is a very important issue. In recent years, as the driving voltage has been lowered, liquid crystals having a large dielectric constant and a different dielectric constant have been used. However, in accordance with this tendency, a problem of uneven display (uneven brightness) occurs on the display surface. Since the sizing of the alignment film after honing may occur, the phenomenon is not removed and the water is washed. At this time, uneven display may occur due to residual washing marks, and this phenomenon is a major problem. 11 591056 9825 pif 1 The present invention provides a liquid crystal alignment agent, which is used to obtain among the various characteristics required by the aforementioned liquid crystal display elements, in particular, it has a better front tilt angle, liquid crystal alignment, and electrical characteristics (current consumption, voltage, voltage Liquid crystal display elements with better balance such as retention, residual charge, and sintering). Description of the Invention The present inventors have conducted research in order to solve the above problems, and as a result, the above-mentioned object can be achieved by using polyimide-imide in the following structure in a liquid crystal alignment agent varnish. . That is, the present invention has the following structure. < [1] Polyamidamine-imidoamine having a structural unit represented by formula (1-1) or a structural unit represented by formula (1-2) and formula (1-3), respectively.
Ο II C T2" XN-E^-- (1-2)Ο II C T2 " XN-E ^-(1-2)
(1-3) 上式中,所使用之記號係定義如下。 τ1、T2及T3係指來自羧酸類的有機殘基(missing 12 9825 pif 1 residue) 〇 D1、D2及D3係指來自二氨化合物的有機殘基。 其中,T1、T2、T3、D1、D2、D3中至少一個爲具有碳 數爲3以上之側鏈基的有機殘基。 R1、R2及R3係指分別獨立的氫或一價有機基。 此一價有機基係選自於碳數爲1〜20的烷基、碳數爲1 〜8的羥基烷基、碳數爲2〜20的烷氧烷基、碳數爲2〜15的 不飽和脂肪族基、具有脂環式基的基團、芳香族系碳氫基、 含有氧之雜環系基、具有巢骨架之基團、具有羰基之基團、 有機甲矽烷基、以及具有有機甲矽烷基的基團等所組成之 族群中。此類有機基含有之烷基及烷撐上之任意氫也可以 置換成氟。在芳香族碳氫基中,芳香環之任意氫也可以置 換成烷基、烷氧基或-CN。前述烷基及烷氧基之任意氫也可 以置換成氟。作爲一種芳香族碳氫基的芳烷基上之烷撐也 可以藉由氧原子而結合於芳香環上。而且,聚醯胺-亞醯胺 分子中之R1〜R3之總量之30莫爾%以上係爲一價之有機 基。 [2]在[1]項所記載之聚醯胺-亞醯胺中,來自二氨化合 物之有機殘基中至少一個係選自式(2)〜式(5)所分別表示 之基團所組成之族群。 13 591056 9825 pif 1(1-3) In the above formula, the symbols used are defined as follows. τ1, T2 and T3 refer to organic residues derived from carboxylic acids (missing 12 9825 pif 1 residue). D1, D2 and D3 refer to organic residues derived from diamine compounds. Among them, at least one of T1, T2, T3, D1, D2, and D3 is an organic residue having a side chain group having a carbon number of 3 or more. R1, R2 and R3 are each independently hydrogen or a monovalent organic group. This monovalent organic group is selected from alkyl groups having 1 to 20 carbon atoms, hydroxyalkyl groups having 1 to 8 carbon atoms, alkoxyalkyl groups having 2 to 20 carbon atoms, and Saturated aliphatic group, alicyclic group, aromatic hydrocarbon group, oxygen-containing heterocyclic group, group having nest skeleton, group having carbonyl group, organosilyl group, and organic Silyl groups. Any hydrogen contained in the alkyl group and alkylene group contained in such an organic group may be replaced with fluorine. In the aromatic hydrocarbon group, any hydrogen of the aromatic ring may be replaced with an alkyl group, an alkoxy group, or -CN. Any hydrogen of the aforementioned alkyl and alkoxy groups may be replaced with fluorine. Alkylene on an aralkyl group, which is an aromatic hydrocarbon group, can also be bonded to the aromatic ring through an oxygen atom. Moreover, 30 mol% or more of the total amount of R1 to R3 in the polyamidoamine-iminomine molecule is a monovalent organic group. [2] In the polyamidoamine-iminomine described in the item [1], at least one of the organic residues derived from the diamine compound is selected from the group consisting of groups represented by formulas (2) to (5) Group of people. 13 591056 9825 pif 1
在式(2)中所使用之記號係定義如下。 R4係指氫或碳數爲1〜12的烷基。The symbols used in the formula (2) are defined as follows. R4 means hydrogen or an alkyl group having 1 to 12 carbon atoms.
環A係指1,4·亞苯基(l,4_phenylene)或1,4-環己亞基 (l,4-cyclohexylene)。前述環之任意氫也可以置換成碳數爲1 〜4的烷基。 Z1及Z2係爲個別獨立之單鍵、-CH2-、-CH2CH2-或-0·。 r係爲0〜3之整數,s係爲0〜5之整數,tl係爲0〜3的 整數,而且t2係爲0〜3之整數。 然而,當tl爲2或3之情形時,多個的Z1可以爲相互間 相同的,也可以爲相互間不同的。當t2爲2或3之情形時, 多個的Z2可以爲相互間相同的,也可以爲相互間不同的。Ring A means 1,4 · phenylene (l, 4-phenylene) or 1,4-cyclohexylene. Arbitrary hydrogen in the ring may be substituted with an alkyl group having 1 to 4 carbon atoms. Z1 and Z2 are independent single bonds, -CH2-, -CH2CH2- or -0. r is an integer of 0 to 3, s is an integer of 0 to 5, tl is an integer of 0 to 3, and t2 is an integer of 0 to 3. However, when t1 is 2 or 3, a plurality of Z1 may be the same as each other, or may be different from each other. When t2 is 2 or 3, a plurality of Z2 may be the same as each other or may be different from each other.
(3) 在式(3)中,苯環中之游離基的位置係爲任意的。而且 此式中之記號係定義如下。 X1及X2係爲個別獨立之單鍵、-0-、-00-、-OCO-、 -NH-、-C0NH-或碳數爲1〜12的烷撐。 G1及G2係爲個別獨立之單鍵或含有1〜3個環的二價 基團。前述環係選自芳香族環及脂環式之環所構成之族群。 R5係指氫、氟、-CN、-0H、碳數爲1〜12的烷基、或 14 591056 释釋 9825 pif 1 碳數爲1〜12的烷氧基。此烷基之任意氫也可以置換成氟。 然而,當G2爲單鍵且X2不是單鍵也不是烷撐之情形 時,R5係爲氫或烷基。當G1及G2 —同爲單鍵時,X1、X2及 R5之總和碳數爲3以上。(3) In the formula (3), the position of the radical in the benzene ring is arbitrary. The symbols in this formula are defined as follows. X1 and X2 are individually independent single bonds, -0-, -00-, -OCO-, -NH-, -C0NH- or alkylenes having 1 to 12 carbon atoms. G1 and G2 are individually independent single bonds or divalent groups containing 1 to 3 rings. The ring system is selected from the group consisting of an aromatic ring and an alicyclic ring. R5 means hydrogen, fluorine, -CN, -0H, an alkyl group having 1 to 12 carbon atoms, or 14 591056. 9825 pif 1 alkoxy group having 1 to 12 carbon atoms. Any hydrogen of this alkyl group may be replaced with fluorine. However, when G2 is a single bond and X2 is not a single bond or an alkylene group, R5 is hydrogen or an alkyl group. When G1 and G2 are both single bonds, the total carbon number of X1, X2 and R5 is 3 or more.
在式(4)中,1,4-亞苯基之任意氫也可以置換成碳數爲1 〜4的烷基。而且,此式中之記號係定義如下。 X3及X4係爲個別獨立的單鍵、-ch2-、、ch2ch2-或-0-。 R6及R7係爲個別獨立的氫、碳數爲1〜12的烷基或碳 數爲1〜12的氣代院基。 ul及u2係爲個別獨立的〇〜3的整數。In formula (4), any hydrogen of 1,4-phenylene may be substituted with an alkyl group having 1 to 4 carbon atoms. The symbols in this formula are defined as follows. X3 and X4 are independent single bonds, -ch2-, ch2ch2-, or -0. R6 and R7 are each independently hydrogen, an alkyl group having 1 to 12 carbons, or a gas-substituted compound having 1 to 12 carbons. ul and u2 are independent integers of 0 to 3.
然而,R6及R7之至少一邊係爲碳數爲3以上的烷基或 碳數爲3以上的氟代烷基。當ul爲2或3之情形時,多個的X3 可以爲相互間相同的,也可以爲相互間不同的。當u2爲2或 3之情形時,多個的X4可以爲相互間相同的’也可以爲相互 間不同的。However, at least one of R6 and R7 is an alkyl group having 3 or more carbon atoms or a fluoroalkyl group having 3 or more carbon atoms. When ul is 2 or 3, multiple X3s may be the same as each other or different from each other. When u2 is 2 or 3, a plurality of X4 may be the same as each other or may be different from each other.
在式(5)中,相對於苯環之置換基及游離基之結合位置 係爲任意的。而且,此式中之記號係定義如下。 R8係爲氫或碳數爲1〜12之烷基。此院基中之任意 -CH2-也可以置換成-0-。 X5係指單鍵或碳數爲1〜5的烷撐。此烷撐中任意-CH2_ 15 591056 9825 pif 1 也可以置換成-〇-。 m爲0〜3的整數,η爲1〜5的整數。 [3] 在[1]或[2]項中所記載之聚醯胺-亞醯胺中’記載 於[1]項之式(1-1)中之R1以及記載於[1]項之式(I-2)中之r2 及R3係爲個別獨立的氫或碳數爲5以下之一價有機基’而且 分子中之R1〜R3之總量之50莫爾%以上係爲一價有機基。 [4] 在[3]項中所記載之聚醯胺-亞醯胺中,碳數爲5以 . 下之一價有機基係選自碳數爲5以下之烷基、碳數爲5以下 0 之羥基烷基及碳數爲5以下之烷氧烷基等所組成之基團,其 中分子中之R1〜R3之總量的70莫爾%以上係爲此碳數爲5 以下之一價有機基。 [5] 含有高分子化合物及溶劑且高分子化合物之比例 在以淸漆之全部重量爲基準之情形下係爲0.1重量%〜40重 量%的液晶配向劑淸漆,其中高分子化合物係爲N置換聚醯 胺-亞醯胺或N置換聚醯胺_亞醯胺及其他高分子的混合 物。然,此N置換聚醯胺-亞醯胺係爲[1]項所記載之聚醯胺― 亞醯胺,其他的高分子係選自聚醯胺酸、可溶性聚亞醯胺、 籲 聚醯胺及其他的聚醯胺_亞醯胺之族群所組成之族群中至 少選擇一個。 # [6] 含有高分子化合物及溶劑且高分子化合物之比例 * 在以淸漆之全部重量爲基準之情形下係爲〇· 1重量%〜4〇重 量%的液晶配向劑淸漆,其中高分子化合物係爲N置換聚醯 胺-亞醯胺或N置換聚醯胺·亞醯胺及其他高分子的混合 物。然,此N置換聚醯胺-亞醯胺係爲[2]項所記載之聚醯胺- 591056 9825 pifl 亞醯胺,其他的高分子係選自聚醯胺酸、可溶性聚亞醯胺、 聚醯胺及其他的聚醯胺-亞醯胺之族群所組成之族群中至 少選擇一個。 [7] 含有高分子化合物及溶劑且高分子化合物之比例 在以淸漆之全部重量爲基準之情形下係爲0.1重量%〜40重 量%的液晶配向劑淸漆,其中高分子化合物係爲N置換聚醯 胺-亞醯胺或N置換聚醯胺-亞醯胺及其他高分子的混合 物。然,此N置換聚醯胺-亞醯胺係爲[3]項所記載之聚醯胺-亞醯胺,其他的高分子係選自聚醯胺酸、可溶性聚亞醯胺、 聚醯胺及其他的聚醯胺-亞醯胺之族群所組成之族群中至 少選擇一個。 [8] 含有高分子化合物及溶劑且高分子化合物之比例 在以淸漆之全部重量爲基準之情形下係爲〇·1重量%〜40重 量%的液晶配向劑淸漆,其中高分子化合物係爲N置換聚醯 胺-亞醯胺或N置換聚醯胺-亞醯胺及其他高分子的混合 物。然,此N置換聚醯胺-亞醯胺係爲[4]項所記載之聚醯胺-亞醯胺,其他的高分子係選自聚醯胺酸、可溶性聚亞醯胺、 聚醯胺及其他的聚醯胺-亞醯胺之族群所組成之族群中至 少選擇一個。 [9] 一種液晶顯示元件,於一對透明基板上設置透明 電極,在此透明電極上形成液晶配向膜,藉由間隙材料將 此基板以面對面的方式組合之後,封入液晶材料而得到液 晶顯示元件。至少一個形成於基板上之液晶配向膜係爲使 用[5]〜[8]中任一項所記載之液晶配向劑淸漆所形成之液晶 17 591056 9825 pif 1 配向膜。 在上述結構巾,本賴;^_胺·麵_翻以形成 配向膜、賴腿緣酵的軸。龍是適腿作爲液晶 顯示元件用的配向劑淸漆的材料。而且,「其他的麵胺_ 亞醯胺」係麵本發明之軸外的_胺_亞醯胺。 較佳實施例之詳細說明 在本發明中,烷基、烷撐、烷氧基、羥基烷基、烷氧 烷基、及氟代烷基等可以爲直鏈基,也可以爲分枝基。在 以工之說明中,式(1_1)所表示之結構單位係以結構單位(M) 進行說明。式(I-2)所表示之結構單位係以結構單位(1-2)進 行說明。式(1-3)所表示之結構單位係以結構單位(1_3)進行 說明。具有碳數爲3以上之側鏈基的有機殘基係以較大之 側鏈的殘基進行說明。 本發明之聚醯胺-亞醯胺之第一特徵係爲具有結構單 位U — 1)的結構或是兼具有結構單位(1-2)及(1_3)的結構。具 有結構單位(1_1)的聚醯胺-亞醯胺也可以更包括結構單位 (1-2)及(1-3)中至少一個。第二特徵係爲至少有一個較大的 側鏈殘基。此較大側鏈之殘基也可以爲來自羧酸之殘基的 至少一個。此較大側鏈之殘基也可以爲來自二氨之殘基的 至少一個。此較大側鏈之殘基也可以兼具有來自羧酸之殘 基的至少一個及來自二氨之殘基的至少一個。而且,第三 特徵係爲醯胺鍵(-CONH-)之氫原子之部分或全部可被置換 成一價有機基。在以下之說明中,本發明之聚醯胺-亞醯胺 統稱爲N置換聚醯胺_亞醯胺。 591056----------- 9825 pifl ΟIn formula (5), the bonding position of the substituent and the radical with respect to the benzene ring is arbitrary. The symbols in this formula are defined as follows. R8 is hydrogen or an alkyl group having 1 to 12 carbon atoms. Any -CH2- in this courtyard can also be replaced with -0-. X5 refers to a single bond or an alkylene group having 1 to 5 carbon atoms. Any -CH2_ 15 591056 9825 pif 1 in this alkylene can also be replaced with -〇-. m is an integer of 0 to 3, and η is an integer of 1 to 5. [3] In the polyamidoamine-iminomine described in the item [1] or [2], R1 in the formula (1-1) of the item [1] and the formula described in the item [1] In (I-2), r2 and R3 are individually independent hydrogen or monovalent organic groups having a carbon number of 5 or less, and more than 50 mol% of the total amount of R1 to R3 in the molecule are monovalent organic groups. . [4] In the polyfluorenimidine-methyleneimide described in the item [3], the carbon number is 5 or less. The monovalent organic group is selected from an alkyl group having a carbon number of 5 or less and a carbon number of 5 or less. A group consisting of a hydroxyalkyl group of 0 and an alkoxyalkyl group having a carbon number of 5 or less. Among them, 70 mol% or more of the total amount of R1 to R3 in the molecule is a carbon number of 5 or less. Organic. [5] Liquid crystal alignment agent lacquer containing polymer compound and solvent and the proportion of polymer compound is 0.1% to 40% by weight based on the total weight of lacquer, wherein the polymer compound is N A mixture of substituted polyamidoamine-iminomine or N-substituted polyamidoamine-amidoamine and other polymers. However, the N-substituted polyamidoamine-iminomine system is the polyamidoamine-iminomine described in item [1], and the other polymer systems are selected from polyamic acid, soluble polyimide, and polyamidamine. Choose at least one of the groups consisting of amines and other polyamidoamines. # [6] Contains high molecular compounds and solvents and the proportion of high molecular compounds * In the case of the total weight of the lacquer as the basis, it is 0.1% to 40% by weight of the liquid crystal alignment agent lacquer, which is high The molecular compound is a mixture of N-substituted polyamidoamine-iminomine or N-substituted polyamidoamine-iminomine and other polymers. However, the N-substituted polyamidamine-imidamine system is polyamidine-591056 9825 pifl imidazine described in item [2], and other polymer systems are selected from polyamic acid, soluble polyimide, Select at least one group of polyamidamine and other polyamidamine-amidamine groups. [7] Liquid crystal alignment agent lacquer containing polymer compound and solvent and the proportion of polymer compound is 0.1% to 40% by weight based on the total weight of lacquer, wherein the polymer compound is N Mixtures of polyamidoamine-iminomine or N-substituted polyamidoamine-iminomine and other polymers. However, the N-substituted polyamidamine-amidamine system is the polyamidamine-amidamine described in item [3], and the other polymer systems are selected from polyamic acid, soluble polyimide, and polyamidamine. And at least one of the polyamidamine-amidamine groups. [8] A liquid crystal alignment agent lacquer containing a polymer compound and a solvent and the proportion of the polymer compound based on the total weight of the lacquer is 0.1% to 40% by weight, in which the polymer compound is It is a mixture of N-substituted polyamidoamine-iminomine or N-substituted polyamidoamine-iminomine and other polymers. However, the N-substituted polyamidamine-amidamine system is the polyamidamine-amidamine described in item [4], and the other polymer systems are selected from polyamic acid, soluble polyimide, and polyamidamine. And at least one of the polyamidamine-amidamine groups. [9] A liquid crystal display element, a transparent electrode is provided on a pair of transparent substrates, a liquid crystal alignment film is formed on the transparent electrodes, and the substrate is combined face-to-face with a gap material, and then a liquid crystal material is sealed to obtain a liquid crystal display element . At least one liquid crystal alignment film formed on the substrate is a liquid crystal 17 591056 9825 pif 1 alignment film formed using the liquid crystal alignment agent paint described in any one of [5] to [8]. In the above-mentioned structure towel, the base is turned to form an alignment film and a shaft of a leg leaven. Dragon is a material suitable for lacquering as an alignment agent for liquid crystal display elements. In addition, "another amine_iminomine" refers to _amine_iminomine which is outside the axis of the present invention. Detailed description of the preferred embodiment In the present invention, the alkyl group, alkylene group, alkoxy group, hydroxyalkyl group, alkoxyalkyl group, and fluoroalkyl group may be a linear group or a branched group. In the description of construction, the structural unit represented by the formula (1_1) is described by the structural unit (M). The structural unit represented by the formula (I-2) is described in terms of the structural unit (1-2). The structural unit represented by the formula (1-3) is described in the structural unit (1_3). An organic residue having a side chain group having a carbon number of 3 or more will be described as a residue with a larger side chain. The first feature of the polyamidoamine-iminomine of the present invention is a structure having a structural unit U-1) or a structure having both structural units (1-2) and (1-3). The polyamidoamine-iminomine having the structural unit (1_1) may further include at least one of the structural units (1-2) and (1-3). The second feature is at least one large side chain residue. The residue of this larger side chain may also be at least one residue from a carboxylic acid. The residues of this larger side chain may also be at least one residue from a diamine. The residue of this larger side chain may also have at least one residue from a carboxylic acid and at least one residue from a diamine. Moreover, the third feature is that a part or all of the hydrogen atoms of the amine bond (-CONH-) may be replaced with a monovalent organic group. In the following description, the polyamidoamine-iminomine of the present invention is collectively referred to as N-substituted polyamidoamine-iminomine. 591056 ----------- 9825 pifl Ο
(1-1)(1-1)
(1-2)(1-2)
式(1-1)中之T1係指來自三元羧酸類的有機殘基。式 (1-2)中之Τ2係指來自二羧酸類的有機殘基。式(1-3)中之 Τ3係指來自四羧酸類的有機殘基。而且,D1〜D3係指所謂 之來自二胺的有機基。又,在本發明中之用辭「二羧酸類」 係爲包括二羧酸、二羧酸無水化合物、及二羧酸之氧鹵代 化合物等之總稱。三元羧酸類及四羧酸類也具有相同之含 義。而且,多價之羧酸類係爲二羧酸類、三元羧酸類及四 羧酸類的總稱。此多價羧酸類也可以屬於芳香族系(含雜 環)、脂環式系(含雜環)及脂肪族系(非環狀)。而且, 具有環狀結構之多價羧酸類係可保持較佳之液晶配向性。 因此,當使用脂肪族系(非環狀)之物質之際,此指環族 系或芳香族系也可以同時使用,而其使用量可控制在對液 晶配向性不會造成不良影響之範圍內。另外,τ1〜τ3較佳 係爲結構中不含有醚、酯、硫醚、硫酯等一般性基團的結 19 591056 9825 pif 1 構的物質。其理由是,此類基團係爲造成液晶顯示元件之 電特性降低的原因。但,即使具有前述結構,只要在不對 電特性造成影響的限度下,就沒有問題。 本發明所使用之二羧酸類之實例可區分成脂肪族二 羧酸類、脂環式二羧酸類及芳香族二羧酸類,詳述如下所 示0 脂肪族二羧酸類例如是丙二酸雙鹵化物、草酸雙鹵化 物、二甲基丙二酸雙鹵化物、丁二酸雙鹵化物、反式丁烯 二酸雙鹵化物、戊二酸雙鹵化物、己二酸雙鹵化物、己二 烯二酸雙鹵化物、2-甲基己二酸雙鹵化物、三甲基己二酸 雙鹵化物、庚二酸雙鹵化物、2,2-二甲基戊二酸雙鹵化物、 3,3-二乙基丁二酸雙鹵化物、壬二酸雙鹵化物、癸二酸雙鹵 化物、辛二酸雙鹵化物等。 脂環式二羧酸例如是1,1_環丙烷二羧酸雙鹵化物、1,2-環丙烷二羧酸雙鹵化物、1,1_環丁烷二羧酸雙鹵化物、1,2-環丁烷二羧酸雙鹵化物、1,3-環丁烷二羧酸雙鹵化物、3,4-二苯基-1,2-環丁烷二羧酸雙鹵化物、2,4-二苯基-1,3-環丁烷 二羧酸雙鹵化物、3,4-雙(羥基苯基)-1,2-環丁烷二羧酸雙 鹵化物、2,4-雙(羥基苯基)-1,3-環丁烷二羧酸雙鹵化物、 1-環丁烯-1,2-二羧酸雙鹵化物、1-環丁烯-3,4-二羧酸雙鹵化 物、1,1-環戊烷二羧酸雙鹵化物、1,2-環戊烷二羧酸雙鹵化 物、1,3-環戊烷二羧酸雙鹵化物、1,1-環己烷二羧酸雙鹵化 物、1,2-環己烷二羧酸雙鹵化物、1,3-環己烷二羧酸雙鹵化 物、M-環己烷二羧酸雙鹵化物、1,4- (2-二環庚烯)二羧 20 591056 9825 pif 1 酸雙鹵化物、二環庚烯-2,3-二羧酸雙鹵化物、二環[2.2.2] 辛烷-M-二羧酸雙鹵化物、二環[2.2.2]辛烷-2,3-二羧酸雙 鹵化物、2,5-二氧代-1,4-二環[2.2.2]辛烷二羧酸雙鹵化物、 1,3-金剛烷二羧酸雙鹵化物、4,8-二氧代-1,3-金剛烷二羧酸 雙鹵化物、2,6-螺[3.3]庚烷二羧酸雙鹵化物、1,3-金剛烷二 乙酸雙鹵化物、樟腦酸雙鹵化物等。 芳香族二羧酸類例如是鄰苯二甲酸雙鹵化物、間苯二 _ 甲酸雙鹵化物、對苯二甲酸雙鹵化物、5-甲基間苯二甲酸 0 雙鹵化物、5-叔-丁基間苯二甲酸雙鹵化物、5-氨間苯二甲 酸雙鹵化物、5-羥基間苯二甲酸雙鹵化物、2,5-二甲基對苯 二甲酸雙鹵化物、四甲基對苯二甲酸雙鹵化物、1,4-萘二羧 酸雙鹵化物、2,5-萘二羧酸雙鹵化物、2,6-萘二羧酸雙鹵化 物、2,7-萘二羧酸雙鹵化物、1,4-蒽二羧酸雙鹵化物、1,4-蒽醌二羧酸雙鹵化物、2,5-聯苯二羧酸雙鹵化物、4,4’-聯苯 二羧酸雙鹵化物、1,5-聯苯撐二羧酸雙鹵化物、4,4”-聯三 苯二羧酸雙鹵化物、4,4’-二苯基甲烷二羧酸雙鹵化物、4,4’-二苯基乙烷二羧酸雙鹵化物、4,4-二苯基丙烷二羧酸雙鹵化 籲 物、4,4’-二苯基六氟丙烷二羧酸雙鹵化物、4,4’-二苯基醚 二羧酸雙鹵化物、4,4’-聯苄二羧酸雙鹵化物、4,4’-芪二羧 酸雙鹵化物、4,4’-二苯乙炔二羧酸雙鹵化物、4,4’-羰基二 ' 苯甲酸雙鹵化物、4,4’-硫醯二苯甲酸雙鹵化物、4,4’-二硫 代二苯甲酸雙鹵化物、對苯二乙酸雙鹵化物、3,3’-對苯二 丙酸雙鹵化物、4-羧基肉桂酸雙鹵化物、對苯二丙烯酸雙 鹵化物、3,3’-(4,4’-(甲撐二對苯))二丙酸雙鹵化物、4,4’- 21 591056 (WipMIU y,, 9825 pifl (4,4’·(羥基二對苯))二丙酸雙鹵化物、4,4,_ (4,4,-(羥 基二對苯))二丁酸雙鹵化物、(異丙叉二對苯二羥基)二 丁酸雙鹵化物、雙(對羧基)二甲基矽烷、1,5-(9-氧代芴) 二竣酸雙鹵化物、3,4-咲喃二殘酸雙鹵化物、4,5-噻唑二殘 酸雙鹵化物、2-苯基-4,5-噻唑二羧酸雙鹵化物、噻二 唑-3,4-二羧酸雙鹵化物、1,2,5-噁二唑_3,4_二羧酸雙鹵化 物、2,3_吡嗪二羧酸雙鹵化物、2,4-吡嗪二羧酸雙鹵化物、 2,5-吡嗪二殘酸雙鹵化物、2,6-吡嗪二羧酸雙鹵化物、3,4-吡嗪二羧酸雙鹵化物、3,5-吡嗪二羧酸雙鹵化物、3,6-吡嗦 二羧酸雙鹵化物等。 本發明所使用之二羧酸類並不以上述之二羧酸雙鹵 化物爲限。當T2爲提供此有機殘基之物質時,也可以使用 雙鹵化物以外之二羧酸衍生物。在此,二羧酸衍生物例如 是活性醯基衍生物。例如:二羧酸雙鹵化物之鹵素之替代 物可改用乙醯基氧基、烷基氧基、苯基氧基或由苯硫基等 基結合而得之二羧酸衍生物等。更甚之,不僅是衍生物, 也可以使用其他的二羧酸(具有2個-COOH的化合物)之 物質。而且,本發明所使用之二羧酸類,爲了避免對液晶 配向性造成影響,較佳係爲形成有直鏈狀結構之聚醯胺-亞 醯胺的二羧酸類。此較佳之二羧酸類例如是1,4_環己烷二 羧酸雙鹵化物、對苯二甲酸雙鹵化物、間苯二甲酸雙鹵化 物、吡嗪二羧酸雙鹵化物、萘二羧酸雙鹵化物、1,4_蒽二羧 酸雙鹵化物、4,4’-聯苯二羧酸雙鹵化物、4,4”-叔-苯二羧酸 雙鹵化物、4,4’-二苯甲烷二羧酸雙鹵化物、4,4’-二苯乙烷 22 591056 9825 pifl 二羧酸雙鹵化物、4,4’-二苯丙烷二羧酸雙鹵化物、4,4’-二 苯六氟丙烷二羧酸雙鹵化物、4’-二苯醚二羧酸雙鹵化物 等。可給予與此類化合物相同之殘基的化合物,也可以使 用此類二羧酸雙鹵化物以外之種類之二羧酸衍生物。 再者,當以提高對基板之聚醯胺-亞醯胺之接著性爲目 的時,也可以改用式(6)所示之聚矽氧烷二羧酸雙鹵化物或 可給予相同之殘基且酸雙鹵化物以外之活性醯基衍生物。 在此情形下,也可以使用式(6)中之X更換爲氫的化合物。T1 in formula (1-1) refers to an organic residue derived from a tricarboxylic acid. T2 in formula (1-2) refers to an organic residue derived from a dicarboxylic acid. T3 in formula (1-3) means an organic residue derived from a tetracarboxylic acid. D1 to D3 refer to so-called diamine-derived organic groups. The term "dicarboxylic acids" used in the present invention is a general term including dicarboxylic acids, dicarboxylic anhydrides, and oxyhalo compounds of dicarboxylic acids. Tricarboxylic acids and tetracarboxylic acids have the same meaning. The polyvalent carboxylic acids are a general term for dicarboxylic acids, tricarboxylic acids, and tetracarboxylic acids. These polyvalent carboxylic acids may also belong to aromatic systems (containing heterocyclic rings), alicyclic systems (containing heterocyclic rings), and aliphatic systems (non-cyclic). In addition, the polyvalent carboxylic acids having a cyclic structure can maintain good liquid crystal alignment. Therefore, when using aliphatic (non-cyclic) materials, this ring or aromatic system can be used at the same time, and the amount used can be controlled within a range that will not adversely affect the liquid crystal alignment. In addition, τ1 to τ3 are preferably those having a structure that does not contain general groups such as ether, ester, thioether, and thioester. 19 591056 9825 pif 1 structure. The reason is that such groups are the cause of the decrease in the electrical characteristics of the liquid crystal display element. However, even with the aforementioned structure, there is no problem as long as it does not affect the electrical characteristics. Examples of the dicarboxylic acids used in the present invention can be divided into aliphatic dicarboxylic acids, alicyclic dicarboxylic acids and aromatic dicarboxylic acids. The details are shown below. 0 Aliphatic dicarboxylic acids are, for example, malonic dihalides. Product, oxalic acid dihalide, dimethylmalonic acid dihalide, succinic acid dihalide, trans-butenedioic acid dihalide, glutaric acid dihalide, adipic acid dihalide, adipate Diene dihalide, 2-methyladipate dihalide, trimethyladipate dihalide, pimelic acid dihalide, 2,2-dimethylglutarate dihalide, 3 , 3-diethylsuccinic acid dihalide, azelaic acid dihalide, sebacic acid dihalide, suberic acid dihalide, and the like. The alicyclic dicarboxylic acid is, for example, 1,1-cyclopropanedicarboxylic acid dihalide, 1,2-cyclopropanedicarboxylic acid dihalide, 1,1-cyclobutanedicarboxylic acid dihalide, 1, 2-cyclobutanedicarboxylic acid dihalide, 1,3-cyclobutanedicarboxylic acid dihalide, 3,4-diphenyl-1,2-cyclobutanedicarboxylic acid dihalide, 2, 4-diphenyl-1,3-cyclobutanedicarboxylic acid dihalide, 3,4-bis (hydroxyphenyl) -1,2-cyclobutanedicarboxylic acid dihalide, 2,4-bis (Hydroxyphenyl) -1,3-cyclobutanedicarboxylic acid dihalide, 1-cyclobutene-1,2-dicarboxylic acid dihalide, 1-cyclobutene-3,4-dicarboxylic acid Dihalide, 1,1-cyclopentanedicarboxylic acid dihalide, 1,2-cyclopentanedicarboxylic acid dihalide, 1,3-cyclopentanedicarboxylic acid dihalide, 1,1- Cyclohexanedicarboxylic acid dihalide, 1,2-cyclohexanedicarboxylic acid dihalide, 1,3-cyclohexanedicarboxylic acid dihalide, M-cyclohexanedicarboxylic acid dihalide, 1,4- (2-bicycloheptene) dicarboxylic acid 20 591056 9825 pif 1 acid dihalide, dicycloheptene-2,3-dicarboxylic acid dihalide, bicyclo [2.2.2] octane- M-dicarboxylic acid dihalide, bicyclo [2.2.2] octane-2,3-di Carboxylic acid dihalide, 2,5-dioxo-1,4-bicyclo [2.2.2] octane dicarboxylic acid dihalide, 1,3-adamantane dicarboxylic acid dihalide, 4,8 -Dioxo-1,3-adamantane dicarboxylic acid dihalide, 2,6-spiro [3.3] heptane dicarboxylic acid dihalide, 1,3-adamantane diacetic acid dihalide, camphoric acid dihalide Halides, etc. Aromatic dicarboxylic acids are, for example, phthalic acid dihalide, isophthalic acid dihalide, terephthalic acid dihalide, 5-methylisophthalic acid 0 dihalide, 5-tert-butyl Diisophthalic acid dihalide, 5-aminoisophthalic acid dihalide, 5-hydroxyisophthalic acid dihalide, 2,5-dimethylterephthalic acid dihalide, tetramethylparahalide Phthalic acid dihalide, 1,4-naphthalenedicarboxylic acid dihalide, 2,5-naphthalenedicarboxylic acid dihalide, 2,6-naphthalenedicarboxylic acid dihalide, 2,7-naphthalenedicarboxylic acid Acid dihalide, 1,4-anthracene dicarboxylic acid dihalide, 1,4-anthraquinone dicarboxylic acid dihalide, 2,5-biphenyldicarboxylic acid dihalide, 4,4'-biphenyl Dicarboxylic acid dihalides, 1,5-biphenylene dicarboxylic acid dihalides, 4,4 "-biphenyldicarboxylic acid dihalides, 4,4'-diphenylmethanedicarboxylic acid dihalides Compounds, 4,4'-diphenylethanedicarboxylic acid dihalides, 4,4-diphenylpropanedicarboxylic acid dihalides, 4,4'-diphenylhexafluoropropanedicarboxylic acid bis Halide, 4,4'-diphenyl ether dicarboxylic acid dihalide, 4,4'-bibenzyl dicarboxylic acid dihalide, 4,4'-stilbene Acid dihalide, 4,4'-diphenylacetylene dicarboxylic acid dihalide, 4,4'-carbonyldi'benzoic acid dihalide, 4,4'-thithiodibenzoic acid dihalide, 4, 4'-dithiodibenzoic acid dihalide, terephthalic acid dihalide, 3,3'-terephthalic acid dihalide, 4-carboxycinnamic acid dihalide, terephthalic acid dihalide Compounds, 3,3 '-(4,4'-(methylene diphenylene)) dipropionate dihalide, 4,4'- 21 591056 (WipMIU y ,, 9825 pifl (4,4 '· (hydroxyl Di-p-benzene)) dipropionate dihalide, 4,4, _ (4,4,-(hydroxydi-p-phenylene)) dibutyric acid dihalide, (isopropylidene diphenylene dihydroxy) dibutyric acid Dihalides, bis (p-carboxyl) dimethylsilane, 1,5- (9-oxofluorene) dihalide dihalides, 3,4-pyrano diresidue dihalides, 4,5-thiazoles Di-residual acid dihalide, 2-phenyl-4,5-thiazoledicarboxylic acid dihalide, thiadiazole-3,4-dicarboxylic acid dihalide, 1,2,5-oxadiazole_3 2,4-dicarboxylic acid dihalide, 2,3-pyrazine dicarboxylic acid dihalide, 2,4-pyrazine dicarboxylic acid dihalide, 2,5-pyrazine diresidic acid dihalide, 2 , 6-pyrazine dicarboxylate Acid dihalide, 3,4-pyrazinedicarboxylic acid dihalide, 3,5-pyrazinedicarboxylic acid dihalide, 3,6-pyridinedicarboxylic acid dihalide, etc. Used in the present invention Dicarboxylic acids are not limited to the dicarboxylic acid dihalides described above. When T2 is a substance that provides this organic residue, dicarboxylic acid derivatives other than dihalides can also be used. Here, dicarboxylic acid derivatives For example, the active fluorenyl derivative. For example, the dihalide of the dicarboxylic acid dihalide can be replaced by ethenyloxy, alkyloxy, phenyloxy or phenylthio. Dicarboxylic acid derivatives and the like. Furthermore, not only derivatives but also other dicarboxylic acids (compounds having 2 -COOH) can be used. In addition, in order to avoid affecting the alignment of the liquid crystal, the dicarboxylic acids used in the present invention are preferably a dicarboxylic acid having a linear structure of polyamidamine-imideneamine. The preferred dicarboxylic acids are, for example, 1,4-cyclohexanedicarboxylic acid dihalide, terephthalic acid dihalide, isophthalic acid dihalide, pyrazinedicarboxylic acid dihalide, naphthalenedicarboxylic acid. Acid dihalide, 1,4-anthracene dicarboxylic acid dihalide, 4,4'-biphenyldicarboxylic acid dihalide, 4,4 "-tert-benzenedicarboxylic acid dihalide, 4,4 ' -Diphenylmethanedicarboxylic acid dihalide, 4,4'-diphenylethane 22 591056 9825 pifl dicarboxylic acid dihalide, 4,4'-diphenylpropanedicarboxylic acid dihalide, 4,4 ' -Diphenylhexafluoropropane dicarboxylic acid dihalide, 4'-diphenyl ether dicarboxylic acid dihalide, etc. Compounds which can give the same residues as such compounds can also be used. Dicarboxylic acid derivatives other than substances. In addition, for the purpose of improving the adhesion between polyamidoamine and iminomine to the substrate, the polysiloxane of formula (6) may be used instead. A carboxylic acid dihalide or an active fluorenyl derivative other than an acid dihalide which can give the same residue. In this case, a compound in which X in formula (6) is replaced with hydrogen may also be used.
⑹ 在式(6)中所示之記號定義如下。 R9及R1Q係指個別獨立的甲基、乙基、苯基、或環己 X係指鹵素。 V、W及X係指個別獨立的1〜5的整數。记 The symbols shown in formula (6) are defined as follows. R9 and R1Q refer to each independently methyl, ethyl, phenyl, or cyclohexyl. X refers to halogen. V, W, and X refer to independent integers of 1 to 5.
本發明之N置換聚醯胺-亞醯胺係具有至少一個較大之 側鏈之殘基。而且’當使用此類$ N置換聚麵·亞酿胺時, 可以得到液晶中賤大之__配_。賊大之側鍵 之殘基也可以藉_用式⑺示之三雜雙画化 物而導人。可給予馳_之殘_化合_可以改用酸 隹^齒化物以外之職_衍_。更甚之,也可以改用將 前述式中之X更換成氫的化合物。 23 591056 9825 pifl X-^-\ x^Rn ⑺ x—οΛ==/The N-substituted polyamidoamine-iminomine system of the present invention has at least one large side chain residue. Moreover, when using such $ N to replace polyhedral and iminoamine, it is possible to obtain a low-value __ compound_ in liquid crystal. The residue of the side bond of the thief can also be guided by the three miscellaneous double-painted objects shown by the formula. Can be given to Chi_ 的 残 _ 化合 _ can be used instead of acid _ ^ dents _ Yan_. Furthermore, a compound in which X in the foregoing formula is replaced with hydrogen may be used instead. 23 591056 9825 pifl X-^-\ x ^ Rn ⑺ x—οΛ == /
II ο 在式(7)中,相對於苯環之-COX之結合位置係爲任意 的。而且,此式中之記號係定義如下。 式(7)中之記號係定義如下。 X6 係指單鍵、-0_、-COO-、_OCO_、-NH-、-NHCO-、 -CONH-、-S_或碳數爲1〜6的烷撐。 X係指鹵素,較佳係爲氯或溴。 R11係指碳數爲3〜20之烷基、碳數爲3〜20之氟代 烷基或是具有置換基的巢基。巢骨架例如是膽巢基、雄巢 基、β膽巢基、表雄巢基、Ergosteryl、雌巢基、11α-經基 甲基巢基、11α黃體巢基、羊毛巢基、Methyltestostery卜II ο In formula (7), the bonding position of -COX with respect to the benzene ring is arbitrary. The symbols in this formula are defined as follows. The symbols in the formula (7) are defined as follows. X6 means a single bond, -0_, -COO-, _OCO_, -NH-, -NHCO-, -CONH-, -S_ or an alkylene group having 1 to 6 carbon atoms. X means halogen, preferably chlorine or bromine. R11 means an alkyl group having 3 to 20 carbon atoms, a fluoroalkyl group having 3 to 20 carbon atoms, or a nested group having a substituent. Nesting skeletons are, for example, biliary, basal, β-biliary, epistasal, Ergosteryl, estrogen, 11α-mesomethyl, 11α luteal nest, wool nest, Methyltestostery.
Norethisteryl、孕巢基、β谷巢基、丑巢基、Test〇steryl、乙 酸膽巢醇酯等。Norethisteryl, gestational base, β-granular base, ugly nest base, Testosteryl, cholicol acetate
在式(8)中,相對於苯環之-C0X之結合位置係爲任意 的。而且,此式中之記號係定義如下。 R12及R13係指個別獨立的碳數爲1〜12的烷基,且 R12及R13之碳數合計爲4以上。 X係指鹵素,較佳係爲氯或溴。 本發明中所使用之二竣酸類,並不以上述化合物爲 24 591056 9825 pif 1 限,也可以組合使用前述二種以上的化合物。 接著,對本發明所使用之三元羧酸類進行說明,其具In formula (8), the bonding position of -C0X with respect to the benzene ring is arbitrary. The symbols in this formula are defined as follows. R12 and R13 refer to individual alkyl groups having 1 to 12 carbon atoms, and the total carbon number of R12 and R13 is 4 or more. X means halogen, preferably chlorine or bromine. The dibasic acids used in the present invention are not limited to the above compounds as 24 591056 9825 pif 1, and two or more of the foregoing compounds may be used in combination. Next, the tricarboxylic acids used in the present invention will be described.
在上述各式中,X係指鹵素,較佳係爲氯或溴。 用以製造本發明之N置換聚醯胺-亞醯胺的三元羧 酸,只需爲於T1中給予此有機殘基的化合物即可,因此並 不以上述之三元羧酸酐鹵化物爲限。另外,也可以使用鹵 化物之外之活性醯基衍生物,其實例爲三元羧酸酐鹵化物 之鹵素之替代物可改用乙醯基氧基、烷基氧基、苯基氧基 25 9825 pif 1 或由苯硫基等基結合而得之三元羧酸衍生物等。更甚之, 也可以使用三元羧酸中2個羧基爲脫水聚合之酸酐結構且 殘留之1個則爲僅有羧基的化合物或含有三元羧酸(具有3 個-COOH的化合物)等。其中,較佳係使用式(9)之偏苯 三酸酐鹵化物。再者,此三元羧酸類也可組合使用前述兩 種以上的化合物。 本發明所使用之四羧酸類之一部份實例可區分成脂 環式系四羧酸類、脂肪族系四羧酸類及芳香族系四羧酸 類,詳述如下所示。 脂環式系四羧酸類例如是1,2,3,4-環丁烷四羧酸二酸 酐、1,2,3,4-環戊烷四羧酸二酸酐、1,2,5,6-環己烷四羧酸二 酸酐、二環(2,2,2)-辛⑺烯烴-2,3,5,6-四羧酸二酸酐3,3’-聯 二環己烷-1,1’,2,2’-四羧酸二酸酐、2,3,5-三羧基環戊基乙酸 二酸酐、5- (2,5-二氧代四氫化呋喃甲叉基)-3-甲基-3-環 己烯-1,2-二羧酸二酸酐、1,3,3&,4,5,91)-六氫-5-(四氫-2,5_ —^氧代-3-咲喃基)-萘[l,2,-c]-咲喃-1,3-一嗣、3,5,6-三竣基 二環庚烷-2-乙酸酐、2,3,4,5-四氫呋喃四羧酸二酸酐等。而 且,也可以爲以甲基、乙基等低級烷基置換部分結合於此 化合物之環之氫的化合物。 脂肪族系四羧酸類例如是乙烯四羧酸二酸酐、丁烷四 羧酸二酸酐、戊烷四羧酸二酸酐、己烷四羧酸二酸酐、庚 烷四羧酸二酸酐等。 芳香族系四羧酸類例如是焦苯六甲酸二酸酐、 26 591056 9825 pif 1 3,3’,4,4’-二苯四羧酸二酸酐、3,3’,4,4’-苯醯苯四羧酸二酸 酐、2,3,6,7-萘酸二酸酐、3,3’,4,4’-聯苯楓四羧酸二酸酐、 3,3’,4,4’-聯苯醚四羧酸二酸酐、3,3’,4,4’-二甲基二苯矽烷 四羧酸二酸酐、4,4’-雙(3,4-二羧基苯氧基)二苯基硫醚二 酸酐、4,4’-雙(3,4-二羧基苯氧基)二苯基楓二酸酐、4,4’-雙(3,4-二羧基苯氧基)二苯基丙烷二酸酐、3,3’,4,4’-聯苯 四羧酸二酸酐、雙(鄰苯二甲酸)苯基亞磺氧化物酸酐、 , 對苯雙(三苯基對苯二甲酸)二酸酐、間苯雙(三苯基對 φ 苯二甲酸)二酸酐、雙(三苯基對苯二甲酸)_4,4’_二苯醚 二酸酐、雙(三苯基對苯二甲酸)_4,4’_二苯甲烷二酸酐等。 上述中較佳之四羧酸類係爲環丁烷四羧酸二酸酐、環 戊烷四羧酸二酸酐、三羧基環戊基乙酸二酸酐、環己烷四 羧酸二酸酐、丁烷四羧酸二酸酐、以及焦苯六甲酸二酸酐。 用以製造本發明之N置換聚醯胺-亞醯胺的四羧酸,只需爲 於T2中給予此有機殘基的化合物即可,因此並不以上述之 四羧酸二酸酐爲限。即,也可以使用除了二酸酐以外之種 類的四羧酸類。此實例之一種例如是將四羧酸中之2個羧 籲 基脫水縮合成酸酐且將殘留之羧基之氫以鹵素、乙醯基氧 _ 基、烷基氧基、苯基氧基或苯硫基等基置換的衍生物。更 進一步之1個實例係爲將四羧酸中之4個羧基之氫全部以 ‘ 鹵素、乙醯基氧基、烷基氧基、苯基氧基或苯硫基等基置 換的衍生物。更甚之,不僅是衍生物,也可以改用含有四 羧酸(具有4個-COOH之化合物的物質。而且也可以組合 使用含前述四羧酸類2種以上之物質。 27 9825 pif 1 在前述中,本發明之N置換聚醯胺-亞醯胺係具有至 少一個較大之側鏈的殘基。而且,此較大之側鏈的殘基可 以爲來自羧酸的有機殘基,也可以爲來自二胺之有機殘 基,或是兼具兩者。即,在含有結構單位(1-1)且不含有結 構單位(1-2)及結構單位(1-3)的N置換聚醯胺-亞醯胺中,T1 及D1之至少一個係具有較大側鏈的殘基。而且,較佳係爲 D1具有較大側鏈的殘基,更甚之,也可以爲T1及D1同時 具有較大側鏈的殘基。 在含有結構單位(1-1)及結構單位(1-2)之N置換聚醯 胺-亞醯胺中,T1、T2、D1及D2中至少一個必需具有較大 側鏈的殘基。而且,較佳係爲D1及D2中至少一個具有較 大側鏈的殘基。更甚之,當D1及D2中至少一個具有較大 側鏈的殘基時,T2也具有較大側鏈的殘基。 在含有結構單位(1-1)及結構單位(1-3)之N置換聚醯 胺-亞醯胺中,T1、T3、D1及D3中至少一個必需具有較大 側鏈的殘基。而且,較佳係爲D1及D3中至少一個具有較 大側鏈的殘基。 在含有結構單位(1-2)及結構單位(1-3)之N置換聚醯 胺-亞醯胺中,T2、T3、D2及D3中至少一個必需具有較大 側鏈的殘基。而且,較佳係爲D2及D3中至少一個具有較 大側鏈的殘基。更甚之,當D2及D3中至少一個具有較大 側鏈的殘基時,T2也具有較大側鏈的殘基。 在含有結構單位(1-1)、結構單位(1-2)及結構單位(1-3) 之N置換聚醯胺-亞醯胺中,T1、T2、T3、D1、D2及D3中 28 591056- 9825 pifl 至少一個必需具有較大側鏈的殘基。而且,較佳係爲D1〜 D3中至少一個具有較大側鏈的殘基。更甚之,當D1〜D3 中至少一個具有較大側鏈的殘基時,T2也具有較大側鏈的 殘基。 用於本發明之N置換聚醯胺-亞醯胺之製造的二胺化 合物也與前述羧酸類相同,可分屬於芳香族系(包括雜環 系)、脂環系(包括雜環)及脂肪族系(非環狀)等。而且, . 爲了保持良好之液晶配向性,較佳係爲具有環結構的二胺 φ 化合物。 此二胺化合物一般而言較佳係爲結構中不含有醚、 酯、硫醚、硫酯等一般性基團的結構的物質。其理由是, 此類基團係爲造成液晶顯示元件之電特性降低的原因。 但,即使具有前述結構,只要在不對電特性造成影響的限 度下,就沒有問題。 當製造本發明之N置換聚醯胺-亞醯胺之際,在所使 用之羧酸類爲可提供較大側鏈的殘基之情形下,可以使用 無側鏈之二胺化合物。然而,較佳係同時使用具有碳數爲3 · 以上之側鏈基的羧酸類以及具有碳數爲3以上之側鏈基的 二胺化合物。再者,當沒有使用具有碳數爲3以上之側鏈 > 基的羧酸類之情形下,必需使用具有碳數爲3以上之側鏈 ' 基的二胺化合物。在此情形下,碳數爲3以上之側鏈基例 如是脂肪族系碳氫基、含有脂環式結構的碳氫基、含有芳 香族的碳氫基、具有矽氧烷基的基團、具有巢骨架的基團 或是混合有前述結構的側鏈基等。脂環式碳氫基或芳香族 29 591056 9825 pifl 碳氫基也可以具有烷基、烷氧基、鹵素、〇H等的置換基。 此類碳氫基之結構之一部份也可以置換成氧等其他原子。 但是,較佳係不要含有-S-、-CO·、-COO-或-SOO-等基團。 側鏈基之碳數在含有環己烷等環狀結構之情形下,係表示 含有構成此環之碳的數目。 具有碳數爲3以上之側鏈基的二胺化合物之較佳實例 係爲可提供式(2)〜式(5)所分別表示之有機殘基的化合 物。此類之化合物較佳係用於本發明之N置換聚醯胺-亞醯 胺之製造中。而且,在本發明之N置換聚醯胺-亞醯胺中, 較佳係含有自上述有機殘基之族群中至少選擇一個的殘 基。In each of the above formulae, X means halogen, preferably chlorine or bromine. The tricarboxylic acid used to produce the N-substituted polyamidoamine-iminomine of the present invention need only be a compound that gives this organic residue in T1, so the above-mentioned tricarboxylic acid anhydride halide is not used as limit. In addition, active fluorenyl derivatives other than halides can also be used, examples of which are trivalent carboxylic acid anhydride halides. Halogen substitutes can be replaced with ethenyloxy, alkyloxy, phenyloxy 25 9825 pif 1 or a tricarboxylic acid derivative obtained by combining groups such as phenylthio. Furthermore, it is also possible to use a compound in which two carboxyl groups of the tricarboxylic acid are dehydration-polymerized anhydride structures and the remaining one is a carboxyl-only compound or a compound containing a tricarboxylic acid (a compound having 3 -COOH). Among them, trimellitic anhydride halide of the formula (9) is preferably used. The tricarboxylic acids may be used in combination of two or more of the aforementioned compounds. Some examples of the tetracarboxylic acids used in the present invention can be divided into alicyclic tetracarboxylic acids, aliphatic tetracarboxylic acids, and aromatic tetracarboxylic acids. The details are shown below. The alicyclic tetracarboxylic acids are, for example, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,5,6 -Cyclohexanetetracarboxylic diacid anhydride, bicyclo (2,2,2) -octyl olefin-2,3,5,6-tetracarboxylic diacid anhydride 3,3'-bibicyclohexane-1, 1 ', 2,2'-tetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 5- (2,5-dioxotetrahydrofuranylidene) -3-form Methyl-3-cyclohexene-1,2-dicarboxylic acid dianhydride, 1,3,3 &, 4,5,91) -hexahydro-5- (tetrahydro-2,5_ — ^ oxo-3 -Pyranyl) -naphthalene [l, 2, -c] -pyran-1,3-monofluorene, 3,5,6-tri-n-bicycloheptane-2-acetic anhydride, 2,3,4 , 5-tetrahydrofurantetracarboxylic dianhydride and the like. In addition, a compound substituted with a lower alkyl group such as a methyl group, an ethyl group, or the like which is partially bonded to the hydrogen of the ring of the compound may be used. The aliphatic tetracarboxylic acids are, for example, ethylene tetracarboxylic acid dianhydride, butane tetracarboxylic acid dianhydride, pentane tetracarboxylic acid dianhydride, hexanetetracarboxylic acid dianhydride, heptane tetracarboxylic acid dianhydride, and the like. Aromatic tetracarboxylic acids are, for example, pyromellitic acid dianhydride, 26 591056 9825 pif 1 3,3 ', 4,4'-diphenyltetracarboxylic acid dianhydride, 3,3', 4,4'-phenylhydrazone Pyromellitic acid dianhydride, 2,3,6,7-naphthoic acid dianhydride, 3,3 ', 4,4'-biphenylmethylenetetracarboxylic dianhydride, 3,3', 4,4'-bi Phenyl ether tetracarboxylic acid anhydride, 3,3 ', 4,4'-dimethyldiphenylsilane tetracarboxylic acid anhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenyl Sulfide diacid anhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylmaphenic anhydride, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylpropane Dianhydride, 3,3 ', 4,4'-biphenyltetracarboxylic dianhydride, bis (phthalic acid) phenylsulfinic acid anhydride, terephthalic acid (triphenylterephthalic acid) Acid anhydride, m-benzenebis (triphenylterephthalic acid) diacid anhydride, bis (triphenylterephthalic acid) _4,4'_diphenyl ether diacid anhydride, bis (triphenylterephthalic acid) _4 , 4'_diphenylmethane dianhydride and so on. Among the above-mentioned preferred tetracarboxylic acids are cyclobutanetetracarboxylic acid anhydride, cyclopentanetetracarboxylic acid anhydride, tricarboxycyclopentylacetic acid anhydride, cyclohexanetetracarboxylic acid anhydride, butanetetracarboxylic acid. Dianhydride, and pyromellitic dianhydride. The tetracarboxylic acid used to produce the N-substituted polyamidoamine-iminomine of the present invention need only be a compound that gives this organic residue in T2, so it is not limited to the tetracarboxylic dianhydride described above. That is, tetracarboxylic acids other than dianhydride may be used. One example of this is the dehydration condensation of two carboxyl groups in a tetracarboxylic acid to an anhydride and the hydrogen of the remaining carboxyl group is halogen, ethoxyl, alkyloxy, phenyloxy, or phenylsulfide. Derivatives substituted with a base. A further example is a derivative in which all hydrogens of four carboxyl groups in a tetracarboxylic acid are replaced with a group such as' halogen, ethenyloxy, alkyloxy, phenyloxy, or phenylthio. What's more, not only derivatives but also substances containing tetracarboxylic acids (compounds having 4 -COOH). It is also possible to use a combination of two or more substances containing the aforementioned tetracarboxylic acids. 27 9825 pif 1 In the present invention, the N-substituted polyamidoamine-iminomine system has at least one large side chain residue. The residue of the larger side chain may be an organic residue derived from a carboxylic acid, or may be It is an organic residue derived from a diamine, or both. That is, the polyfluorene is replaced by N containing the structural unit (1-1) and not including the structural unit (1-2) and the structural unit (1-3). In the amine-iminomine, at least one of T1 and D1 has a residue having a large side chain. Further, it is preferably a residue with a large side chain of D1, and moreover, T1 and D1 may be at the same time. Residues with larger side chains. Among N-substituted polyamido-amidoamines containing the structural unit (1-1) and the structural unit (1-2), at least one of T1, T2, D1, and D2 must have Residues with larger side chains. Moreover, it is preferred that at least one of D1 and D2 has a residue with a larger side chain. Furthermore, when at least one of D1 and D2 is In the case of a residue having a larger side chain, T2 also has a residue of a larger side chain. In the N-substituted polyamidamine-sulfuronamine containing the structural unit (1-1) and the structural unit (1-3), At least one of T1, T3, D1, and D3 must have a residue with a large side chain. Further, it is preferably a residue with at least one of D1 and D3 having a large side chain. The structural unit (1-2) is included. In the N-substituted polyamido-iminomine of the structural unit (1-3), at least one of T2, T3, D2, and D3 must have a residue having a large side chain. Moreover, it is preferably D2 and D3. At least one residue with a larger side chain. Furthermore, when at least one of D2 and D3 has a residue with a larger side chain, T2 also has a residue with a larger side chain. 1) In the structural unit (1-2) and the N-substituted polyamidoamine-iminomine of the structural unit (1-3), at least one of T1, T2, T3, D1, D2, and D3 is required. 28 591056- 9825 pifl Residues having larger side chains. Furthermore, it is preferable that at least one of D1 to D3 has a residue having a large side chain. Furthermore, when at least one of D1 to D3 has a residue having a large side chain , T2 also has Residues with larger side chains. The diamine compounds used in the production of the N-substituted polyamidoamines and sulfoximines of the present invention are also the same as the aforementioned carboxylic acids, and can be classified as aromatic (including heterocyclic) and alicyclic (Including heterocyclic), aliphatic (non-cyclic), etc. In addition, in order to maintain good liquid crystal alignment, a diamine φ compound having a ring structure is preferred. This diamine compound is generally preferred It is a substance having a structure that does not contain general groups such as ether, ester, thioether, and thioester in the structure. The reason is that such groups are the cause of lowering the electrical characteristics of the liquid crystal display element. However, even with the aforementioned structure, there is no problem as long as it does not affect the electrical characteristics. When the N-substituted polyamidoamine-iminomine of the present invention is produced, in the case where the carboxylic acid used is a residue capable of providing a large side chain, a diamine compound having no side chain can be used. However, it is preferred to use both a carboxylic acid having a side chain group having a carbon number of 3 · or more and a diamine compound having a side chain group having a carbon number of 3 or more. Furthermore, when a carboxylic acid having a side chain with a carbon number of 3 or more is not used, it is necessary to use a diamine compound having a side chain with a carbon number of 3 or more. In this case, the side chain group having a carbon number of 3 or more is, for example, an aliphatic hydrocarbon group, a hydrocarbon group containing an alicyclic structure, an aromatic hydrocarbon group, a group having a siloxane group, A group having a nested skeleton or a side chain group mixed with the aforementioned structure. An alicyclic hydrocarbon group or an aromatic group 29 591056 9825 pifl A hydrocarbon group may have a substituent such as an alkyl group, an alkoxy group, a halogen, or 0H. Part of this type of hydrocarbon structure can also be replaced with other atoms such as oxygen. However, it is preferable not to contain groups such as -S-, -CO ·, -COO-, or -SOO-. When the carbon number of the side chain group includes a cyclic structure such as cyclohexane, it means the number of carbons constituting the ring. Preferred examples of the diamine compound having a side chain group having a carbon number of 3 or more are compounds capable of providing the organic residues represented by the formulas (2) to (5), respectively. Such compounds are preferably used in the production of the N-substituted polyamidoamines of the present invention. Furthermore, in the N-substituted polyamidoamine-iminomine of the present invention, it is preferable that the residue contains at least one residue selected from the group of organic residues.
在式(2)中所使用之記號係定義如下。 R4係指氫或碳數爲1〜12的烷基。 環A係指1,4-亞苯基(1,4-phenylene)或1,4-環己亞基 (1,4-cyclohexylene)。前述環之任意氫也可以置換成碳數爲1 〜4的烷基。 Z1及Z2係爲個別獨立之單鍵、-CH2_、-CH2CH2-或-0-。 Γ係爲〇〜3之整數,s係爲0〜5之整數,tl係爲0〜3的 整數,而且t2係爲0〜3之整數。 然而,當tl爲2或3之情形時,多個的Z1可以爲相 30 591056 9825 pifl 互間相同的,也可以爲相互間不同的。當t2爲2或3之情 形時,多個的Z2可以爲相互間相同的,也可以爲相互間不 同的。 (3) 12 2 5The symbols used in the formula (2) are defined as follows. R4 means hydrogen or an alkyl group having 1 to 12 carbon atoms. Ring A refers to 1,4-phenylene or 1,4-cyclohexylene. Arbitrary hydrogen in the ring may be substituted with an alkyl group having 1 to 4 carbon atoms. Z1 and Z2 are independent single bonds, -CH2_, -CH2CH2- or -0. Γ is an integer of 0 to 3, s is an integer of 0 to 5, tl is an integer of 0 to 3, and t2 is an integer of 0 to 3. However, when tl is 2 or 3, a plurality of Z1 may be the same as each other, or may be different from each other. When t2 is 2 or 3, a plurality of Z2 may be the same as each other or different from each other. (3) 12 2 5
G—X—G-R 在式(3)中,對於苯環中之置換基的結合位置及2個游G-X-G-R In formula (3), for the bonding position of the substituent in the benzene ring and two positions
離基之位置係爲任意的。而且此式中之記號係定義如下。 X1及X2係爲個別獨立之單鍵、-〇-、-00-、-OCO-、 _NH_、_CONH·或碳數爲1〜12的烷撐。 G1及G2係爲個別獨立之單鍵或含有1〜3個環的二價 基團。前述環係選自芳香族環及脂環式之環所構成之族群。 R5係指氫、氟、-CN、-OH、碳數爲1〜12的烷基、或 碳數爲1〜12的烷氧基。 然而,當G2爲單鍵且X2不是單鍵也不是烷撐之情形 時,R5係爲氫或烷基。當G1及G2 —同爲單鍵時,X1、X2 及R5之總和碳數爲3以上。 6The position of the radical is arbitrary. The symbols in this formula are defined as follows. X1 and X2 are individually independent single bonds, -0-, -00-, -OCO-, _NH_, _CONH · or alkylenes having 1 to 12 carbon atoms. G1 and G2 are individually independent single bonds or divalent groups containing 1 to 3 rings. The ring system is selected from the group consisting of an aromatic ring and an alicyclic ring. R5 means hydrogen, fluorine, -CN, -OH, an alkyl group having 1 to 12 carbons, or an alkoxy group having 1 to 12 carbons. However, when G2 is a single bond and X2 is not a single bond or an alkylene group, R5 is hydrogen or an alkyl group. When G1 and G2 are both single bonds, the total carbon number of X1, X2 and R5 is 3 or more. 6
在式(4)中,1,4-亞苯基之任意氫也可以置換成碳數爲1 〜4的烷基。而且,此式中之記號係定義如下。 X3及X4係爲個別獨立的單鍵、-CH2-、-CH2CH2·或-〇-。 r6及R7係爲個別獨立的氫、碳數爲1〜12的烷基或碳 數爲1〜12的氟代烷基。 ul及u2係爲個別獨立的〇〜3的整數。 31 591056 然而,R6及R7之至少一邊係爲碳數爲3以上的烷基 或碳數爲3以上的氟代烷基。當ul爲2或3之情形時,多 個的X3可以爲相互間相同的,也可以爲相互間不同的。當 u2爲2或3之情形時,多個的X4可以爲相互間相同的,也 可以爲相互間不同的。In formula (4), any hydrogen of 1,4-phenylene may be replaced with an alkyl group having 1 to 4 carbon atoms. The symbols in this formula are defined as follows. X3 and X4 are independent single bonds, -CH2-, -CH2CH2 ·, or -〇-. r6 and R7 are each independently hydrogen, an alkyl group having 1 to 12 carbons, or a fluoroalkyl group having 1 to 12 carbons. ul and u2 are independent integers of 0 to 3. 31 591056 However, at least one of R6 and R7 is an alkyl group having 3 or more carbon atoms or a fluoroalkyl group having 3 or more carbon atoms. When ul is 2 or 3, multiple X3s may be the same as each other or different from each other. When u2 is 2 or 3, a plurality of X4 may be the same as each other, or may be different from each other.
在式(5)中,相對於苯環之置換基及游離基之結合位置 春 係爲任意的。而且,此式中之記號係定義如下。 R8係爲氫或碳數爲1〜12之烷基。此烷基中之任意 -CH2-也可以置換成〇_。 X5係指單鍵或碳數爲1〜5的烷撐。此烷撐中任意-CH2-也可以置換成-0_。 m爲0〜3的整數,η爲1〜5的整數。 可給予式(2)中所表示之有機殘基的二胺化合物係如 式(17)所示。In formula (5), the spring position with respect to the bonding position of the substituent and the radical of the benzene ring is arbitrary. The symbols in this formula are defined as follows. R8 is hydrogen or an alkyl group having 1 to 12 carbon atoms. Any -CH2- in this alkyl group may be replaced with 0-. X5 refers to a single bond or an alkylene group having 1 to 5 carbon atoms. Any -CH2- in this alkylene can be replaced with -0_. m is an integer of 0 to 3, and η is an integer of 1 to 5. The diamine compound capable of giving an organic residue represented by the formula (2) is represented by the formula (17).
在式(17)中,R4、a、Ζ1、Ζ2、r、s、tl及t2係分別與 式(2)所示之記號爲同一的。 此式(17)中所示之二胺化合物之具體例之一部份係由 R、環A、Z、r、s及t之組合而得,如同表1〜表5所示。 32 591056 9825 pifl 而且’ Z1 = Z2=Z ’ tl = t2=t。再者’在此表之環A之欄所 記載之B係表示1,4-亞苯基,Ch係表示1,4-環己烯。 33 591056 9825 pif 1 表1In Formula (17), R4, a, Z1, Z2, r, s, tl, and t2 are the same as the symbols shown in Formula (2), respectively. Part of the specific examples of the diamine compound shown in this formula (17) is obtained by a combination of R, ring A, Z, r, s, and t, as shown in Tables 1 to 5. 32 591056 9825 pifl and ‘Z1 = Z2 = Z’ tl = t2 = t. In addition, in the column of ring A in this table, B represents 1,4-phenylene, and Ch represents 1,4-cyclohexene. 33 591056 9825 pif 1 Table 1
No· R4 A Z r s t 1 H 0 0 2 ch3 0 0 3 C2H5 0 0 4 11-C3H7 0 0 5 11-C4H9 0 0 6 n-CsHn 0 0 7 n-C6H13 0 0 8 11-C7H15 0 0 9 n-CgHis 0 0 10 11-C9H19 0 0 11 11-C10H21 0 0 12 11-C11H23 0 0 13 11-C12H25 0 0 14 H Ch 1 0 0 15 ch3 Ch 1 0 0 16 c2h5 Ch 1 0 0 17 n-C3H7 Ch 1 0 0 18 11-C4H9 Ch 1 0 0 19 11-C5H11 Ch 1 0 0 20 η-〇6Ηΐ3 Ch 1 0 0 21 11-C7H15 Ch 1 0 0 22 η-〇8Ηΐ8 Ch 1 0 0 23 11-C9H19 Ch 1 0 0 24 n-Ci〇H2i Ch 1 0 0 25 11-C11H23 Ch 1 0 0 26 n-Ci2H25 Ch 1 0 0 27 H B 1 0 0 28 ch3 B 1 0 0 29 C2H5 B 1 0 0 30 11-C3H7 B 1 0 0 31 11-C4H9 B 1 0 0 32 n-C5Hu B 1 0 0 33 n-C6Hi3 B 1 0 0 34 11-C7H15 B 1 0 0 35 η-〇δΗΐ8 B 1 0 0 36 11-C9H19 B 1 0 0 37 n-C10H21 B 1 0 0 38 11-C11H23 B 1 0 0 39 11-C12H25 B 1 0 0 34 591056 9825 pifl 表2No · R4 AZ rst 1 H 0 0 2 ch3 0 0 3 C2H5 0 0 4 11-C3H7 0 0 5 11-C4H9 0 0 6 n-CsHn 0 0 7 n-C6H13 0 0 8 11-C7H15 0 0 9 n- CgHis 0 0 10 11-C9H19 0 0 11 11-C10H21 0 0 12 11-C11H23 0 0 13 11-C12H25 0 0 14 H Ch 1 0 0 15 ch3 Ch 1 0 0 16 c2h5 Ch 1 0 0 17 n-C3H7 Ch 1 0 0 18 11-C4H9 Ch 1 0 0 19 11-C5H11 Ch 1 0 0 20 η-〇6Ηΐ3 Ch 1 0 0 21 11-C7H15 Ch 1 0 0 22 η-〇8Ηΐ8 Ch 1 0 0 23 11-C9H19 Ch 1 0 0 24 n-Ci〇H2i Ch 1 0 0 25 11-C11H23 Ch 1 0 0 26 n-Ci2H25 Ch 1 0 0 27 HB 1 0 0 28 ch3 B 1 0 0 29 C2H5 B 1 0 0 30 11-C3H7 B 1 0 0 31 11-C4H9 B 1 0 0 32 n-C5Hu B 1 0 0 33 n-C6Hi3 B 1 0 0 34 11-C7H15 B 1 0 0 35 η-〇δΗΐ8 B 1 0 0 36 11-C9H19 B 1 0 0 37 n-C10H21 B 1 0 0 38 11-C11H23 B 1 0 0 39 11-C12H25 B 1 0 0 34 591056 9825 pifl Table 2
No. R4 A Z r s t 1 H Ch 1 1 0 2 ch3 Ch 1 1 0 3 C2H5 Ch 1 1 0 4 11-C3H7 Ch 1 1 0 5 n-C4H9 Ch 1 1 0 6 Π-〇5Ηιι Ch 1 1 0 7 n-C6Hi3 Ch 1 1 0 8 I1-C7H15 Ch 1 1 0 9 n-CgHi8 Ch 1 1 0 10 11-C9H19 Ch 1 1 0 11 11-C10H21 Ch 1 1 0 12 11-C11H23 Ch 1 1 0 13 11-C12H25 Ch 1 1 0 14 H B 1 0 15 ch3 B 1 1 0 16 C2H5 B 1 1 0 17 11-C3H7 B 1 1 0 18 11-C4H9 B 1 1 0 19 11-C5H11 B 1 1 0 20 n-C6H13 B 1 1 0 21 11-C7H15 B 1 1 0 22 n-CgHis B 1 1 0 23 11-C9H19 B 1 1 0 24 11-C10H21 B 1 1 0 25 11-C11H23 B 1 1 0 26 11-C12H25 B 1 1 0 27 H 0 0 1 28 ch3 0 0 1 29 C2H5 0 0 1 30 11-C3H7 0 0 1 31 11-C4H9 0 0 1 32 n-CsHu 0 0 1 33 n-C6H13 0 0 1 34 11-C7H15 0 0 1 35 η-ΟδΗΐδ 0 0 1 36 11-C9H19 0 0 1 37 n-Ci〇H2i 0 0 1 38 11-C11H23 0 0 1 39 11-C12H25 0 0 1 35 591056 9825 pif 1 表3No. R4 AZ rst 1 H Ch 1 1 0 2 ch3 Ch 1 1 0 3 C2H5 Ch 1 1 0 4 11-C3H7 Ch 1 1 0 5 n-C4H9 Ch 1 1 0 6 Π-〇5Ηι Ch 1 1 0 7 n -C6Hi3 Ch 1 1 0 8 I1-C7H15 Ch 1 1 0 9 n-CgHi8 Ch 1 1 0 10 11-C9H19 Ch 1 1 0 11 11-C10H21 Ch 1 1 0 12 11-C11H23 Ch 1 1 0 13 11-C12H25 Ch 1 1 0 14 HB 1 0 15 ch3 B 1 1 0 16 C2H5 B 1 1 0 17 11-C3H7 B 1 1 0 18 11-C4H9 B 1 1 0 19 11-C5H11 B 1 1 0 20 n-C6H13 B 1 1 0 21 11-C7H15 B 1 1 0 22 n-CgHis B 1 1 0 23 11-C9H19 B 1 1 0 24 11-C10H21 B 1 1 0 25 11-C11H23 B 1 1 0 26 11-C12H25 B 1 1 0 27 H 0 0 1 28 ch3 0 0 1 29 C2H5 0 0 1 30 11-C3H7 0 0 1 31 11-C4H9 0 0 1 32 n-CsHu 0 0 1 33 n-C6H13 0 0 1 34 11-C7H15 0 0 1 35 η-ΟδΗΐδ 0 0 1 36 11-C9H19 0 0 1 37 n-Ci〇H2i 0 0 1 38 11-C11H23 0 0 1 39 11-C12H25 0 0 1 35 591056 9825 pif 1 Table 3
No. R4 A Z Γ s t 1 H Ch 0 1 0 1 2 ch3 Ch 0 1 0 1 3 C2H5 Ch 0 1 0 1 4 11-C3H7 Ch 0 1 0 1 5 n-C4H9 Ch 0 1 0 1 6 n-C5Hn Ch 0 1 0 1 7 n-C6H13 Ch 0 1 0 1 8 n-CyHis Ch 0 1 0 1 9 n-C8Hi8 Ch 0 1 0 1 10 11-C9H19 Ch 0 1 0 1 11 n-Ci〇H2i Ch 0 1 0 1 12 11-C11H23 Ch 0 1 0 1 13 11-C12H25 Ch 0 1 0 1 14 H Ch 0 1 2 1 15 ch3 Ch 0 1 2 1 16 C2H5 Ch 0 1 2 1 17 n-C3H7 Ch 0 1 2 1 18 11-C4H9 Ch 0 1 2 1 19 n-C5Hn Ch 0 1 2 1 20 n-CeHn Ch 0 1 2 1 21 11-C7H15 Ch 0 1 2 1 22 η-〇8Ηΐ8 Ch 0 1 2 1 23 11-C9H19 Ch 0 1 2 1 24 n-Ci〇H2i Ch 0 1 2 1 25 11-C11H23 Ch 0 1 2 1 26 11-C12H25 Ch 0 1 2 1 27 H B 0 1 0 1 28 ch3 B 0 1 0 1 29 C2H5 B 0 1 0 1 30 11-C3H7 B 0 1 0 1 31 n-C4H9 B 0 1 0 1 32 11-C5H11 B 0 1 0 1 33 n-C6H13 B 0 1 0 1 34 11-C7H15 B 0 1 0 1 35 η-〇δΗΐ8 B 0 1 0 1 36 11-C9H19 B 0 1 0 1 37 n-Ci〇H2i B 〇 1 0 1 38 11-C11H23 B 0 1 0 1 39 n-Ci2H25 B 0 1 0 1 36 591056No. R4 AZ Γ st 1 H Ch 0 1 0 1 2 ch3 Ch 0 1 0 1 3 C2H5 Ch 0 1 0 1 4 11-C3H7 Ch 0 1 0 1 5 n-C4H9 Ch 0 1 0 1 6 n-C5Hn Ch 0 1 0 1 7 n-C6H13 Ch 0 1 0 1 8 n-CyHis Ch 0 1 0 1 9 n-C8Hi8 Ch 0 1 0 1 10 11-C9H19 Ch 0 1 0 1 11 n-Ci〇H2i Ch 0 1 0 1 12 11-C11H23 Ch 0 1 0 1 13 11-C12H25 Ch 0 1 0 1 14 H Ch 0 1 2 1 15 ch3 Ch 0 1 2 1 16 C2H5 Ch 0 1 2 1 17 n-C3H7 Ch 0 1 2 1 18 11-C4H9 Ch 0 1 2 1 19 n-C5Hn Ch 0 1 2 1 20 n-CeHn Ch 0 1 2 1 21 11-C7H15 Ch 0 1 2 1 22 η-〇8Ηΐ8 Ch 0 1 2 1 23 11-C9H19 Ch 0 1 2 1 24 n-Ci〇H2i Ch 0 1 2 1 25 11-C11H23 Ch 0 1 2 1 26 11-C12H25 Ch 0 1 2 1 27 HB 0 1 0 1 28 ch3 B 0 1 0 1 29 C2H5 B 0 1 0 1 30 11-C3H7 B 0 1 0 1 31 n-C4H9 B 0 1 0 1 32 11-C5H11 B 0 1 0 1 33 n-C6H13 B 0 1 0 1 34 11-C7H15 B 0 1 0 1 35 η -〇δΗΐ8 B 0 1 0 1 36 11-C9H19 B 0 1 0 1 37 n-Ci〇H2i B 〇1 0 1 38 11-C11H23 B 0 1 0 1 39 n-Ci2H25 B 0 1 0 1 36 591056
9825 pif 1 表49825 pif 1 Table 4
No. R4 A Z r s t 1 H ch2 0 1 2 ch3 ch2 0 1 3 C2H5 ch2 0 1 4 11-C3H7 ch2 0 1 5 11-C4H9 ch2 0 1 6 11-C5H11 ch2 0 1 7 n-C6Hi3 ch2 0 1 8 11-C7H15 ch2 0 1 9 η-ΟδΗΐδ ch2 0 1 10 11-C9H19 ch2 0 1 11 n-Ci〇H2i ch2 0 1 12 n-CuH23 ch2 0 1 13 11-C12H25 ch2 0 1 14 H Ch ch2 1 0 1 15 ch3 Ch ch2 1 0 1 16 C2H5 Ch ch2 1 0 1 17 n-C3H7 Ch ch2 1 0 1 18 11-C4H9 Ch ch2 1 0 1 19 11-C5H11 Ch ch2 1 0 1 20 n-CeHn Ch ch2 1 0 1 21 11-C7H15 Ch ch2 1 0 1 22 η-〇8Ηΐ8 Ch ch2 1 0 1 23 11-C9H19 Ch ch2 1 0 1 24 n-Ci〇H2i Ch ch2 1 0 1 25 n-CnH23 Ch ch2 1 0 1 26 tl-Ci2H25 Ch ch2 1 0 1 27 H Ch ch2 1 2 1 28 ch3 Ch ch2 1 2 1 29 C2H5 Ch ch2 1 2 1 30 11-C3H7 Ch ch2 1 2 1 31 11-C4H9 Ch ch2 1 2 1 32 n-C5Hn Ch ch2 1 2 1 33 n-C6H13 Ch ch2 1 2 1 34 n-C7H15 Ch ch2 1 2 1 35 n-CgHis Ch ch2 1 2 1 36 11-C9H19 Ch ch2 1 2 1 37 n-Ci〇H2i Ch ch2 1 2 1 38 11-C11H23 Ch ch2 1 2 1 39 11-C12H25 Ch ch2 1 2 1 37 591056 9825 pif 1 表5No. R4 AZ rst 1 H ch2 0 1 2 ch3 ch2 0 1 3 C2H5 ch2 0 1 4 11-C3H7 ch2 0 1 5 11-C4H9 ch2 0 1 6 11-C5H11 ch2 0 1 7 n-C6Hi3 ch2 0 1 8 11 -C7H15 ch2 0 1 9 η-ΟδΗΐδ ch2 0 1 10 11-C9H19 ch2 0 1 11 n-Ci〇H2i ch2 0 1 12 n-CuH23 ch2 0 1 13 11-C12H25 ch2 0 1 14 H Ch ch2 1 0 1 15 ch3 Ch ch2 1 0 1 16 C2H5 Ch ch2 1 0 1 17 n-C3H7 Ch ch2 1 0 1 18 11-C4H9 Ch ch2 1 0 1 19 11-C5H11 Ch ch2 1 0 1 20 n-CeHn Ch ch2 1 0 1 21 11-C7H15 Ch ch2 1 0 1 22 η-〇8Ηΐ8 Ch ch2 1 0 1 23 11-C9H19 Ch ch2 1 0 1 24 n-Ci〇H2i Ch ch2 1 0 1 25 n-CnH23 Ch ch2 1 0 1 26 tl- Ci2H25 Ch ch2 1 0 1 27 H Ch ch2 1 2 1 28 ch3 Ch ch2 1 2 1 29 C2H5 Ch ch2 1 2 1 30 11-C3H7 Ch ch2 1 2 1 31 11-C4H9 Ch ch2 1 2 1 32 n-C5Hn Ch ch2 1 2 1 33 n-C6H13 Ch ch2 1 2 1 34 n-C7H15 Ch ch2 1 2 1 35 n-CgHis Ch ch2 1 2 1 36 11-C9H19 Ch ch2 1 2 1 37 n-Ci〇H2i Ch ch2 1 2 1 38 11-C11H23 Ch ch2 1 2 1 39 11-C12H25 Ch ch2 1 2 1 37 591056 9825 pif 1 Table 5
No. R4 A Z Γ s t 1 Η B ch2 1 0 1 2 ch3 B ch2 1 0 1 3 C2H5 B ch2 1 0 1 4 11-C3H7 B ch2 1 0 1 5 n-C4H9 B ch2 1 0 1 6 n-CsHn B ch2 1 0 1 7 n-C6Hi3 B ch2 1 0 1 8 11-C7H15 B ch2 1 0 1 9 n-C8Hi8 B ch2 1 0 1 10 11-C9H19 B ch2 1 0 1 11 n-Ci〇H2i B ch2 1 0 1 12 n-CnH23 B ch2 1 0 1 13 n-Ci2H25 B ch2 1 0 1 14 H B ch2 1 ^ 1 1 15 ch3 B ch2 1 1 1 16 C2H5 B ch2 1 1 1 17 11-C3H7 B ch2 1 1 1 18 11-C4H9 B ch2 1 1 1 19 n-CsHn B ch2 1 1 1 20 11-C6H13 B ch2 1 1 1 21 11-C7H15 B ch2 1 1 1 22 n-CgHis B ch2 1 1 1 23 11-C9H19 B ch2 1 1 1 24 11-C10H21 B ch2 1 1 1 25 11-C11H23 B ch2 1 1 1 26 11-C12H25 B ch2 1 1 1 式(Π)所示之二胺化合物並不以上述實例所示之化合 物爲限。也可以組合使用上述化合物之2種以上。在此類 之二胺化合物中,當r爲0時,R4爲氫或短鏈之烷基之情 形時,則可以給予液晶上具有稍微小的前傾角的液晶配向 膜。當r爲1〜3之情形下,R4爲氫時,則可以給予液晶上 具有較大的前傾角的液晶配向膜。具有較小之前傾角的液 晶配向膜較適合於IPS型液晶顯示元件。具有3〜8度之前 傾角的液晶配向膜較適合於TN型液晶顯示元件。再者,在 STN型液晶顯示元件、VA型液晶顯示元件及〇CB型液晶 38 9825 pif 1 顯示元件之情形下,由於需要更大的前傾角,因此在此情 形下較佳係使用側鏈基較長的二胺化合物。 另外,也可以改用式(18)、式(19)及式(20)所分別表示 之具有碳數爲3以上之側鏈基的二胺化合物。 39 591056 9825 pif 1No. R4 AZ Γ st 1 Η B ch2 1 0 1 2 ch3 B ch2 1 0 1 3 C2H5 B ch2 1 0 1 4 11-C3H7 B ch2 1 0 1 5 n-C4H9 B ch2 1 0 1 6 n-CsHn B ch2 1 0 1 7 n-C6Hi3 B ch2 1 0 1 8 11-C7H15 B ch2 1 0 1 9 n-C8Hi8 B ch2 1 0 1 10 11-C9H19 B ch2 1 0 1 11 n-Ci〇H2i B ch2 1 0 1 12 n-CnH23 B ch2 1 0 1 13 n-Ci2H25 B ch2 1 0 1 14 HB ch2 1 ^ 1 1 15 ch3 B ch2 1 1 1 16 C2H5 B ch2 1 1 1 17 11-C3H7 B ch2 1 1 1 18 11-C4H9 B ch2 1 1 1 19 n-CsHn B ch2 1 1 1 20 11-C6H13 B ch2 1 1 1 21 11-C7H15 B ch2 1 1 1 22 n-CgHis B ch2 1 1 1 23 11-C9H19 B ch2 1 1 1 24 11-C10H21 B ch2 1 1 1 25 11-C11H23 B ch2 1 1 1 26 11-C12H25 B ch2 1 1 1 The diamine compound represented by formula (Π) is not the compound shown in the above example as limit. Two or more of the above compounds may be used in combination. In such a diamine compound, when r is 0 and R4 is hydrogen or a short-chain alkyl group, a liquid crystal alignment film having a slightly smaller forward tilt angle on the liquid crystal can be imparted. When r is 1 to 3 and R4 is hydrogen, a liquid crystal alignment film having a large forward tilt angle on the liquid crystal can be given. A liquid crystal alignment film having a small front tilt angle is more suitable for an IPS type liquid crystal display element. A liquid crystal alignment film having an inclination angle of 3 to 8 degrees is more suitable for a TN type liquid crystal display element. Furthermore, in the case of STN-type liquid crystal display elements, VA-type liquid crystal display elements and 0CB-type liquid crystal 38 9825 pif 1 display elements, since a larger forward tilt angle is required, it is preferable to use a side chain group in this case. Longer diamine compound. Alternatively, a diamine compound having a side chain group having a carbon number of 3 or more represented by the formula (18), the formula (19), and the formula (20) may be used instead. 39 591056 9825 pif 1
(18)(18)
(19) 在此式中,z1、Z2、tl及t2係分別與式(2)所示之記 號爲同一的。R14及R15係爲個別獨立的氫或碳數爲1〜12 40 591056 9825 pifl 的烷基。但’式(18)及式(19)之巢骨架中之任意環也可以爲 縮小、擴大或開環等的物質,也可以爲聯二環,也可以爲 不飽和鍵結在任意位置上增加或減少的物質,也可以爲任 意位置之氫或烷基置換成其他一價有機基的物質。 可給予式(3)所示之有機殘基的二胺化合物係如式(21) 所示。(19) In this formula, z1, Z2, tl, and t2 are the same as the symbols shown in formula (2), respectively. R14 and R15 are each independently hydrogen or an alkyl group having 1 to 12 40 591056 9825 pifl. However, any ring in the nest skeleton of the formulas (18) and (19) may be a material that shrinks, expands, or opens the ring, or may be a bicyclic ring, or an unsaturated bond may be added at any position The reduced or reduced substance may be one in which hydrogen or an alkyl group at any position is replaced with another monovalent organic group. The diamine compound capable of giving an organic residue represented by the formula (3) is represented by the formula (21).
在式(21)中X1、X2、G1、G2及R5係分別與式(3)所示 之記號爲同一的。 式(21)所示之二胺化合物之具體例一部份係由χ1、 、Gi、G2及R5之組合而得,如同表6〜表12所示。在 此表中,「-」係表示單鍵,「B」係表示1,4-亞苯基,「Ch」 係表示I,4-環己燦。再者,「B-Ch」、「Ch-B」、「B-Ch_Ch」、 等係表示環的種類及鍵結之順序。例如G1爲B_Ch之情形 時,係表不以χ1、U4·亞苯基、1,4-環己燦、X2之順序鍵結。 G2爲Ch-B之情形時,係表示以X2、l,4-環己烯、i,心亞苯 基、R5之順序鍵結。而且,在此表中所記載之化合物係爲 1,3-二胺苯衍生物,X1係爲在二胺苯之第5位上鍵結的二 胺化合物。 41 591056 9825 pif 1 表6In the formula (21), X1, X2, G1, G2, and R5 are the same as the symbols shown in the formula (3), respectively. Part of the specific examples of the diamine compound represented by the formula (21) is obtained by a combination of χ1, Gi, G2, and R5, as shown in Tables 6 to 12. In this table, "-" means a single bond, "B" means 1,4-phenylene, and "Ch" means I, 4-cyclohexyl. In addition, "B-Ch", "Ch-B", "B-Ch_Ch", etc. represent the kind of ring and the order of bonding. For example, when G1 is B_Ch, it means that they are not bonded in the order of χ1, U4 · phenylene, 1,4-cyclohexane, and X2. When G2 is Ch-B, it means that they are bonded in the order of X2, 1,4-cyclohexene, i, phenylene, and R5. The compounds described in this table are 1,3-diaminebenzene derivatives, and X1 is a diamine compound bonded to the fifth position of diaminebenzene. 41 591056 9825 pif 1 Table 6
No. X1 Gl X" Gl R5 1 - - - - n-CsHn 2 - - - n-Ci2H25 3 - - - 11-C5H11 4 - - - - 11-C12H25 5 0 - - - n-CsHn 6 0 - - - Il-Ci2H25 7 0 - - - n-CsHn 8 0 - - - 11-C12H25 9 co-o - - - 11-C5H11 10 co-o - - - 11-C12H25 11 co-o - - - n-CsHn 12 co-o - - - 11-C12H25 13 o-co - - n-C5Hn 14 o-co - - - 11-C12H25 15 o-co - - - n-C5Hu 16 o-co - - - 11-C12H25 17 NH - - - n-C5Hu 18 NH - - - 11-C12H25 19 NH - - - n-C5Hu 20 NH - - - 11-C12H25 21 CO-NH - - 一 11-C5H11 22 CO-NH - - - 11-C12H25 23 CO-NH - - - n-C5Hn 24 CO-NH - - - n-Ci2H25 25 - B - - n-CsHn 26 - B - - 11-C12H25 27 - Ch - - n-CsHn 28 - Ch - - 11-C12H25 29 - B-B - - n-CsHn 30 - B-B - - 11-C12H25 31 - B-Ch - - n-CsHn 32 - B-Ch - - 11-C12H25 33 - Ch-B - - n-CsHn 34 - Ch-B - - n-Ci2H25 35 - Ch-Ch - - n-C5Hn 36 - Ch-Ch - - 11-C12H25 37 - B-B-B - - n-C5Hu 38 - B-B-B - - 11-C12H25 42 591056 9825 pifl 表7No. X1 Gl X " Gl R5 1----n-CsHn 2---n-Ci2H25 3---11-C5H11 4----11-C12H25 5 0---n-CsHn 6 0-- -Il-Ci2H25 7 0---n-CsHn 8 0---11-C12H25 9 co-o----11-C5H11 10 co-o---11-C12H25 11 co-o---n-CsHn 12 co-o---11-C12H25 13 o-co--n-C5Hn 14 o-co---11-C12H25 15 o-co---n-C5Hu 16 o-co---11-C12H25 17 NH---n-C5Hu 18 NH---11-C12H25 19 NH---n-C5Hu 20 NH---11-C12H25 21 CO-NH---11-C5H11 22 CO-NH---11- C12H25 23 CO-NH---n-C5Hn 24 CO-NH---n-Ci2H25 25-B--n-CsHn 26-B--11-C12H25 27-Ch--n-CsHn 28-Ch-- 11-C12H25 29-BB--n-CsHn 30-BB--11-C12H25 31-B-Ch--n-CsHn 32-B-Ch--11-C12H25 33-Ch-B--n-CsHn 34 -Ch-B--n-Ci2H25 35-Ch-Ch--n-C5Hn 36-Ch-Ch--11-C12H25 37-BBB--n-C5Hu 38-BBB--11-C12H25 42 591056 9825 pifl table 7
No. X1 G1 X2 G2 R, 1 - B-B-Ch - - n-CsHn 2 - B-B-Ch - - 11-C12H25 3 - B-Ch-Ch - - n-CsHn 4 - B-Ch-Ch - - 11-C12H25 5 - Ch-Ch-Ch - - n-CsHn 6 - Ch-Ch-Ch - - 11-C12H25 7 0 B - - 11-C5H11 8 0 B - 11-C12H25 9 0 Ch - n-C5Hu 10 0 Ch - - Il-Ci2H25 11 0 B-B - - 11-C5H11 12 0 B-B - - 11-C12H25 13 0 B-Ch - 11-C5H11 14 0 B-Ch - - 11-C12H25 15 0 Ch-B - - n-CsHn 16 0 Ch-B - - n-Ci2H25 17 0 Ch-Ch - - 11-C5H11 18 0 Ch-Ch - - I1-C12H25 19 0 B-B-B - - n-CsHn 20 0 B-B-B - - 11-C12H25 21 0 B-B-Ch - - n-CsHn 22 0 B-B-Ch - - 11-C12H25 23 0 B-Ch-Ch - - n-CsHn 24 0 B-Ch-Ch - - 11-C12H25 25 0 Ch-Ch-Ch - - 11-C5H11 26 0 Ch-Ch-Ch - - 11-C12H25 27 co-o B - - 11-C5H11 28 co-o B - - n-Ci2H25 29 co-o Ch - - I1-C5H11 30 co-o Ch - - 11-C12H25 31 co-o B-B - - n-CsH,, 32 co-o B-B - - 11-C12H25 33 co-o B-Ch - - n-CsHn 34 co-o B-Ch - - 11-C12H25 35 co-o Ch-B - - n-C5Hu 36 co-o Ch-B - - 11-C12H25 37 co-o Ch-Ch - - n-C5Hn 38 co-o Ch-Ch - - n-Ci2H25 43 591056 9825 pif 1 表8No. X1 G1 X2 G2 R, 1-BB-Ch--n-CsHn 2-BB-Ch--11-C12H25 3-B-Ch-Ch--n-CsHn 4-B-Ch-Ch--11 -C12H25 5-Ch-Ch-Ch--n-CsHn 6-Ch-Ch-Ch--11-C12H25 7 0 B--11-C5H11 8 0 B-11-C12H25 9 0 Ch-n-C5Hu 10 0 Ch--Il-Ci2H25 11 0 BB--11-C5H11 12 0 BB--11-C12H25 13 0 B-Ch-11-C5H11 14 0 B-Ch--11-C12H25 15 0 Ch-B--n- CsHn 16 0 Ch-B--n-Ci2H25 17 0 Ch-Ch--11-C5H11 18 0 Ch-Ch--I1-C12H25 19 0 BBB--n-CsHn 20 0 BBB--11-C12H25 21 0 BB -Ch--n-CsHn 22 0 BB-Ch--11-C12H25 23 0 B-Ch-Ch--n-CsHn 24 0 B-Ch-Ch--11-C12H25 25 0 Ch-Ch-Ch-- 11-C5H11 26 0 Ch-Ch-Ch--11-C12H25 27 co-o B--11-C5H11 28 co-o B--n-Ci2H25 29 co-o Ch--I1-C5H11 30 co-o Ch --11-C12H25 31 co-o BB--n-CsH ,, 32 co-o BB--11-C12H25 33 co-o B-Ch--n-CsHn 34 co-o B-Ch--11- C12H25 35 co-o Ch-B--n-C5Hu 36 co-o Ch-B--11-C12H25 37 co-o Ch-Ch--n-C5Hn 38 co-o Ch-Ch--n-Ci2H25 43 591056 9825 pif 1 Table 8
No. X1 G1 X" G2 R" 1 co-o B-B-B - - n-CsHn 2 co-o B-B-B - - Il-Ci2H25 3 co-o B-B-Ch - - 11-C5H11 4 co-o B-B-Ch - - n-Ci2H25 5 co-o B-Ch-Ch - - n-CsHn 6 co-o B-Ch-Ch - - 11-C12H25 7 co-o Ch-Ch-Ch - - n-C5Hu 8 co-o Ch-Ch-Ch - - 11-C12H25 9 ch2 B - - n-CsHn 10 ch2 B - - 11-C12H25 11 ch2 Ch - - n-C5Hn 12 ch2 Ch - 〆 11-C12H25 13 ch2 B-B - - n-C5Hu 14 ch2 B-B - - n-Ci2H25 15 ch2 B-Ch - - n-C5Hu 16 ch2 B-Ch - - 11-C12H25 17 ch2 Ch-B - - n-CsHn 18 ch2 Ch-B - - 11-C12H25 19 ch2 Ch-Ch - - 11-C5H11 20 ch2 Ch-Ch - - 11-C12H25 21 ch2 B-B-B - - n-CsHn 22 ch2 B-B-B - - II-C12H25 23 ch2 B-B-Ch - n-CsHn 24 ch2 B-B-Ch - - n-Ci2H25 25 ch2 B-Ch-Ch - - 26 ch2 B-Ch-Ch - - 11-C12H25 27 ch2 Ch-Ch-Ch - - n-C5Hn 28 ch2 Ch-Ch-Ch - - 11-C12H25 29 0 - CH2CH2 B n-CsHn 30 0 - CH2CH2 B 11-C12H25 31 0 - CH2CH2 Ch n-C5Hu 32 0 - CH2CH2 Ch 11-C12H25 33 0 - CH2CH2 B-B n-C5Hn 34 0 - CH2CH2 B-B 11-C12H25 35 0 - CH2CH2 B-Ch n-C5Hn 36 0 - CH2CH2 B-Ch 11-C12H25 37 0 - CH2CH2 Ch-B n-CsHn 38 0 - CH2CH2 Ch-B 11-C12H25 44 591056 9825 pif 1 表9No. X1 G1 X " G2 R " 1 co-o BBB--n-CsHn 2 co-o BBB--Il-Ci2H25 3 co-o BB-Ch--11-C5H11 4 co-o BB-Ch-- n-Ci2H25 5 co-o B-Ch-Ch--n-CsHn 6 co-o B-Ch-Ch--11-C12H25 7 co-o Ch-Ch-Ch--n-C5Hu 8 co-o Ch -Ch-Ch--11-C12H25 9 ch2 B--n-CsHn 10 ch2 B--11-C12H25 11 ch2 Ch--n-C5Hn 12 ch2 Ch-〆11-C12H25 13 ch2 BB--n-C5Hu 14 ch2 BB--n-Ci2H25 15 ch2 B-Ch--n-C5Hu 16 ch2 B-Ch--11-C12H25 17 ch2 Ch-B--n-CsHn 18 ch2 Ch-B--11-C12H25 19 ch2 Ch -Ch--11-C5H11 20 ch2 Ch-Ch--11-C12H25 21 ch2 BBB--n-CsHn 22 ch2 BBB--II-C12H25 23 ch2 BB-Ch-n-CsHn 24 ch2 BB-Ch--n -Ci2H25 25 ch2 B-Ch-Ch--26 ch2 B-Ch-Ch--11-C12H25 27 ch2 Ch-Ch-Ch--n-C5Hn 28 ch2 Ch-Ch-Ch--11-C12H25 29 0- CH2CH2 B n-CsHn 30 0-CH2CH2 B 11-C12H25 31 0-CH2CH2 Ch n-C5Hu 32 0-CH2CH2 Ch 11-C12H25 33 0-CH2CH2 BB n-C5Hn 34 0-CH2CH2 BB 11-C12H25 35 0-CH2CH2 B -Ch n-C5Hn 36 0-CH2CH2 B-Ch 11-C12H25 37 0-CH2CH2 C h-B n-CsHn 38 0-CH2CH2 Ch-B 11-C12H25 44 591056 9825 pif 1 Table 9
No. X1 Gl G" R, 1 0 - CH2CH2 Ch-Ch n-CsHn 2 0 - CH2CH2 Ch-Ch 11-C12H25 3 0 - CH2CH2 B-B-B n-CsHn 4 0 - CH2CH2 B-B-B 11-C12H25 5 0 - CH2CH2 B-B-Ch n-C5Hn 6 0 - CH2CH2 B-B-Ch 11-C12H25 7 0 - CH2CH2 B-Ch-Ch n-CsHn 8 0 - CH2CH2 B-Ch-Ch 11-C12H25 9 0 - CH2CH2 Ch-Ch-Ch n-CsHn 10 0 - CH2CH2 Ch-Ch-Ch 11-C12H25 11 co-o - CH2CH2 B n-CsHn 12 co-o - CH2CH2 B 11-C12H25 13 co-o - CH2CH2 Ch n-CsHn 14 co-o - CH2CH2 Ch 11-C12H25 15 co-o - CH2CH2 B-B n-C5Hn 16 co-o - CH2CH2 B-B 11-C12H25 17 co-o - CH2CH2 B-Ch n-C5Hn 18 co-o - CH2CH2 B-Ch 11-C12H25 19 co-o - CH2CH2 Ch-B n-C5Hu 20 co-o - CH2CH2 Ch-B 11-C12H25 21 co-o - CH2CH2 Ch-Ch 11-C5H11 22 co-o - CH2CH2 Ch-Ch n-Ci2H25 23 co-o - CH2CH2 B-B-B n-C5Hn 24 co-o - CH2CH2 B-B-B 11-C12H25 25 co-o - CH2CH2 B-B-Ch 11-C5H11 26 co-o - CH2CH2 B-B-Ch 11-C12H25 27 co-o - CH2CH2 B-Ch-Ch n-C5Hn 28 co-o - CH2CH2 B-Ch-Ch 11-C12H25 29 co-o - GH2CH2 Ch-Ch-Ch n-CsHn 30 co-o - CH2CH2 Ch-Ch-Ch 11-C12H25 31 - B CH2CH2 B n-C5Hn 32 - B CH2CH2 Ch n-C5Hn 33 - B CH2CH2 B-B n-C5Hn 34 - B CH2CH2 B-Ch n-CsHn 35 - B CH2CH2 Ch-B 11-C5H11 36 - B CH2CH2 Ch-Ch n-C5Hn 37 - Ch CH2CH2 B n-CsHn 38 - Ch CH2CH2 Ch n-C5HuNo. X1 Gl G " R, 1 0-CH2CH2 Ch-Ch n-CsHn 2 0-CH2CH2 Ch-Ch 11-C12H25 3 0-CH2CH2 BBB n-CsHn 4 0-CH2CH2 BBB 11-C12H25 5 0-CH2CH2 BB- Ch n-C5Hn 6 0-CH2CH2 BB-Ch 11-C12H25 7 0-CH2CH2 B-Ch-Ch n-CsHn 8 0-CH2CH2 B-Ch-Ch 11-C12H25 9 0-CH2CH2 Ch-Ch-Ch n-CsHn 10 0-CH2CH2 Ch-Ch-Ch 11-C12H25 11 co-o-CH2CH2 B n-CsHn 12 co-o-CH2CH2 B 11-C12H25 13 co-o-CH2CH2 Ch n-CsHn 14 co-o-CH2CH2 Ch 11 -C12H25 15 co-o-CH2CH2 BB n-C5Hn 16 co-o-CH2CH2 BB 11-C12H25 17 co-o-CH2CH2 B-Ch n-C5Hn 18 co-o-CH2CH2 B-Ch 11-C12H25 19 co-o -CH2CH2 Ch-B n-C5Hu 20 co-o-CH2CH2 Ch-B 11-C12H25 21 co-o-CH2CH2 Ch-Ch 11-C5H11 22 co-o-CH2CH2 Ch-Ch n-Ci2H25 23 co-o-CH2CH2 BBB n-C5Hn 24 co-o-CH2CH2 BBB 11-C12H25 25 co-o-CH2CH2 BB-Ch 11-C5H11 26 co-o-CH2CH2 BB-Ch 11-C12H25 27 co-o-CH2CH2 B-Ch-Ch n -C5Hn 28 co-o-CH2CH2 B-Ch-Ch 11-C12H25 29 co-o-GH2CH2 Ch-Ch-Ch n-CsHn 30 co-o-CH2CH2 Ch-Ch-Ch 11-C12H25 31-B CH2CH2 B n -C5Hn 32-B CH2 CH2 Ch n-C5Hn 33-B CH2CH2 BB n-C5Hn 34-B CH2CH2 B-Ch n-CsHn 35-B CH2CH2 Ch-B 11-C5H11 36-B CH2CH2 Ch-Ch n-C5Hn 37-Ch CH2CH2 B n- CsHn 38-Ch CH2CH2 Ch n-C5Hu
45 591056 9825 pif 1 表1045 591056 9825 pif 1 Table 10
No. X1 G1 X2 G2 R5 1 - Ch ch2ch2 B-B 11-C5H11 2 - Ch CH2CH2 B-Ch 11-C5H11 3 - Ch ch2ch2 Ch-B 11-C5H11 4 - Ch CH2CH2 Ch-Ch n-C5Hu 5 - B-B CH2CH2 B n-C5Hn 6 - B-B CH2CH2 Ch n-C5Hn 7 - B-Ch CH2CH2 B 11-C5H11 8 - B-Ch CH2CH2 Ch n-C5Hn 9 - Ch-B CH2CH2 B 11-C5H11 10 - Ch-B ch2ch2 Ch n-C5Hn 11 - Ch-Ch CH2CH2 B n-C5Hn 12 - Ch-Ch CH2CH2 ,Ch 11-C5H11 13 0 B CH2CH2 B n-C5Hn 14 0 B ch2ch2 Ch n-C5Hn 15 0 B CH2CH2 B-B n-C5Hu 16 0 B CH2CH2 B-Ch 11-C5H11 17 0 B CH2CH2 Ch-B n-C5Hn 18 0 B ch2ch2 Ch-Ch 11-C5H11 19 0 Ch ch2ch2 B 11-C5H11 20 0 Ch ch2ch2 Ch Ϊ1-〇5Ηιι 21 0 Ch ch2ch2 B-B II-C5H11 22 0 Ch CH2CH2 B-Ch n-CsHn 23 0 Ch CH2CH2 Ch-B n-C5Hn 24 0 Ch ch2ch2 Ch-Ch n-CsHi, 25 0 B-B CH2CH2 B n-C5Hu 26 0 B-B CH2CH2 Ch n-C5Hu 27 0 B-Ch CH2CH2 B n-C5Hu 28 0 B-Ch ch2ch2 Ch n-C5Hii 29 0 Ch-B GH2CH2 B n-C5Hn 30 0 Ch-B CH2CH2 Ch n-CsHn 31 0 Ch-Ch CH2CH2 B n-C5Hu 32 0 Ch-Ch CH2CH2 Ch 11-C5H11 33 co-o B CH2CH2 B n-C5Hu 34 co-o B CH2CH2 Ch n-C5Hu 35 co-o B CH2CH2 B-B n-C5Hu 36 co-o B CH2CH2 B-Ch 11-C5H11 37 co-o B CH2CH2 Ch-B 11-C5H11 38 co-o B CH2CH2 Ch-Ch n-C5HuNo. X1 G1 X2 G2 R5 1-Ch ch2ch2 BB 11-C5H11 2-Ch CH2CH2 B-Ch 11-C5H11 3-Ch ch2ch2 Ch-B 11-C5H11 4-Ch CH2CH2 Ch-Ch n-C5Hu 5-BB CH2CH2 B n-C5Hn 6-BB CH2CH2 Ch n-C5Hn 7-B-Ch CH2CH2 B 11-C5H11 8-B-Ch CH2CH2 Ch n-C5Hn 9-Ch-B CH2CH2 B 11-C5H11 10-Ch-B ch2ch2 Ch n- C5Hn 11-Ch-Ch CH2CH2 B n-C5Hn 12-Ch-Ch CH2CH2, Ch 11-C5H11 13 0 B CH2CH2 B n-C5Hn 14 0 B ch2ch2 Ch n-C5Hn 15 0 B CH2CH2 BB n-C5Hu 16 0 B CH2CH2 B-Ch 11-C5H11 17 0 B CH2CH2 Ch-B n-C5Hn 18 0 B ch2ch2 Ch-Ch 11-C5H11 19 0 Ch ch2ch2 B 11-C5H11 20 0 Ch ch2ch2 Ch Ϊ1-〇5Ηιι 21 0 Ch ch2ch2 BB II- C5H11 22 0 Ch CH2CH2 B-Ch n-CsHn 23 0 Ch CH2CH2 Ch-B n-C5Hn 24 0 Ch ch2ch2 Ch-Ch n-CsHi, 25 0 BB CH2CH2 B n-C5Hu 26 0 BB CH2CH2 Ch n-C5Hu 27 0 B-Ch CH2CH2 B n-C5Hu 28 0 B-Ch ch2ch2 Ch n-C5Hii 29 0 Ch-B GH2CH2 B n-C5Hn 30 0 Ch-B CH2CH2 Ch n-CsHn 31 0 Ch-Ch CH2CH2 B n-C5Hu 32 0 Ch-Ch CH2CH2 Ch 11-C5H11 33 co-o B CH2CH2 B n-C5Hu 34 co-o B CH2CH2 Ch n-C5Hu 35 co-o B CH2CH2 BB n-C5Hu 36 co-o B CH2CH2 B-Ch 11-C5H11 37 co-o B CH2CH2 Ch-B 11-C5H11 38 co-o B CH2CH2 Ch-Ch n-C5Hu
46 591056 9825 pif 1 表1146 591056 9825 pif 1 Table 11
No. ΧΑ 1 co-o 2 co-o 3 co-o 4 co-o 5 co-o 6 co-o 7 co-o 8 co-o 9 co-o 10 co-o 11 co-o 12 co-o 13 co-o 14 co-o 15 ch2 16 ch2 17 ch2 18 ch2 19 ch2 20 ch2 21 ch2 22 ch2 23 ch2 24 ch2 25 ch2 26 ch2 27 ch2 28 ch2 29 ch2 30 ch2 31 ch2 32 ch2 33 ch2 34 ch2 35 0 36 0 37 0 38 0 G1 X2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 B-B CH2CH2 B-B CH2CH2 B-Ch CH2CH2 B-Ch CH2CH2 Ch-B CH2CH2 Ch-B CH2CH2 Ch-Ch CH2CH2 Ch-Ch CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch ch2ch2 B-B CH2CH2 B-B CH2CH2 B-Ch GH2CH2 B-Ch CH2CH2 Ch-B CH2CH2 Ch-B CH2CH2 Ch-Ch CH2CH2 Ch-Ch CH2CH2 - -No. ΧΑ 1 co-o 2 co-o 3 co-o 4 co-o 5 co-o 6 co-o 7 co-o 8 co-o 9 co-o 10 co-o 11 co-o 12 co- o 13 co-o 14 co-o 15 ch2 16 ch2 17 ch2 18 ch2 19 ch2 20 ch2 21 ch2 22 ch2 23 ch2 24 ch2 25 ch2 26 ch2 27 ch2 28 ch2 29 ch2 30 ch2 31 ch2 32 ch2 33 ch2 34 ch2 35 0 36 0 37 0 38 0 G1 X2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 BB CH2CH2 BB CH2CH2 B-Ch CH2CH2 B-Ch CH2CH2 Ch-B CH2CH2 Ch-B CH2CH2 Ch-Ch CH2CH2 Ch-Ch CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 B CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch CH2CH2 Ch ch2ch2 BB CH2CH2 BB CH2CH2 B-Ch GH2CH2 B-Ch CH2CH2 Ch-B CH2CH2 Ch-B CH2CH2--
G2 R" B 11-C5H11 Ch n-CsHn B-B n-C5Hn B-Ch 11-C5H11 Ch-B n-CsHn Ch-Ch 11-C5H11 B n-CsHn Ch n-CsHu B n-CsHn Ch n-C5Hn B n-CsHn Ch 11-C5H11 B n-C5Hu Ch n-C5Hn B n-CsHn Ch 11-C5H11 B-B n-C5Hn B-Ch n-CsHn Ch-B n-C5Hn Ch-Ch n-CsHn B n-CsHn Ch n-CsHn B-B n-C5Hn B-Ch 11-C5H11 Ch-B n-CsHn Ch-Ch 11-C5H11 B n-CsHn Ch n-CsHn B n-CsHn Ch 11-C5H11 B n-C5H" Ch n-C5Hu B n-C5Hu Ch n-CsHn B-B H B-B H B-B F B-B F 47 591056 9825 pifl 表12G2 R " B 11-C5H11 Ch n-CsHn BB n-C5Hn B-Ch 11-C5H11 Ch-B n-CsHn Ch-Ch 11-C5H11 B n-CsHn Ch n-CsHu B n-CsHn Ch n-C5Hn B n-CsHn Ch 11-C5H11 B n-C5Hu Ch n-C5Hn B n-CsHn Ch 11-C5H11 BB n-C5Hn B-Ch n-CsHn Ch-B n-C5Hn Ch-Ch n-CsHn B n-CsHn Ch n-CsHn BB n-C5Hn B-Ch 11-C5H11 Ch-B n-CsHn Ch-Ch 11-C5H11 B n-CsHn Ch n-CsHn B n-CsHn Ch 11-C5H11 B n-C5H " Ch n-C5Hu B n-C5Hu Ch n-CsHn BB H BB H BB F BB F 47 591 056 9825 pifl Table 12
No. X1 G1 X2 G2 R5 1 0 - - B-B CN 2 0 - - B-B CN 3 0 - - B-B OH 4 0 - 一 B-B OH 5 0 - B-B O-C2H5 6 0 - - B-B O-C2H5 7 C0-0 - - B-B H 8 C0-0 - - B-B H 9 C0-0 - - B-B F 10 C0-0 - - B-B F 11 C0-0 - - B-B CN 12 C0-0 - - B-B CN 13 C0-0 - 漏 B-B OH 14 C0-0 - - B-B OH 15 C0-0 - - B-B O-C2H5 16 C0-0 - - B-B O-C2H5 17 0 - ch2ch2 B-B H 18 0 - CH2CH2 B-B H 19 0 - CH2CH2 B-B F 20 0 - CH2CH2 B-B F 21 0 - CH2CH2 B-B CN 22 0 - CH2CH2 B-B CN 23 0 - CH2CH2 B-B OH 24 0 - CH2CH2 B-B OH 25 0 - CH2CH2 B-B O-C2H5 26 0 CH2CH2 B-B O-C2H5 27 C0-0 - CH2CH2 B-B H 28 C0-0 - CH2CH2 B-B H 29 C0-0 - CH2CH2 B-B F 30 C0-0 - CH2CH2 B-B F 31 C0-0 - CH2CH2 B-B CN 32 C0-0 - CH2CH2 B-B CN 33 C0-0 CH2CH2 B-B OH 34 C0-0 - CH2CH2 B-B OH 35 C0-0 - CH2CH2 B-B O-C2H5 36 C0-0 - ch2ch2 B-B O-C2H5 式(21)所示之二胺化合物並不以上述實例所示之化合 物爲限。也可以組合使用上述化合物之2種以上。在此類 之二胺化合物中,在G1及/或G2具有多個環,X1及/或X2 48 591056 9825 pif 1 爲長鏈之烷撐之情形下,當R5爲碳數較大之基團時,可得 到液晶上具有較大之前傾角的液晶配向膜。 可提供式(4)所示之有機殘基的二胺化合物係如同式 (22)所示。 6No. X1 G1 X2 G2 R5 1 0--BB CN 2 0--BB CN 3 0--BB OH 4 0-One BB OH 5 0-BB O-C2H5 6 0--BB O-C2H5 7 C0-0 --BB H 8 C0-0--BB H 9 C0-0--BB F 10 C0-0--BB F 11 C0-0--BB CN 12 C0-0--BB CN 13 C0-0-Leak BB OH 14 C0-0--BB OH 15 C0-0--BB O-C2H5 16 C0-0--BB O-C2H5 17 0-ch2ch2 BB H 18 0-CH2CH2 BB H 19 0-CH2CH2 BB F 20 0 -CH2CH2 BB F 21 0-CH2CH2 BB CN 22 0-CH2CH2 BB CN 23 0-CH2CH2 BB OH 24 0-CH2CH2 BB OH 25 0-CH2CH2 BB O-C2H5 26 0 CH2CH2 BB O-C2H5 27 C0-0-CH2CH2 BB H 28 C0-0-CH2CH2 BB H 29 C0-0-CH2CH2 BB F 30 C0-0-CH2CH2 BB F 31 C0-0-CH2CH2 BB CN 32 C0-0-CH2CH2 BB CN 33 C0-0 CH2CH2 BB OH 34 C0 -0-CH2CH2 BB OH 35 C0-0-CH2CH2 BB O-C2H5 36 C0-0-ch2ch2 BB O-C2H5 The diamine compound represented by the formula (21) is not limited to the compounds shown in the above examples. Two or more of the above compounds may be used in combination. In such a diamine compound, when G1 and / or G2 have multiple rings, and X1 and / or X2 48 591056 9825 pif 1 is a long-chain alkylene, when R5 is a group having a large carbon number At this time, a liquid crystal alignment film having a large previous tilt angle on the liquid crystal can be obtained. The diamine compound capable of providing an organic residue represented by the formula (4) is as represented by the formula (22). 6
在式(22)中X3、X4、R6、R7、ul及u2係分別與式(4) 所示之記號爲同一的。 式(22)所示之二胺化合物之具體例i部份係由X3、 ul、R6及R7之組合而得,如同表13〜表19所示。然X4 = X3,且u2 = ul。在此表中,「-」係表示單鍵。 49 5 殳 1056 9825 pifl 表13In formula (22), X3, X4, R6, R7, ul, and u2 are respectively the same as the symbols shown in formula (4). Part i of the specific example of the diamine compound represented by formula (22) is obtained by a combination of X3, ul, R6, and R7, as shown in Tables 13 to 19. Then X4 = X3 and u2 = ul. In this table, "-" indicates a single bond. 49 5 殳 1056 9825 pifl Table 13
No. X3 ul R6 R7 1 0 H n-C3H7 2 0 H iso-C3H7 3 0 H 11-C4H9 4 0 H 1S0-C4H9 5 0 H SCC-C4H9 6 0 H tcrt-C4H9 7 0 H n_C5Hu 8 0 H η-〇6Ηΐ3 9 0 H 11-C7H15 10 0 H η-〇δΗΐ7 11 0 H 11-C9H19 12 0 H n-Ci〇H2i 13 0 H n-CnH23 14 0 H n-Ci2H25 15 0 CII3 n-C3H7 16 0 ch3 1S0-C3H7 17 0 ch3 11-C4H9 18 0 ch3 1SO-C4H9 19 0 ch3 sec-C4H9 20 0 ch3 tert-C4H9 21 0 ch3 n-C5Hu 22 0 ch3 n-C6H13 23 0 ch3 11-C7H15 24 0 ch3 n-CgHn 25 0 ch3 11-C9H19 26 0 ch3 11-C10H21 27 0 ch3 11-C11H23 28 0 ch3 11-C12H25 29 0 I1-C3H7 c2h5 30 0 11-C3H7 11-C3H7 31 0 I1-C3H7 11-C4H9 32 0 I1-C3H7 n-C5Hn 33 0 11-C3H7 n-QHu 34 0 I1-C3H7 n-C7H15 35 0 n-C3H7 n-CeHn 36 0 n-C3H7 11-C9H19 37 0 11-C3H7 n-Ci〇H2i 38 0 n-C3H7 n-CnH23 39 0 11-C3H7 11-C12H25 40 0 n-C4H9 11-C4H9 41 0 1SO-C4H9 1SO-C4H9 42 0 sec-C4H9 sec-C4H9 43 0 tert-C4H9 tert-C4H9 44 0 n-CeHn η-ΟόΗπ 45 0 11-C12H25 11-C12H25 50 591056 9825 pif 1 表14No. X3 ul R6 R7 1 0 H n-C3H7 2 0 H iso-C3H7 3 0 H 11-C4H9 4 0 H 1S0-C4H9 5 0 H SCC-C4H9 6 0 H tcrt-C4H9 7 0 H n_C5Hu 8 0 H η -〇6Ηΐ3 9 0 H 11-C7H15 10 0 H η-〇δΗΐ7 11 0 H 11-C9H19 12 0 H n-Ci〇H2i 13 0 H n-CnH23 14 0 H n-Ci2H25 15 0 CII3 n-C3H7 16 0 ch3 1S0-C3H7 17 0 ch3 11-C4H9 18 0 ch3 1SO-C4H9 19 0 ch3 sec-C4H9 20 0 ch3 tert-C4H9 21 0 ch3 n-C5Hu 22 0 ch3 n-C6H13 23 0 ch3 11-C7H15 24 0 ch3 n -CgHn 25 0 ch3 11-C9H19 26 0 ch3 11-C10H21 27 0 ch3 11-C11H23 28 0 ch3 11-C12H25 29 0 I1-C3H7 c2h5 30 0 11-C3H7 11-C3H7 31 0 I1-C3H7 11-C4H9 32 0 I1-C3H7 n-C5Hn 33 0 11-C3H7 n-QHu 34 0 I1-C3H7 n-C7H15 35 0 n-C3H7 n-CeHn 36 0 n-C3H7 11-C9H19 37 0 11-C3H7 n-CioH2i 38 0 n-C3H7 n-CnH23 39 0 11-C3H7 11-C12H25 40 0 n-C4H9 41 0 1SO-C4H9 1SO-C4H9 42 0 sec-C4H9 sec-C4H9 43 0 tert-C4H9 44 0 n- CeHn η-ΟόΗπ 45 0 11-C12H25 11-C12H25 50 591056 9825 pif 1 Table 14
No. X3 ill R6 R7 1 - 1 H 11-C3H7 2 - 1 H 1SO-C3H7 3 - 1 H 11-C4H9 4 - 1 H 1SO-C4H9 5 - 1 H sec-C4H9 6 1 H tert-C4H9 7 - 1 H n-C5Hn 8 - 1 H η-〇6Ηΐ3 9 - 1 H n-C7H15 10 - 1 H n-CgHn 11 - 1 H 11-C9H19 12 - 1 H 11-C10H21 13 - 1 H n-CnH23 14 - 1 H n-Ci2H25 15 - 1 ch3 n - C3H7 16 - 1 ch3 iso-C3H7 17 - 1 ch3 n-C4H9 18 - 1 ch3 ISO-C4H9 19 - 1 ch3 sec-C4H9 20 - 1 ch3 tdt-C4H9 21 - 1 ch3 n-C5Hn 22 - 1 ch3 η-ΟόΗπ 23 - 1 ch3 n-C7H15 24 - 1 ch3 n-C8H17 25 1 ch3 11-C9H19 26 - 1 ch3 11-C10H21 27 - 1 ch3 11-C11H23 28 - 1 ch3 11-C12H25 29 - 1 I1-C3H7 c2h5 30 - 1 n-C3H7 I1-C3H7 31 - 1 11-C3H7 11-C4H9 32 - 1 11-C3H7 11-C5H11 33 - 1 11-C3H7 n-CeH^ 34 - 1 11-C3H7 n-C7H15 35 - 1 11-C3H7 n-CgHn 36 禪 1 11-C3H7 11-C9H19 37 - 1 11-C3H7 11-C10H21 38 - 1 11-C3H7 n-CiiH23 39 - 1 11-C3H7 11-C12H25 40 - 1 11-C4H9 11-C4H9 41 - 1 1S0-C4H9 1SO-C4H9 42 - 1 sec-C4H9 sec-C4H9 43 - 1 tert-C4H9 tert-C4H9 44 - 1 n-C^Hn n-CeHn 45 - 1 11-C12H25 11-C12H25 51 591056 9825 pif 1 表15No. X3 ill R6 R7 1-1 H 11-C3H7 2-1 H 1SO-C3H7 3-1 H 11-C4H9 4-1 H 1SO-C4H9 5-1 H sec-C4H9 6 1 H tert-C4H9 7-1 H n-C5Hn 8-1 H η-〇6Ηΐ3 9-1 H n-C7H15 10-1 H n-CgHn 11-1 H 11-C9H19 12-1 H 11-C10H21 13-1 H n-CnH23 14-1 H n-Ci2H25 15-1 ch3 n-C3H7 16-1 ch3 iso-C3H7 17-1 ch3 n-C4H9 18-1 ch3 ISO-C4H9 19-1 ch3 sec-C4H9 20-1 ch3 tdt-C4H9 21-1 ch3 n-C5Hn 22-1 ch3 η-ΟόΗπ 23-1 ch3 n-C7H15 24-1 ch3 n-C8H17 25 1 ch3 11-C9H19 26-1 ch3 11-C10H21 27-1 ch3 11-C11H23 28-1 ch3 11- C12H25 29-1 I1-C3H7 c2h5 30-1 n-C3H7 I1-C3H7 31-1 11-C3H7 11-C4H9 32-1 11-C3H7 11-C5H11 33-1 11-C3H7 n-CeH ^ 34-1 11- C3H7 n-C7H15 35-1 11-C3H7 n-CgHn 36 Zen 1 11-C3H7 11-C9H19 37-1 11-C3H7 11-C10H21 38-1 11-C3H7 n-CiiH23 39-1 11-C3H7 40 -1 11-C4H9 11-C4H9 41-1 1S0-C4H9 1SO-C4H9 42-1 sec-C4H9 sec-C4H9 43-1 tert-C4H9 tert-C4H9 44-1 nC ^ Hn n-CeHn 45-1 11-C12H25 11-C12H25 51 591056 9825 pif 1 Table 15
No. X3 ul R6 R7 1 ch2 1 H 11-C3H7 2 ch2 1 H ISO-C3H7 3 ch2 1 H η-〇4Η9 4 ch2 1 H 1S0-C4H9 5 ch2 1 H sec-C4H9 6 ch2 1 H 7 ch2 1 H n-CsHn 8 ch2 1 H η-〇Η13 9 ch2 1 H 11-C7H15 10 ch2 1 H n-CgHn 11 ch2 1 H 11-C9H19 12 ch2 1 H n-Ci〇H2i 13 ch2 1 H n-CnH23 14 ch2 1 H 11-C12H25 15 ch2 1 ch3 11-C3H7 16 ch2 1 ch3 1S0-C3H7 17 ch2 1 ch3 11-C4H9 18 ch2 1 ch3 1SO-C4H9 19 ch2 1 ch3 sec-C4H9 20 ch2 1 ch3 tert-C4H9 21 ch2 1 ch3 11-C5H11 22 ch2 1 ch3 n-C6H13 23 ch2 1 ch3 11-C7H15 24 ch2 1 ch3 n-C8H17 25 ch2 1 ch3 11-C9H19 26 ch2 1 ch3 11-C10H21 27 ch2 1 ch3 11-C11H23 28 ch2 1 ch3 11-C12H25 29 ch2 1 11-C3H7 c2h5 30 ch2 1 I1-C3H7 11-C3H7 31 ch2 1 11-C3H7 11-C4H9 32 ch2 1 H-C3H7 n-CsHn 33 ch2 1 n-C3H7 n-QHu 34 ch2 1 11-C3H7 η-〇7Ηΐ5 35 ch2 1 11-C3H7 n-CgHn 36 ch2 1 11-C3H7 11-C9H19 37 ch2 1 11-C3H7 n-Ci〇H2i 38 ch2 1 11-C3H7 11-C11H23 39 ch2 1 n-C3H7 11-C12H25 40 ch2 1 n-C4H9 11-C4H9 41 ch2 1 1SO-C4H9 1SO-C4H9 42 ch2 1 sec-C4H9 sec-C4H9 43 ch2 1 44 ch2 1 n-CgHn η-〇Η13 45 ch2 1 11-C12H25 11-C12H25 52 591056 9825 pifl 表16No. X3 ul R6 R7 1 ch2 1 H 11-C3H7 2 ch2 1 H ISO-C3H7 3 ch2 1 H η-〇4Η9 4 ch2 1 H 1S0-C4H9 5 ch2 1 H sec-C4H9 6 ch2 1 H 7 ch2 1 H n-CsHn 8 ch2 1 H η-〇Η13 9 ch2 1 H 11-C7H15 10 ch2 1 H n-CgHn 11 ch2 1 H 11-C9H19 12 ch2 1 H n-Ci〇H2i 13 ch2 1 H n-CnH23 14 ch2 1 H 11-C12H25 15 ch2 1 ch3 11-C3H7 16 ch2 1 ch3 1S0-C3H7 17 ch2 1 ch3 11-C4H9 18 ch2 1 ch3 1SO-C4H9 19 ch2 1 ch3 sec-C4H9 20 ch2 1 ch3 tert-C4H9 ch3 11-C5H11 22 ch2 1 ch3 n-C6H13 23 ch2 1 ch3 11-C7H15 24 ch2 1 ch3 n-C8H17 25 ch2 1 ch3 11-C9H19 26 ch2 1 ch3 11-C10H21 27 ch2 1 ch3 11-C11H23 28 ch2 11-C12H25 29 ch2 1 11-C3H7 c2h5 30 ch2 1 I1-C3H7 11-C3H7 31 ch2 1 11-C3H7 11-C4H9 32 ch2 1 H-C3H7 n-CsHn 33 ch2 1 n-C3H7 n-QHu 34 ch2 1 11 -C3H7 η-〇7Ηΐ5 35 ch2 1 11-C3H7 n-CgHn 36 ch2 1 11-C3H7 11-C9H19 37 ch2 1 11-C3H7 n-Ci〇H2i 38 ch2 1 11-C3H7 11-C11H23 39 ch2 1 n-C3H7 11-C12H25 40 ch2 1 n-C4H9 11-C4H9 41 ch2 1 1SO-C4H9 1SO-C4H9 42 ch2 1 sec-C4H9 sec-C4H9 43 ch2 1 4 4 ch2 1 n-CgHn η-〇Η13 45 ch2 1 11-C12H25 11-C12H25 52 591056 9825 pifl Table 16
No. X3 ul R6 Rv 1 ch2ch2 1 H 11-C3H7 2 ch2ch2 1 H 1S0-C3H7 3 ch2ch2 1 H 11-C4H9 4 ch2ch2 1 H 1S0-C4H9 5 ch2ch2 1 H sec-C4H9 6 ch2ch2 1 H tcrt-C4H9 7 ch2ch2 1 H n-C5Hn 8 ch2ch2 1 H η-〇6Ηΐ3 9 CH2CH2 1 H n-C7H15 10 ch2ch2 1 H n-C8H17 11 CH2CH2 1 H 11-C9H19 12 ch2ch2 1 H 11-C10H21 13 ch2ch2 1 H 11-C11H23 14 CH2CH2 1 H 11-C12H25 15 ch2ch2 1 CII3 11-C3H7 16 CH2CH2 1 ch3 1SO-C3H7 17 ch2ch2 1 ch3 11-C4H9 18 CH2CH2 1 ch3 IS0-C4H9 19 ch2ch2 1 ch3 sec-C4H9 20 ch2ch2 1 ch3 tert-C4H9 21 ch2ch2 1 ch3 n-CsHn 22 ch2ch2 1 ch3 n-C6H13 23 CH2CH2 1 ch3 11-C7H15 24 ch2ch2 1 ch3 n-CsHn 25 CH2CH2 1 ch3 11-C9H19 26 CH2CH2 1 ch3 n-Ci〇H2i 27 ch2ch2 1 ch3 11-C11H23 28 ch2ch2 1 ch3 11-C12H25 29 ch2ch2 1 I1-C3H7 c2h5 30 ch2ch2 1 I1-C3H7 11-C3H7 31 CH2CH2 1 11-C3H7 n-C4H9 32 ch2ch2 1 I1-C3H7 n-C5Hn 33 CH2CH2 1 I1-C3H7 11-C6H13 34 ch2ch2 1 n-C3H7 n-C7H15 35 ch2ch2 1 n-C3H7 n-CgHn 36 ch2ch2 1 11-C3H7 11-C9H19 37 CH2CH2 1 n-C3H7 n-Ci〇H2i 38 ch2ch2 1 n-C3H7 n-CnH23 39 ch2ch2 1 11-C3H7 11-C12H25 40 ch2ch2 1 11-C4H9 11-C4H9 41 CH2CH2 1 1SO-C4H9 1S0-C4H9 42 ch2ch2 1 sec-C4H9 sec-C4H9 43 ch2ch2 1 tert-C4H9 tert-C4H9 44 ch2ch2 1 n-C6H13 11-C6H13 45 CH2CH2 1 n-Ci2H25 11-C12H25 53 591056 9825 pif 1 表17No. X3 ul R6 Rv 1 ch2ch2 1 H 11-C3H7 2 ch2ch2 1 H 1S0-C3H7 3 ch2ch2 1 H 11-C4H9 4 ch2ch2 1 H 1S0-C4H9 5 ch2ch2 1 H sec-C4H9 6 ch2ch2 1H 2 1 H n-C5Hn 8 ch2ch2 1 H η-〇6Ηΐ3 9 CH2CH2 1 H n-C7H15 10 ch2ch2 1 H n-C8H17 11 CH2CH2 1 H 11-C9H19 12 ch2ch2 1 H 11-C10H21 13 ch2ch2 1 H 11-C11H23 14 CH2CH2 1 H 11-C12H25 15 ch2ch2 1 CII3 11-C3H7 16 CH2CH2 1 ch3 1SO-C3H7 17 ch2ch2 1 ch3 11-C4H9 18 CH2CH2 1 ch3 IS0-C4H9 19 ch2ch2 1 ch3 sec-C4H9 20 ch2ch2 1 2 ch3 n-CsHn 22 ch2ch2 1 ch3 n-C6H13 23 CH2CH2 1 ch3 11-C7H15 24 ch2ch2 1 ch3 n-CsHn 25 CH2CH2 1 ch3 11-C9H19 26 CH2CH2 1 ch3 n-CioH2i 27 ch2 ch2C2 1H 1 ch3 11-C12H25 29 ch2ch2 1 I1-C3H7 c2h5 30 ch2ch2 1 I1-C3H7 11-C3H7 31 CH2CH2 1 11-C3H7 n-C4H9 32 ch2ch2 1 I1-C3H7 n-C5Hn 33 CH2CH2 1 I1-C3H3 11- 1 n-C3H7 n-C7H15 35 ch2ch2 1 n-C3H7 n-CgHn 36 ch2ch2 1 11-C3H7 11-C9H19 37 CH2CH2 1 n-C3H7 n-Ci〇H2i 38 ch2ch2 1 n-C3H7 n-CnH23 39 ch2 ch2 1 11-C3H7 11-C12H25 40 ch2ch2 1 11-C4H9 11-C4H9 41 CH2CH2 1 1SO-C4H9 1S0-C4H9 42 ch2ch2 1 sec-C4H9 sec-C4H9 43 ch2ch2 1 tert-C4H9 1 1 t-C4H9 11-C6H13 45 CH2CH2 1 n-Ci2H25 11-C12H25 53 591056 9825 pif 1 Table 17
No. X3 ul R6 Rv 1 0 1 Η n-C3H7 2 0 1 Η 1SO-C3H7 3 0 1 Η 11-C4H9 4 ο 1 Η 1SO-C4H9 5 0 1 Η sec-C4H9 6 ο 1 Η tert-C4H9 7 ο 1 Η n-C5Hn 8 ο 1 Η n-C6H13 9 0 1 Η n-C7H15 10 0 1 Η n-CgHn 11 0 1 Η 11-C9H19 12 0 1 Η 11-C10H21 13 0 1 Η n-CiiH23 14 0 1 Η 11-C12H25 15 ο 1 ch3 11-C3H7 16 ο 1 ch3 1SO-C3H7 17 ο 1 ch3 n-C4H9 18 0 1 ch3 1SO-C4H9 19 0 1 ch3 sec-C4H9 20 0 1 ch3 tert-C4H9 21 0 1 ch3 n-C5Hn 22 ο 1 ch3 n-C6H13 23 0 1 ch3 n-C7H15 24 ο 1 ch3 n-CsHn 25 ο 1 ch3 11-C9H19 26 ο 1 ch3 n-Ci〇H2i 27 0 1 ch3 n-CiiH23 28 ο 1 ch3 11-C12H25 29 0 1 11-C3H7 c2h5 30 0 1 I1-C3H7 11-C3H7 31 0 1 n-C3H7 11-C4H9 32 0 1 11-C3H7 n-C5Hn 33 ο 1 11-C3H7 n-CeH^ 34 ο 1 n-C3H7 n-C7H15 35 0 1 11-C3H7 n-CsHp 36 ο 1 11-C3H7 11-C9H19 37 0 1 11-C3H7 n-Ci〇H2i 38 0 1 11-C3H7 n-CiiH23 39 0 1 11-C3H7 11-C12H25 40 0 1 11-C4H9 n-C4H9 41 0 1 1SO-C4H9 1SO-C4H9 42 ο 1 sec-C4H9 sec-C4H9 43 ο 1 tcrt-C4H9 tert-C4H9 44 ο 1 n-C6H13 II-C6H13 45 ο 1 11-C12H25 II-C12H25 54 9825 pif 1 表18No. X3 ul R6 Rv 1 0 1 Η n-C3H7 2 0 1 Η 1SO-C3H7 3 0 1 Η 11-C4H9 4 ο 1 Η 1SO-C4H9 5 0 1 Η sec-C4H9 6 ο 1 Η tert-C4H9 7 ο 1 Η n-C5Hn 8 ο 1 Η n-C6H13 9 0 1 Η n-C7H15 10 0 1 Η n-CgHn 11 0 1 Η 11-C9H19 12 0 1 Η 11-C10H21 13 0 1 Η n-CiiH23 14 0 1 Η 11-C12H25 15 ο 1 ch3 11-C3H7 16 ο 1 ch3 1SO-C3H7 17 ο 1 ch3 n-C4H9 18 0 1 ch3 1SO-C4H9 19 0 1 ch3 sec-C4H9 20 0 1 ch3 tert-C4H9 21 0 1 ch3 n-C5Hn 22 ο 1 ch3 n-C6H13 23 0 1 ch3 n-C7H15 24 ο 1 ch3 n-CsHn 25 ο 1 ch3 11-C9H19 26 ο 1 ch3 n-Ci〇H2i 27 0 1 ch3 n-CiiH23 28 ο 1 ch3 11-C12H25 29 0 1 11-C3H7 c2h5 30 0 1 I1-C3H7 11-C3H7 31 0 1 n-C3H7 11-C4H9 32 0 1 11-C3H7 n-C5Hn 33 ο 1 11-C3H7 n-CeH ^ 34 ο 1 n-C3H7 n-C7H15 35 0 1 11-C3H7 n-CsHp 36 ο 1 11-C3H7 11-C9H19 37 0 1 11-C3H7 n-Ci〇H2i 38 0 1 11-C3H7 n-CiiH23 39 0 1 11- C3H7 11-C12H25 40 0 1 11-C4H9 n-C4H9 41 0 1 1SO-C4H9 1SO-C4H9 42 ο 1 sec-C4H9 sec-C4H9 43 ο 1 tcrt-C4H9 tert-C4H9 44 ο 1 n-C6H13 II-C6H13 45 ο 1 11-C12H25 II -C12H25 54 9825 pif 1 Table 18
No. X3 ul R6 R1 1 0 1 H 11-C3F7 2 0 1 H 1SO-C3F7 3 0 1 H 11-C4F9 4 0 1 H 1SO-C4F9 5 0 1 H sec-C4F9 6 o 1 H tert-C4F9 7 0 1 H 11-C5F11 8 0 1 H n-C6F13 9 o 1 H n-C7F15 10 0 1 H n-C8Fn 11 o 1 H 11-C9F19 12 0 1 H n-Ci〇F2i 13 0 1 H n-CnF23 14 o 1 H 11-C12F25 15 0 1 cf3 11-C3F7 16 o 1 cf3 1SO-C3F7 17 0 1 cf3 11-C4F9 18 0 1 cf3 ISO-C4F9 19 0 1 cf3 sec-C4F9 20 0 1 cf3 tert-C4F9 21 0 1 cf3 11-C5F11 22 0 1 cf3 n-QF13 23 0 1 cf3 11-C7F15 24 o 1 cf3 n-CgFn 25 0 1 cf3 11-C9F19 26 0 1 cf3 11-C10F21 27 0 1 cf3 11-C11F23 28 0 1 cf3 11-C12F25 29 0 1 11-C3F7 c2f5 30 0 1 I1-C3F7 11-C3F7 31 0 1 H-C3F7 11-C4F9 32 0 1 11-C3F7 n-CsFn 33 0 1 I1-C3F7 n-CeFn 34 0 1 11-C3F7 11-C7F15 35 o 1 I1-C3F7 n-CgFn 36 0 1 11-C3F7 11-C9F19 37 0 1 11-C3F7 n-Ci〇F2i 38 0 1 11-C3F7 11-C11F23 39 0 1 n-C3F7 11-C12F25 40 o 1 11-C4F9 11-C4F9 41 0 1 1SO-C4F9 1SO-C4F9 42 o 1 sec-C4F9 sec-C4F9 43 0 1 tcrt-C4F9 tert-C4p9 44 o 1 n-C6F13 n-C6Fi3 45 0 1 n-Ci2F25 n-Ci2F25 55 591056 9825 pifl 表19No. X3 ul R6 R1 1 0 1 H 11-C3F7 2 0 1 H 1SO-C3F7 3 0 1 H 11-C4F9 4 0 1 H 1SO-C4F9 5 0 1 H sec-C4F9 6 o 1 H tert-C4F9 7 0 1 H 11-C5F11 8 0 1 H n-C6F13 9 o 1 H n-C7F15 10 0 1 H n-C8Fn 11 o 1 H 11-C9F19 12 0 1 H n-Ci〇F2i 13 0 1 H n-CnF23 14 o 1 H 11-C12F25 15 0 1 cf3 11-C3F7 16 o 1 cf3 1SO-C3F7 17 0 1 cf3 11-C4F9 18 0 1 cf3 ISO-C4F9 19 0 1 cf3 sec-C4F9 20 0 1 cf3 tert-C4F9 21 0 1 cf3 11-C5F11 22 0 1 cf3 n-QF13 23 0 1 cf3 11-C7F15 24 o 1 cf3 n-CgFn 25 0 1 cf3 11-C9F19 26 0 1 cf3 11-C10F21 27 0 1 cf3 11-C11F23 28 0 1 cf3 11-C12F25 29 0 1 11-C3F7 c2f5 30 0 1 I1-C3F7 11-C3F7 31 0 1 H-C3F7 11-C4F9 32 0 1 11-C3F7 n-CsFn 33 0 1 I1-C3F7 n-CeFn 34 0 1 11-C3F7 11-C7F15 35 o 1 I1-C3F7 n-CgFn 36 0 1 11-C3F7 11-C9F19 37 0 1 11-C3F7 n-Ci〇F2i 38 0 1 11-C3F7 11-C11F23 39 0 1 n-C3F7 11-C12F25 40 o 1 11-C4F9 11-C4F9 41 0 1 1SO-C4F9 1SO-C4F9 42 o 1 sec-C4F9 sec-C4F9 43 0 1 tcrt-C4F9 tert-C4p9 44 o 1 n-C6F13 n-C6Fi3 45 0 1 n-Ci2F25 n-Ci2F25 55 591056 9825 pifl Table 19
No. XJ ul R6 Ry 1 0 2 ch3 n-C3H7 2 0 2 ch3 11-C4H9 3 0 2 ch3 n-C5H„ 4 0 2 ch3 II-C6H13 5 ο 2 ch3 II-C7H15 6 0 2 ch3 n-C8H17 7 0 2 ch3 11-C9H19 8 ο 2 ch3 11-C10H21 9 0 2 ch3 11-C11H23 10 0 2 ch3 11-C12H25 11 0 2 ch3 11-C3H7 12 0 2 ch3 11-C4H9 13 0 2 ch3 n-C5H„ 14 ο 2 ch3 n-C6H13 15 0 2 ch3 11-C7H15 16 0 2 ch3 n-CgHn 17 0 2 ch3 11-C9H19 18 0 2 ch3 11-C10H21 19 0 2 ch3 11-C11H23 20 0 2 ch3 11-C12H25No. XJ ul R6 Ry 1 0 2 ch3 n-C3H7 2 0 2 ch3 11-C4H9 3 0 2 ch3 n-C5H „4 0 2 ch3 II-C6H13 5 ο 2 ch3 II-C7H15 6 0 2 ch3 n-C8H17 7 0 2 ch3 11-C9H19 8 ο 2 ch3 11-C10H21 9 0 2 ch3 11-C11H23 10 0 2 ch3 11-C12H25 11 0 2 ch3 11-C3H7 12 0 2 ch3 11-C4H9 13 0 2 ch3 n-C5H „14 ο 2 ch3 n-C6H13 15 0 2 ch3 11-C7H15 16 0 2 ch3 n-CgHn 17 0 2 ch3 11-C9H19 18 0 2 ch3 11-C10H21 19 0 2 ch3 11-C11H23 20 0 2 ch3 11-C12H25
式(22)所示之二胺化合物並不以上述實例所示之化合 物爲限。也可以組合使用上述化合物之2種以上。在此類 之二胺化合物中,當R6及R7爲氫或碳數較小之基團時, 用此所得之本發明之液晶配向劑,係得到液晶上具有稍微 小之前傾角的液晶配向膜。 可提供式(5)所示之有機殘基的二胺化合物係如同式 (23)所示。The diamine compound represented by the formula (22) is not limited to the compounds shown in the above examples. Two or more of the above compounds may be used in combination. In such a diamine compound, when R6 and R7 are hydrogen or a small carbon number group, the liquid crystal alignment agent of the present invention thus obtained is used to obtain a liquid crystal alignment film having a slightly smaller pretilt angle on the liquid crystal. The diamine compound capable of providing an organic residue represented by the formula (5) is as represented by the formula (23).
記號爲同一的’且對於苯環之置換基及胺基之結合位置係 爲任意的。 56 591056 9825 pifl 式(23)所示之二胺化合物之具體例一部份係由X5、 R8、m及η之組合而得,如同表20〜表21所示。在此表中, 「-」係表示單鍵。再者,此表中所記載之二胺化合物係爲 2個胺基分別對苯環之甲撐基之鍵結位置以對位相鍵結,且 與環己烯以同一正位相鍵結的化合物。The symbol is the same, and the bonding position of the substituent group and the amine group of the benzene ring is arbitrary. 56 591056 9825 pifl The specific examples of the diamine compound represented by formula (23) are obtained in part from the combination of X5, R8, m and η, as shown in Tables 20 to 21. In this table, "-" indicates a single bond. In addition, the diamine compounds described in this table are compounds in which two amine groups are respectively bonded to the parasite of the phenyl ring by a para phase, and are bonded to the same normal phase with cyclohexene.
57 591056 9825 pif 1 表2057 591056 9825 pif 1 Table 20
No. R" XD m n 1 H - 0 1 2 ch3 - 0 1 3 C2H5 - 0 1 4 n-C3H7 - 0 1 5 n-C4H9 - 0 1 6 n-CsHn - 0 1 7 Π-〇6Ηΐ3 - 0 1 8 n-C7H15 - 0 1 9 n-CgHn - 0 1 10 11-C9H19 - 0 1 11 11-C10H21 - 0 1 12 11-C11H23 - 0 1 13 11-C12H25 - 0 1 14 H - 1 1 15 ch3 - 1 1 16 C2H5 - 1 1 17 n-C3H7 - 1 1 18 H-C4H9 - 1 1 19 n-C5Hn - 1 1 20 n-C6H13 - 1 1 21 n-C7Hi5 - 1 1 22 n-CsHn - 1 1 23 11-C9H19 - 1 1 24 11-C10H21 - 1 1 25 n-CnH23 - 1 1 26 11-C12H25 - 1 1 27 H - 2 1 28 ch3 - 2 1 29 C2H5 - 2 1 30 11-C3H7 - 2 1 31 n-C4H9 - 2 1 32 n-CsHn - 2 1 33 n-C^Hn - 2 1 34 11-C7H15 - 2 1 35 n-CgHn - 2 1 36 11-C9H19 - 2 1 37 11-C10H21 - 2 1 38 n-CnH23 - 2 1 39 11-C12H25 - 2 1 58 591056 9825 pif 1 表21No. R " XD mn 1 H-0 1 2 ch3-0 1 3 C2H5-0 1 4 n-C3H7-0 1 5 n-C4H9-0 1 6 n-CsHn-0 1 7 Π-〇6Ηΐ3-0 1 8 n-C7H15-0 1 9 n-CgHn-0 1 10 11-C9H19-0 1 11 11-C10H21-0 1 12 11-C11H23-0 1 13 11-C12H25-0 1 14 H-1 1 15 ch3- 1 1 16 C2H5-1 1 17 n-C3H7-1 1 18 H-C4H9-1 1 19 n-C5Hn-1 1 20 n-C6H13-1 1 21 n-C7Hi5-1 1 22 n-CsHn-1 1 23 11-C9H19-1 1 24 11-C10H21-1 1 25 n-CnH23-1 1 26 11-C12H25-1 1 27 H-2 1 28 ch3-2 1 29 C2H5-2 1 30 11-C3H7-2 1 31 n-C4H9-2 1 32 n-CsHn-2 1 33 nC ^ Hn-2 1 34 11-C7H15-2 1 35 n-CgHn-2 1 36 11-C9H19-2 1 37 11-C10H21-2 1 38 n -CnH23-2 1 39 11-C12H25-2 1 58 591056 9825 pif 1 Table 21
No. R8 X) m n 1 Η CH2CH2 1 1 2 ch3 CH2CH2 1 1 3 C2H5 CH2CH2 1 1 4 n-C3H7 ch2ch2 1 1 5 11-C4H9 CH2CH2 1 1 6 n-C5H„ CH2CH2 1 1 7 η-〇6Ηΐ3 CH2CH2 1 1 8 n-C7H15 CH2CH2 1 1 9 n-CgHn CH2CH2 1 1 10 11-C9H19 CH2CH2 1 1 11 11-C10H21 CH2CH2 1 1 12 n-CnH23 CH2CH2 1 1 13 11-C12H25 CH2CH2 L 1 14 H CH2CH2 1 2 15 ch3 CH2CH2 1 2 16 C2H5 CH2CH2 1 2 17 11-C3H7 CH2CH2 1 2 18 11-C4H9 CH2CH2 1 2 19 n-C5Hn CH2CH2 1 2 20 n-C6H13 CH2CH2 1 2 21 n-C7H15 CH2CH2 1 2 22 n-C8H17 CH2CH2 1 2 23 11-C9H19 CH2CH2 1 2 24 11-C10H21 CH2CH2 1 2 25 11-C11H23 CH2CH2 1 2 26 11-C12H25 CH2CH2 1 2 27 H CH2CH2 1 4 28 ch3 CH2CH2 1 4 29 C2H5 CH2CH2 1 4 30 n-C3H7 CH2CH2 1 4 31 11-C4H9 CH2CH2 1 4 32 n-C5Hu CH2CH2 1 4 33 n-C6H13 CH2CH2 1 4 34 n-C7H,5 CH2CH2 1 4 35 n-CgHn CH2CH2 1 4 36 11-C9H19 CH2CH2 1 4 37 n-Ci〇H2i CH2CH2 1 4 38 11-C11H23 CH2CH2 1 4 39 11-C12H25 CH2CH2 1 4 式(23)所示之二胺化合物並不以上述實例所示之化合 物爲限。也可以組合使用上述化合物之2種以上。在此類 59 504056 9825 pif 1 之二胺化合物中,在m爲0,R8爲氫或短鏈之院基之情形 下時,當X5爲單鍵或短鏈之烷撐時,前傾角會微微變小。 而當m爲1〜3,且R8爲氫,X5爲單鍵時則前傾角會變大。 以上所示之具體例僅爲可提供式(2)〜式(5)所分別表 不之有機殘基的二胺化合物之一部份。除此之外,也存在 有具有碳數爲3以上之側鏈基的二胺化合物。例如,具有 巢系之側鏈的亞苯基二胺衍生物。本發明所使用之二胺化 合物,只要可以達成本發明之目的,也可以從含有此二胺 化合物之廣泛的範圍中選擇。 在本發明中,爲了調整成所要求之前傾角數値,同時 使用上述具有碳數爲3以上之側鏈基的二胺化合物(以下 簡稱第一群二胺化合物)以及不具有碳數爲3以上之側鏈 基的二胺化合物(以下簡稱第二群二胺化合物),以有效地 增大前傾角。在本發明中所使用之第二群二胺化合物中, 可區分成芳香族系二胺化合物、脂環式系二胺化合物及脂 肪族系二胺化合物,且前述化合物係選自於多種習知文獻 所記載之物質。習知文獻之一實例例如是W001/00732A1 公報之19〜20頁及34〜37頁所記載之二胺化合物。除此 之外,與此公報上所記載之二胺化合物有所關連之物質, 例如是其胺基之鍵結位置不同的物質、其結構中之烷基及/ 或烷撐之碳數不同的物質、任意氫置換成氟的物質、芳香 環之烷基置換基之個數不同的物質。更甚之,例如是具有 醚基的二胺化合物。 在前述中,本發明所使用之第二群二胺化合物可以從 60 591056 9825 pif 1 非常多之化合物中任意選擇一種使用,也可以組合使用2 種以上。唯’第二群二胺化合物內之脂肪族系之物質較佳 係於可保持良好液晶配向性之範圍內使用。再者,第二群 二胺化合物之中,具有醚、酯、硫醚、硫酯等之基團的物 質,爲了保持較高之液晶顯示元件之電性質,需對其使用 量限制。 當製造本發明之N置換聚醯胺-亞醯胺之際,且在第 一群二胺化合物與第二群二胺化合物並用之情形下,表示 兩者之比率的莫爾比(第一群二胺化合物7第二群二胺化合 物)係爲(100/0)〜(1/99)。較佳係爲(100/0)〜(10/90), 更佳係爲(100/0)〜( 20/80)。唯,此範圍可以隨著所並 用之化合物之種類及所要求之前傾角之値而變動,而非爲 一個確定的値。而且,當第一二胺化合物之比率增加時, 前傾角也會變大。 在本發明之N置換聚醯胺-亞醯胺中,分子中所存在 之全部醯胺鍵結之30莫爾%以上之N上係結合有一價之有 機基。此一價之有機基係從由碳數爲1〜20之烷基、碳數 爲1〜8的羥基烷基、碳數爲2〜20的烷氧烷基、碳數爲2 〜15的不飽和脂肪族基、具有脂環式基的基團、芳香族系 碳氫基、具有巢骨架的基團、具有羰基的基團、有機甲矽 烷基、及含有有機甲矽烷基的基團等所組成之族群中選擇 一個以上的基團。在此類之有機基中所含有之院基及院撐 之任意氫也可以置換成氟。在芳香族系碳氫基中’芳香環 之任意氫也可以置換成烷基、烷氧基、或-CN。此烷基及烷 61 591056 9825 pif 1 氧基之任意氫也可以置換成氟。而且,作爲一種芳香族碳 氫基的芳院基上之烷撐也可以藉由氧原子而與芳香環鍵 結。 然而,以撓曲性高的基團作爲一價之有機基時,會導 致液晶配向性極端惡化,因此在考慮對液晶配向性之影響 的情形下係使用碳數爲5以下的有機基,較佳係使用碳數 爲5以下的烷基。而且,此烷基中之任意-CH2_不限於連續 接2個-0_,也可以置換成-0、-CO-或-COO-。然而,此― 價有機基在不會對液晶配向性造成問題的情形下,也可以 使用前述之有機基。而且,此一價有機基之置換比例較佳 係爲50莫爾%以上。此比例更佳係爲7〇莫爾%以上。當將 此一價之有機基導入聚醯胺-亞醯胺以作爲液晶配向劑清 漆使用之情形時’可以得到較大之提高電特性的效果。爲 了完全發揮此效果,N置換聚醯胺_亞醯胺中之此一價有機 基的比例必需爲30莫爾%以上。 此一價有機基之實例如下所不。院基之實例,例如是 甲基、乙基、正丙基、正丁基、正戊基、正己基、正庚 正,基、正壬基、正癸基、正十一院基、正十二烷基、正 十三院基、正十四院基、正十五烷基、正十六烷基、正十 七烷基、正十八烷基、正十九烷基、正二十烷基、異丙基、 異丁基、另丁基、特丁基、異戊基、新戊基、特戊基、卜 甲基戊基、2-甲基戊基、3_甲基戊基、4_甲基戊基、異己基、 1-乙基戊基、2-乙基戊基、3-乙基戊基、‘乙基戊基、2,4_ 一甲基己基、2,3,5-二乙基庚基、Η氟(代)甲基、全氟(代) 62 9825 pifl 乙基、正全氟(代)丙基、正全氟(代)丁基、正全氟(代) 戊基、正全氟(代)己基、正全氟(代)庚基、正全氟(代) 辛基、正全氟(代)壬基、正全氟(代)癸基、正全氟(代) -j——院基、正全贏(代)十二院基、正全氟(代)十三院 基、正全氟(代)十四烷基、正全氟(代)十五烷基、正 全氟(代)十六烷基、正全氟(代)十七烷基、正全氟(代) 十八烷基、正全氟(代)十九烷基、正全氟(代)二十烷 基等。 羥基烷基之實例,例如是羥基甲基、羥基乙基、羥基 丙基、羥基丁基、羥基戊基、羥基己基等。烷氧烷基之實 例,例如是甲氧甲基、甲氧乙基、甲氧丙基、甲氧丁基、 甲氧戊基、甲氧己基、乙氧甲基、乙氧乙基、乙氧丙基、 乙氧丁基、乙氧戊基、乙氧己基、己基羥甲基、己基羥乙 基、己基羥丙基、己基羥丁基、己基羥戊基、己基羥己基、 等。不飽和脂肪族基的實例,例如是乙烯基、乙炔基、ΙΕ烯基、 2-丙烯基 、異丙烯基、 2-丁烯基 、丁二烯-[1,3]_基 、 2-戊烯基、2-戊烯-4炔、2-壬基-2-丁烯基等。 具有脂環式基的基團之實例,例如是環丙基、環丁 基、環戊基、環己基、聯二環己烷基、環丙基甲基、環丁 基甲基、環戊基甲基、環己基甲基、聯二環己基甲基、2-環戊烯-1-炔、2,4-環戊二烯-1-炔等。芳香族系碳氫基之實 例,例如是苯基、2,6-二甲基苯基、2,6-二異丙基苯基、聯 本基、一^本基、聯二本基、卡基、聯苯基甲基、二苯基甲 基、聯三苯基甲基、4-甲基苄基、4-(特丁基)苄基、α- 63 591056 9825 pif 1 甲基苄基、1-萘基、2-萘基、9-蒽基甲基、4-甲氧基苄基、 苯氧基甲基、苄基羥基甲基、二苯基羥基甲基、萘基羥基 甲基、4_三氟甲基苄基、氰基苯基、氰基聯苯基、氰基聯 三苯基、氰基基、氰基苯基甲基、氰基聯苯基甲基、氰基 聯三苯基甲基等。含氧雜環系的基團之實例,例如是糠基、 (3-呋喃基)甲基、2-氧雜環丁基甲基、3-氧雜環丁基甲基、 oxolanyl methyl、dioxolanyl methyl 等。 巢骨架之實例,例如是膽巢基、雄巢基、β膽巢基、 表雄巢基、Ergostery卜雌巢基、Ilex-羥基甲基巢基、Ilex 黃體巢基、羊毛巢基、Methyltestosteryl、Norethisteryl、孕 巢基、β谷巢基、豆巢基、Testostery卜乙酸膽巢醇酯等。 含有羰基之基團的實例,例如是甲醯基、乙醯基、苯醯基、 甲氧基羰基、苯基甲氧基羰基等。有機甲矽烷基及包含有 機甲矽烷基之基團的實例,例如是三甲基矽烷、三乙基矽 烷、三苯基矽烷、4-三甲基矽烷基等。 在上述較佳實例中,較佳係爲碳數爲5以下的一價有 機基。具體而言,例如是甲基、乙基、正丙基、正丁基、 正戊基、異丙基、異丁基、另丁基、特丁基、異戊基、新 戊基、特戊基、乙烯基、乙炔基、1-丙烯基、2-丙烯基、異 丙烯基、2-丁烯基、丁二烯-[1,3]-基、2-戊烯基、2-戊烯-4 炔、環丙基、環丁基、環戊基、環丙基甲基、環丁基甲基、 2-環戊烯-1-炔、2,4-環戊二烯-1-炔、三氟(代)甲基、全 氟(代)乙基、甲氧甲基、甲氧乙基、甲氧丙基、甲氧丁 基、乙氧甲基、乙氧乙基、乙氧丙基、羥基甲基、羥基乙 64 59^^56 9825 pif 1 基、羥基丙基、羥基丁基、羥基戊基、糠基、(3_咲喃基) 甲基、2-氧雜環丁基甲基、3-氧雜環丁基甲基、〇x〇lanyl methyl、dioxolanyl methyl、甲醯基、乙醢基等。 本發明之N置換聚醯胺-亞醯胺係藉由下述之方法所 合成。首先’最初之方法係使二氨化合物與羧酸類反應而 合成聚醯胺-亞醯胺。接著,進行將所得之聚醯胺-亞醯胺之 醯胺鍵結(CONH)之氫原子置換成一價有機基的方法。在下 述說明中,將此方法稱爲後置換法。當聚醯胺-亞醯胺與溶 解於溶劑中之鹽基反應之後,會藉由與一價有機基之鹵化 物所發生之反應,而得到N置換聚醯胺_亞醯胺。此時所使 用之溶劑之實例,例如是二甲亞楓、N-甲基吡喀烷酮、N,N_ 二甲基甲醯胺、N,N-二甲替乙醯胺等。鹽基之實例,例如 是甲醇鈉、氫化鈉氫化鉀、氫氧化鈉、氫氧化鉀、丁基鋰、 三乙胺等。 合成本發明之N置換聚醯胺-亞醯胺的另一種方法係 爲使用預先將氨基(NH2)置換成一價有機基的二氨化合物 (N置換二氨化合物)製造聚醯胺-亞醯胺的方法(以下簡 稱前置換法)。此N置換二氨化合物可藉由參照習知之有機 合成法而輕易地得到。其實例爲(Ο二氨化合物與醛類(如 丙醛、苯甲醛等)或酮類(如甲基乙酮、環己酮等)進行 脫水聚合反應而得亞胺化合物,再將此亞胺之雙鍵還原的 方法;(2)二氨化合物與酸鹵化物類(如乙醯氧化物、苯 甲酸氧化物等)進行反應而得醯胺化合物,再將此醯胺之 羰基以氫化鋰鋁等還原的方法;以及(3 )N置換苯胺類(如 65 591056 9825 pif 1 N_甲基苯胺、N,N-二苯基胺、N-甲基-3-甲苯胺等)與甲醛 在酸催化劑之存在下進行反應’以得到N,N,-置換二醯胺基 二苯基甲烷類的方法等。 接著,對聚醯胺-亞醯胺之製造方法進行說明。生成醯 胺鍵結的反應係爲羧酸鹵化物與氨基在攝氏〇度〜攝氏 300度之溫度範圍內所進行之反應。此反應也可以使用二甲 亞楓、N-甲基吡喀烷酮、N,N-二甲基甲醯胺、N,N-二甲替 , 乙醯胺等的溶劑。再者,也可以在吡啶或三乙基胺等之存 _ 在下進行反應。生成醯胺鍵結之另一種方法係爲羧基與氨 基在吡啶之存在下於攝氏〇度〜攝氏300度之範圍內進行 反應的方法。此時,也可以使用前述溶劑,也可以使用 (PhO)3P、(PhO)PCl2、PhPOCl2 或(C3H7)3P(〇)〇 等的縮合劑。 另一方面,亞醯胺鍵結之生成:首先,在必要之溶劑之存 在下,並於攝氏0度〜攝氏100度之範圍內,使環狀之二 羧酸酐與氨基反應而得到醯胺酸,之後,加入吡啶及無水 醋酸,並於攝氏0度〜攝氏200度之範圍內進行反應而生 成。 ® 也可以使用由二氨化合物與光氣(phosgene) 2量體等 . 反應而得之二異氰酸鹽化合物,進行生成醯胺鍵結的反應 > 及生成亞醯胺鍵結的反應。此生成醯胺鍵結的反應係爲羧 基與前述二異氰酸鹽化合物中之二異氰酸鹽基在攝氏〇度 〜攝氏300度之範圍內所進行之反應。在此反應中,也可 以使用前述溶劑或乙二醇(一)甲基醚、四氫呋喃、環己 酮、甲基乙酮、乙腈、或r-丁內酯等的溶劑。也可以使用 66 591056 9825 pif 1 三級胺類、鹼金屬化合物、鹼土金屬化合物等的觸媒或少 量的水或二甲苯、甲苯等的芳香族碳化氫等。而且,當使 用環狀之二羧酸酐替換羧基時,也與生成醯胺鍵結的反應 相同,而直接生成亞醯胺鍵結。 因此,爲了合成本發明之聚醯胺-亞醯胺的羧酸原料較 佳爲由下列⑴〜(V)之組合。 ⑴酸酐結構及酸鹵化物基中至少具有一種的羧酸類。 (H)具有酸酐結構及酸鹵化物基的羧酸類之至少一種 以及二羧酸二酸鹵化物之至少一種。 (iii)具有酸酐結構及酸鹵化物基的羧酸類之至少一種 以及四羧酸類(四羧酸二酸酐、四羧酸四酸鹵化物、或四 羧酸之2個羧基變成酸酐結構且將殘留之2個羧基酸鹵化 物化的衍生物)之至少一種。 (iv) 二羧酸二酸鹵化物之至少一種以及前述四羧酸類 之至少一種。 (v) 具有環狀二羧酸酐結構及酸鹵化物基的羧酸類之 至少一種、二羧酸二酸鹵化物之至少一種、以及前述四羧 酸類之至少一種。 使用由上述所組合而得之羧酸原料之任一種與二氨 化合物,在溶劑之存在下,使最初的酸酐結構與氨基進行 反應。接著,加入吡啶或三乙基胺等,以使酸鹵化物與氨 基反應而合成聚醯胺-醯胺酸。之後,再加入無水醋酸並加 熱之,以使醯胺酸結構進行脫水閉環,而合成得到聚醯胺_ 67 591056 9825 pifl 亞醯胺。 合成聚醯胺-亞醯胺之方法之次一實例係爲使用下述 之羧酸原料之組合(Vi)〜(X)的方法。 (Vi)酸酐結構及羧基中至少具有一種的羧酸類。 ㈣具有隨浦及__關之至少—種以及二 羧酸之至少一種。 (vm)具有酸酐結構及羧基的羧酸類之至少一種以及四 羧酸二酸酐之至少一種。 · (ix)二羧酸之至少一種以及前述四羧酸二酸酐之至少 _ 一*種。 (X)具有酸酐結構及羧基的羧酸類之至少一種、二羧酸 之至少一種、以及前述四羧酸二酸酐之至少一種。 此組合(vi)〜(x)之任一與二異氰酸鹽化合物,在溶劑之 存在下,且與對應必要之觸媒(如三級胺類、鹼金屬化合 物、鹼土金屬化合物等)一起,或與少量之水或芳香族碳 化氫(如二甲苯、甲苯等)一起,於攝氏〇度〜攝氏3〇〇 · 度之範圍下進行反應。 再者,使用前述組合(vi)〜(X)之任一與二氨化合物,在 溶劑之存在下’由最初之酸酐結構與氨基進行反應,接著 · 與縮合劑(如(PhO)3P、(PhO)PCl2、PhPOCl2 或(C3H7)3P02 等)及吡啶一起,於攝氏0度〜攝氏300度之範圍下進行 反應,也可以合成得到聚醯胺-醯胺酸。之後,再加入無水 醋酸並加熱之,以使醯胺酸結構進行脫水閉環,而合成得 68 9825 pifi 到聚醯胺-亞醯胺。 當使用前置換法合成本發明之N置換聚醯胺-亞醯胺 時,則述聚醯胺-亞醯胺合成法中,係以前述N置換二氨化 口物代替二氨化合物作爲原料。在最初,利用具有酸酐結 構及酸鹵化物基的竣酸類與前述之N置換二氨化合物,合 成而彳守式(24)所示之具有N置換醯胺鍵結的羧酸衍生物。 接者,使此羧酸衍生物與二氨化合物進行縮聚合反應,而 得到具有N置換醯胺鍵結的聚醯胺_醯胺酸。之後,藉由使 醯胺酸鍵結亞醯胺化,而得到聚醯胺_亞醯胺。也可以由式No. R8 X) mn 1 Η CH2CH2 1 1 2 ch3 CH2CH2 1 1 3 C2H5 CH2CH2 1 1 4 n-C3H7 ch2ch2 1 1 5 11-C4H9 CH2CH2 1 1 6 n-C5H „CH2CH2 1 1 7 η-〇6Ηΐ3 CH2CH2 1 1 8 n-C7H15 CH2CH2 1 1 9 n-CgHn CH2CH2 1 1 10 11-C9H19 CH2CH2 1 1 11 11-C10H21 CH2CH2 1 1 12 n-CnH23 CH2CH2 1 1 13 11-C12H25 CH2CH2 L 1 14 H CH2CH2 1 2 15 ch3 CH2CH2 1 2 16 C2H5 CH2CH2 1 2 17 11-C3H7 CH2CH2 1 2 18 11-C4H9 CH2CH2 1 2 19 n-C5Hn CH2CH2 1 2 20 n-C6H13 CH2CH2 1 2 21 n-C7H15 CH2CH2 1 2 22 n-C8H17 CH2CH2 1 2 23 11-C9H19 CH2CH2 1 2 24 11-C10H21 CH2CH2 1 2 25 11-C11H23 CH2CH2 1 2 26 11-C12H25 CH2CH2 1 2 27 H CH2CH2 1 4 28 ch3 CH2CH2 1 4 29 C2H5 CH2CH2 1 4 30 n-C3H7 CH2CH2 1 4 31 11-C4H9 CH2CH2 1 4 32 n-C5Hu CH2CH2 1 4 33 n-C6H13 CH2CH2 1 4 34 n-C7H, 5 CH2CH2 1 4 35 n-CgHn CH2CH2 1 4 36 11-C9H19 CH2CH2 1 4 37 n-Ci〇H2i CH2CH2 1 4 38 11-C11H23 CH2CH2 1 4 39 11-C12H25 CH2CH2 1 4 The diamine compound represented by formula (23) is not limited to the compounds shown in the above examples. The above-mentioned compounds can also be used in combination 2 or more. In this type of diamine compound of 59 504056 9825 pif 1, when m is 0 and R8 is hydrogen or a short-chain radical, when X5 is a single bond or a short-chain alkylene , The rake angle will become slightly smaller. When m is 1 to 3, R8 is hydrogen, and X5 is a single bond, the forward tilt angle becomes larger. The specific examples shown above are only a part of the diamine compounds that can provide the organic residues represented by the formulas (2) to (5), respectively. In addition, there are diamine compounds having a side chain group having 3 or more carbon atoms. For example, a phenylene diamine derivative having a side chain in a nest system. As long as the diamine compound used in the present invention can achieve the purpose of the present invention, it can be selected from a wide range containing the diamine compound. In the present invention, in order to adjust the required inclination angle 値, the above-mentioned diamine compound having a side chain group having a carbon number of 3 or more (hereinafter referred to as the first group of diamine compounds) and a carbon number not having a number of 3 or more are used simultaneously. The side chain group of the diamine compound (hereinafter referred to as the second group of diamine compounds) to effectively increase the forward tilt angle. Among the second group of diamine compounds used in the present invention, they can be divided into aromatic diamine compounds, alicyclic diamine compounds, and aliphatic diamine compounds, and the aforementioned compounds are selected from various conventional methods. Substances recorded in the literature. An example of the conventional literature is, for example, the diamine compounds described in pages 19 to 20 and pages 34 to 37 of the W001 / 00732A1 publication. In addition, the substances related to the diamine compounds described in this bulletin are, for example, substances having different amine bond positions, and different alkyl and / or alkylene carbon numbers in their structures. Substances, substances in which arbitrary hydrogen is replaced with fluorine, and substances in which the number of alkyl substituents of the aromatic ring are different. Furthermore, it is, for example, a diamine compound having an ether group. In the foregoing, the second group of diamine compounds used in the present invention may be used arbitrarily by selecting one of a large number of compounds of 60 591056 9825 pif 1, or may be used in combination of two or more. It is preferred that the aliphatic-based substance in the second group of diamine compounds is used within a range that can maintain good liquid crystal alignment. Furthermore, among the second group of diamine compounds, substances having groups such as ether, ester, thioether, thioester, etc., in order to maintain high electrical properties of the liquid crystal display element, it is necessary to limit the amount of use thereof. When the N-substituted polyamidoamine-iminomine of the present invention is produced, and when the first group of diamine compounds and the second group of diamine compounds are used together, a Mohr ratio (the first group) The diamine compound 7 diamine compound of the second group) is (100/0) to (1/99). The preferred range is (100/0) to (10/90), and the more preferred range is (100/0) to (20/80). However, this range may vary depending on the type of compound used and the 之前 of the required previous inclination, rather than a definite 値. Moreover, as the ratio of the first diamine compound increases, the forward tilt angle also increases. In the N-substituted polyamidoamine-iminomine of the present invention, more than 30 mol% of N of all the amidine bonds present in the molecule is bonded to a monovalent organic group. This monovalent organic group is composed of an alkyl group having 1 to 20 carbon atoms, a hydroxyalkyl group having 1 to 8 carbon atoms, an alkoxyalkyl group having 2 to 20 carbon atoms, and a carbon group having 2 to 15 carbon atoms. Saturated aliphatic groups, alicyclic groups, aromatic hydrocarbon groups, nested skeleton groups, carbonyl groups, organosilyl groups, and organosilyl groups. Select more than one group from the group of the composition. Arbitrary hydrogen contained in the radicals and the radicals contained in such organic radicals can also be replaced with fluorine. In the aromatic hydrocarbon group, any hydrogen of the 'aromatic ring' may be replaced with an alkyl group, an alkoxy group, or -CN. Any hydrogen of this alkyl group and alkane 61 591056 9825 pif 1 oxygen group may be replaced with fluorine. Moreover, an alkylene group on an aromatic compound, which is an aromatic hydrocarbon group, may be bonded to an aromatic ring through an oxygen atom. However, when a highly flexible group is used as a monovalent organic group, the alignment of the liquid crystal will be extremely deteriorated. Therefore, when considering the effect on the alignment of the liquid crystal, an organic group with a carbon number of 5 or less is used. Preferably, an alkyl group having a carbon number of 5 or less is used. Furthermore, any -CH2_ in this alkyl group is not limited to two consecutive -0_, but may be replaced with -0, -CO- or -COO-. However, as long as the valence organic group does not cause a problem in the alignment of the liquid crystal, the aforementioned organic group can also be used. The substitution ratio of the monovalent organic group is preferably 50 mol% or more. This ratio is more preferably 70 mol% or more. When such a monovalent organic group is introduced into polyamidoamine-iminomine to be used as a liquid crystal alignment agent varnish ', a large effect of improving electrical characteristics can be obtained. In order to fully exert this effect, it is necessary that the proportion of the monovalent organic group in the N-substituted polyamidine-iminomine is 30 mol% or more. Examples of this monovalent organic group are as follows. Examples of academic groups are, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, n-heptyl, n-, n-nonyl, n-decyl, n-undecyl, n-decyl Dialkyl, n-tridecyl, n-tetradecyl, n-pentadecyl, n-hexadecyl, n-heptadecyl, n-octadecyl, n-nonadecyl, n-icosane Base, isopropyl, isobutyl, isobutyl, tert-butyl, isopentyl, neopentyl, terpentyl, methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methyl Methylpentyl, isohexyl, 1-ethylpentyl, 2-ethylpentyl, 3-ethylpentyl, 'ethylpentyl, 2,4-monomethylhexyl, 2,3,5-di Ethylheptyl, fluoren (methyl), perfluoro (substituted) 62 9825 pifl Ethyl, n-perfluoro (substituted) propyl, n-perfluoro (substituted) butyl, n-perfluoro (substituted) pentyl , N-perfluoro (generation) hexyl, n-perfluoro (generation) heptyl, n-perfluoro (generation) octyl, n-perfluoro (generation) nonyl, n-perfluoro (generation) decyl, n-perfluoro (generation) ) -J——Fundamental base, Zhengquan wins (on behalf of) Twelve Faculty bases, Full perfluorinated (on behalf) Thirteen homestead bases, Full perfluorinated (on behalf) ) Tetradecyl, n-perfluoro (substituted) pentadecyl, n-perfluoro (substituted) cetyl, n-perfluoro (substituted) heptyl, n-perfluoro (substituted) octadecyl, N-perfluoro (substituted) nonadecanyl, n-perfluoro (substituted) eicosyl, etc. Examples of the hydroxyalkyl group are, for example, hydroxymethyl, hydroxyethyl, hydroxypropyl, hydroxybutyl, hydroxypentyl, and hydroxyhexyl. Examples of alkoxyalkyl are, for example, methoxymethyl, methoxyethyl, methoxypropyl, methoxybutyl, methoxypentyl, methoxyhexyl, ethoxymethyl, ethoxyethyl, ethoxy Propyl, ethoxybutyl, ethoxypentyl, ethoxyhexyl, hexylhydroxymethyl, hexylhydroxyethyl, hexylhydroxypropyl, hexylhydroxybutyl, hexylhydroxypentyl, hexylhydroxyhexyl, and the like. Examples of unsaturated aliphatic groups are, for example, vinyl, ethynyl, IE alkenyl, 2-propenyl, isopropenyl, 2-butenyl, butadiene- [1,3] -yl, 2-pentyl Alkenyl, 2-pentene-4yne, 2-nonyl-2-butenyl, and the like. Examples of the group having an alicyclic group are, for example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, bicyclohexane, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl , Cyclohexylmethyl, bicyclohexylmethyl, 2-cyclopentene-1-yne, 2,4-cyclopentadiene-1-yne, and the like. Examples of the aromatic hydrocarbon group are, for example, phenyl, 2,6-dimethylphenyl, 2,6-diisopropylphenyl, bibenyl, monobenzyl, dibenzyl, card Group, biphenylmethyl, diphenylmethyl, bitriphenylmethyl, 4-methylbenzyl, 4- (tert-butyl) benzyl, α-63 591056 9825 pif 1 methylbenzyl, 1-naphthyl, 2-naphthyl, 9-anthrylmethyl, 4-methoxybenzyl, phenoxymethyl, benzylhydroxymethyl, diphenylhydroxymethyl, naphthylhydroxymethyl, 4-trifluoromethylbenzyl, cyanophenyl, cyanobiphenyl, cyanobitriphenyl, cyano, cyanophenylmethyl, cyanobiphenylmethyl, cyanobitri Phenylmethyl and the like. Examples of the oxygen-containing heterocyclic group are furfuryl, (3-furyl) methyl, 2-oxetanylmethyl, 3-oxetanylmethyl, oxolanyl methyl, dioxolanyl methyl, and the like. Examples of nested skeletons are, for example, biliary, basal, β-biliary, epistasyl, Ergostery, Ilex-hydroxymethyl nest, Ilex luteal nest, wool nest, Methyltestosteryl, Norethisteryl, Pregnostyl, Beta-Nestyl, Bean-Nestyl, Testostery Cholesterol Acetate, etc. Examples of the carbonyl-containing group are, for example, methylamidino, ethylamido, phenylamidino, methoxycarbonyl, phenylmethoxycarbonyl and the like. Examples of the organosilyl group and the group containing an organosilyl group are, for example, trimethylsilane, triethylsilane, triphenylsilane, 4-trimethylsilyl, and the like. Among the above-mentioned preferred examples, a monovalent organic group having a carbon number of 5 or less is preferred. Specifically, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, isopropyl, isobutyl, isobutyl, tert-butyl, isopentyl, neopentyl, tert-pentyl Base, vinyl, ethynyl, 1-propenyl, 2-propenyl, isopropenyl, 2-butenyl, butadiene- [1,3] -yl, 2-pentenyl, 2-pentene -4 alkyne, cyclopropyl, cyclobutyl, cyclopentyl, cyclopropylmethyl, cyclobutylmethyl, 2-cyclopentene-1-yne, 2,4-cyclopentadiene-1-yne, tris Fluoro (methyl), perfluoro (ethyl), methoxymethyl, methoxyethyl, methoxypropyl, methoxybutyl, ethoxymethyl, ethoxyethyl, ethoxypropyl, Hydroxymethyl, hydroxyethyl 64 59 ^^ 98 98 pif 1 group, hydroxypropyl group, hydroxybutyl group, hydroxypentyl group, furfuryl group, (3-pyranyl) methyl group, 2-oxetanylmethyl group, 3 -Oxetanylmethyl, oxolanyl methyl, dioxolanyl methyl, formamyl, ethenyl and the like. The N-substituted polyamidoamine-iminomine of the present invention is synthesized by the following method. First, the first method was to synthesize polyamidoamines by using diamine compounds and carboxylic acids. Next, a method of substituting the hydrogen atom of the amidine bond (CONH) of the obtained polyamidine-imideneamine (CONH) with a monovalent organic group is performed. In the following description, this method is called a post-replacement method. After the polyamidoamine-iminomine reacts with a salt group dissolved in a solvent, the N-substituted polyamidoamine-iminomine is obtained through a reaction with a halogenated compound of a monovalent organic group. Examples of the solvent to be used at this time are, for example, dimethylmethylene maple, N-methylpyrrolidone, N, N-dimethylformamide, N, N-dimethylformamide, and the like. Examples of the base are, for example, sodium methoxide, sodium hydride, potassium hydride, sodium hydroxide, potassium hydroxide, butyllithium, and triethylamine. Another method for synthesizing the N-substituted polyamidoamine-iminomine of the present invention is to use a diamine compound (N-substituted diamine compound) in which an amino group (NH2) is replaced with a monovalent organic group in advance, to produce polyamidoamine-iminomine. Method (hereinafter referred to as pre-replacement method). This N-substituted diamine compound can be easily obtained by referring to a conventional organic synthesis method. An example is dehydration polymerization reaction of (0 diamine compound with aldehydes (such as propionaldehyde, benzaldehyde, etc.) or ketones (such as methyl ethyl ketone, cyclohexanone, etc.) to obtain an imine compound, and then this imine Method for reducing double bond; (2) Diamine compound reacts with acid halide (such as acetamidine oxide, benzoic acid oxide, etc.) to obtain amidine compound, and then the carbonyl group of this amidine is lithium aluminum hydride And other reduction methods; and (3) N-substituted anilines (such as 65 591056 9825 pif 1 N-methylaniline, N, N-diphenylamine, N-methyl-3-toluidine, etc.) and formaldehyde in acid A method of performing a reaction in the presence of a catalyst to obtain N, N,-substituted diamido diphenylmethanes, etc. Next, a method for producing polyamidoamine-iminomine is described. The reaction is a reaction of a carboxylic acid halide and an amino group in a temperature range of 0 ° C to 300 ° C. This reaction can also use dimethylsulfenyl, N-methylpyrrolidone, N, N-di Solvents for methylformamide, N, N-dimethylformamidine, ethamidine, etc. Furthermore, it may be in pyridine or triethyl And so on_ to carry out the reaction. Another method to generate amidine bonding is a method of reacting a carboxyl group with an amino group in the presence of pyridine at a temperature of 0 ° C to 300 ° C. At this time, the foregoing can also be used As the solvent, a condensing agent such as (PhO) 3P, (PhO) PCl2, PhPOCl2, or (C3H7) 3P (〇) 〇 etc. may be used. On the other hand, the formation of amidine bond: first, in the presence of the necessary solvent Then, in the range of 0 ° C to 100 ° C, the cyclic dicarboxylic anhydride is reacted with the amino group to obtain amidinic acid. Then, pyridine and anhydrous acetic acid are added, and the range is from 0 ° C to 200 ° C. It can be produced by reaction within ®. It is also possible to use a diisocyanate compound obtained from the reaction of diammonium compounds and phosgene (phosgene), etc., to carry out the reaction to form amidine bonds and to form sulfonium Amine bonding reaction. The reaction to form amidine bond is the reaction of carboxyl group and diisocyanate group in the aforementioned diisocyanate compound in the range of 0 ° C to 300 ° C. In this reaction, the aforementioned solvent can also be used Agent or solvent of ethylene glycol (mono) methyl ether, tetrahydrofuran, cyclohexanone, methyl ethyl ketone, acetonitrile, or r-butyrolactone, etc. 66 591056 9825 pif 1 tertiary amines, alkali metals Catalysts of compounds, alkaline earth metal compounds, etc., or a small amount of water or aromatic hydrocarbons such as xylene, toluene, etc. In addition, when a cyclic dicarboxylic anhydride is used instead of a carboxyl group, it is also the same as the reaction for forming an amidine bond. Therefore, the sulfonamide bond is directly formed. Therefore, in order to synthesize the carboxylic acid raw material of the polyfluorenamine-sulfonimide of the present invention, it is preferable to use a combination of the following ⑴ ~ (V). ⑴ The anhydride structure and the acid halide group (H) At least one type of carboxylic acid having an acid anhydride structure and an acid halide group, and at least one type of dicarboxylic acid diacid halide. (iii) At least one of carboxylic acids having an acid anhydride structure and an acid halide group, and tetracarboxylic acids (tetracarboxylic acid diacid anhydride, tetracarboxylic acid tetraacid halide, or two carboxyl groups of the tetracarboxylic acid acid anhydride structure and remain At least one of the two carboxylic acid halide derivatives). (iv) at least one dicarboxylic acid diacid halide and at least one of the foregoing tetracarboxylic acids. (v) At least one of carboxylic acids having a cyclic dicarboxylic anhydride structure and an acid halide group, at least one of dicarboxylic acid diacid halides, and at least one of the aforementioned tetracarboxylic acids. Any of the carboxylic acid raw materials obtained in combination with the diamine compound is used, and the initial acid anhydride structure is reacted with the amino group in the presence of a solvent. Next, pyridine, triethylamine, or the like is added to react the acid halide with the amino group to synthesize polyamine-amidate. After that, anhydrous acetic acid was added and heated to dehydration and ring-closing the amido acid structure to synthesize polyamidamine 67 591056 9825 pifl imidoamine. A next example of the method for synthesizing polyamidoamine-iminomine is a method using a combination (Vi) to (X) of the carboxylic acid raw materials described below. (Vi) A carboxylic acid having at least one of an acid anhydride structure and a carboxyl group. ㈣ has at least one of Suipu and __guan and at least one of dicarboxylic acids. (vm) At least one type of carboxylic acid having an acid anhydride structure and a carboxyl group, and at least one type of tetracarboxylic dianhydride. (Ix) at least one type of dicarboxylic acid and at least one of the aforementioned tetracarboxylic acid dianhydride. (X) At least one type of carboxylic acid having an acid anhydride structure and a carboxyl group, at least one type of dicarboxylic acid, and at least one type of the aforementioned tetracarboxylic acid dianhydride. Any one of the combinations (vi) to (x) and a diisocyanate compound, in the presence of a solvent, and corresponding necessary catalysts (such as tertiary amines, alkali metal compounds, alkaline earth metal compounds, etc.) Or, together with a small amount of water or aromatic hydrocarbons (such as xylene, toluene, etc.), the reaction is performed in a range of 0 ° C to 300 ° C. Furthermore, using any of the aforementioned combinations (vi) to (X) with a diamine compound, in the presence of a solvent, 'reacting from the initial anhydride structure with the amino group, and then · with a condensing agent such as (PhO) 3P, ( PhO) PCl2, PhPOCl2 or (C3H7) 3P02, etc.) and pyridine are reacted at a temperature ranging from 0 ° C to 300 ° C, and polyamine-amidate can also be synthesized. After that, anhydrous acetic acid was added and heated to make the ammonium acid structure undergo dehydration and ring closure, and 68 9825 pifi was synthesized to polyamide-sulfuramide. When the N-substituted polyamidoamine-iminomine of the present invention is synthesized using a pre-substitution method, the polyamidoamine-iminomine synthesis method uses the aforementioned N-substituted diamine compound as a raw material instead of a diamine compound. Initially, a carboxylic acid derivative having an N-substituted amidine bond as shown in formula (24) is synthesized by using an acid having an acid anhydride structure and an acid halide group and the aforementioned N-substituted diamine compound. Then, this carboxylic acid derivative is subjected to polycondensation reaction with a diamine compound to obtain polyamidamine-amidate having a N-substituted amidine bond. Thereafter, amidine is bonded to amidine to obtain amidine_imidoamine. Can also be expressed by
在式(24)中,T1、D1及R1係分別與式(1)所示之記號 具有相同之定義。 然而,與前置換法相比較,前述後置換法之方法,由 於具有較佳之反應性,因而可以得到分子量較高之N置換 聚醯胺-亞醯胺。由於使用此可以得到機械性質較佳之液晶 配向膜,因而在進行用以給予液晶配向性的硏磨製程時, 不會對膜造成損傷。如此,可以迴避液晶配向性被攪亂之 問題。 本發明之N置換聚醯胺-亞醯胺之較佳分子量,在以 例如是凝膠滲透色譜法(gel permeation chromatography, GPC)之聚苯乙烯換算而得之重量平均分子量(Mw)時,係爲 69 59^056 9825 pif 1 10000〜500000左右。更佳之分子量係爲20000〜200000。 本發明之液晶配向劑淸漆係使用由含有上述之N置換 聚醯胺-亞醯胺及溶劑的組成物所構成之均勻溶液。此液晶 配向劑淸漆可以在不損及本發明之效果之範圍內’含有其 他高分子。可與本發明之N置換聚醯胺-亞醯胺並用之其他 高分子係爲一般用於液晶配向劑淸漆中的聚醯胺酸、可溶 性聚亞醯胺、聚醯胺等。另外,也可以並用其他的聚醯胺- . 亞醯胺。藉由並用其他的高分子,可以更進一步提高液晶 # 配向劑之特性。 在本發明之液晶配向劑淸漆中,高分子化合物(N置 換聚醯胺-亞醯胺或此置換聚醯胺-亞醯胺與其他高分子的 混合物)之較佳濃度係爲以淸漆之全部重量爲基準之0.1〜 40重量%。當液晶配向劑淸漆塗佈於基板上之際,爲了調 整膜厚,在對應必要之情形下可將該淸漆預先以溶劑稀 釋。爲了使溶劑均勻地混合於淸漆中以更容易進行稀釋, 必需確保高分子化合物之濃度在不超過4〇重量%之範圍 內。當藉由旋轉塗佈法或印刷法進行塗佈之情形時,爲了 籲 保持良好的膜厚,局分子化合物之濃度大多爲10重量%以 下。當使用例如是浸塗法等其他塗佈方法時,使用10重量 · %可以得到更低,度之物。另1面,爲了防止液晶_ · 膜之膜厚翻,1¾分子化合啦濃度至少爲G1重量%。 即,在通常之旋轉塗佈法或印刷法中,高分子化合物之濃 度較適當爲〇·卜關量%社。贿之髓顏g.5〜i〇 重量%左右。然,隨著淸漆之塗佈方法,也可以使用更稀 70 9825 pif 1 薄之濃度。 在本發明之液晶配向劑淸漆中,用以溶解N置換聚醯 胺-亞醯胺的溶劑僅需爲具有可溶解高分子化合物之能力 的液體即可,而無其他特別的限制。因此’當製造聚醯胺-亞醯胺、聚醯胺酸、可溶性聚亞醯胺、聚醯胺等之際’或 者是利用此類之高分子之際,較佳從通常使用之溶劑中’ 對應使用目的而進行適當的選擇。此溶劑係爲對上述高分 子親和的溶劑,爲非質子性的極性有機溶劑。其實例爲N_ 甲基-2-口比瞎院酮、Dimethylimidazolidinorie、N-甲基己內醯 胺、N-甲基丙醯胺、N,N-二甲基乙醯胺、二甲基磺基氧化 物、N,N-二甲基甲醯胺、N,N-二乙基甲醯胺、二乙基乙醯 胺、r ·丁基內酯等。 再者,當以塗佈性改善等爲目的時,也可使用將其他 溶劑添加至上述溶劑中而得的混合溶劑。爲此目的而使用 之其他溶劑的實例係爲乳酸烷、3-甲基-3-甲氧基、四氫化 萘、異佛爾酮、乙二醇(一)烷基醚(如乙二醇(一)丁 基醚等)、二乙二醇(一)烷基醚(如二乙二醇(一)乙基 醚等)、乙二醇(一)烷基乙酸鹽、乙二醇(一)苯基乙酸 鹽、三乙二醇(一)烷基醚、丙二醇(一)烷基醚(如丙 二醇(一)丁基醚等)、二丙二醇(一)烷基醚(如二丙二 醇(一)甲基醚等)、丙二酸二烷(丙二酸二乙烷)、將前 述溶劑之OH醋酸酯化的化合物等。 本發明之液晶配向劑淸漆可於必要之情況下含有各 種添加劑。例如,當爲欲提高塗佈性之情形時,也可以摻 71 591056 9825 pif 1 合符合此目的的界面活性劑。當爲必需提高防帶電性之情 形時,也可以摻合防帶電劑。當爲欲提高與基板之間的密 著性之情形時,也可以摻合有機矽烷偶合劑或鈦系之偶合 劑。由上述所得之液晶配向劑淸漆較適合作爲以TFT用液 晶配向膜之原料爲主的物質。而且,由於可以提供適度的 前傾角,因此,當形成通常之TN型液晶顯示元件用之液晶 配向膜、STN型液晶顯示元件用之液晶配向膜、IPS型液晶 顯示元件用之液晶配向膜、VA型液晶顯示元件用之液晶配 向膜、OCB型液晶顯示元件用之液晶配向膜、強介電性液 晶用之液晶配向膜、或反強介電性液晶顯示元件用之液晶 配向膜等情形時,係爲有用的。另外,由於液晶顯示元件 之電特性較佳,因此也會使用保護膜或絕緣膜等。 本發明之液晶顯示元件係使用形成有使用本發明之 液晶配向劑淸漆的液晶配向膜的基板製造而得。將此基板 與形成有與此基板相異之液晶配向膜的基板,配置成配向 膜成對向的形式,並於其間插入液晶,而得到以習知方法 所得之液晶顯示元件。另外,也可以僅使用此基板製造液 晶顯示元件。液晶配向膜之形成係藉由進行將液晶配向劑 淸漆塗佈於基板上的塗佈製程、接續之乾燥製程、以及脫 水•閉環反應所必需之加熱處理製程等製程而得。一般所 熟知之塗佈方法係爲旋轉塗佈法、印刷法、浸塗法及滴下 法等。前述方法也同樣可以適用於本發明中。乾燥及脫水· 閉環反應所必需之加熱處理之一般的方法習知係爲在加熱 爐或紅外線加熱爐之中進行加熱的方法或是在加熱板上進 72 591056 9825 pif 1 行加熱的方法等。前述方法同樣也可以適用於本發明中。 在乾燥製程中之較佳溫度只要在略低於可使溶劑蒸發之範 圍內的溫度即可。加熱處理製程中之較佳溫度係爲攝氏150 度〜攝氏300度。 本發明之液晶顯示元件中所使用之較佳液晶組成 物,對用於STN型液晶顯示元件而言,例如是日本專利特 開平8-157828號公報、日本專利特開平8-231960號公報、 日本專利特開平9-241644號公報、及日本專利特開平 9-302346號公報等所揭露之液晶組成物。再者,對用於TFT 型液晶顯示元件(TN型、IPS型、VA型、OCB型)而言, 例如是日本專利特開平8-199168號公報、日本專利特開平 9-235552號公報、日本專利特開平9-241643號公報、曰本 專利特開平10-204016號公報、日本專利特開平10-204436 號公報、日本專利特開平10-231482號公報、及日本專利 特開平2000-087040號公報所揭露之液晶組成物。較佳係 使用以前述所揭露之組成物爲主體所構成的液晶組成物。 再者,在前述液晶組成物中可以添加使用一種一上之光學 活性化合物。 [用以實施本發明之較佳方法] 接著,以實例對本發明進行更詳細的說明,然本發明 並不以所述之實例爲限。在實例中’係爲在更進一步提高 特性之目的下所舉出之同時使用N置換聚醯胺-亞醯胺及聚 醯胺酸之情形的實例,然並不以此爲限,也可以在不損及 本發明之效果的情形下,單獨使用N置換聚醯胺-亞醯胺。 73 591056 9825 pif 1 在下述中,「液晶配向劑淸漆」係以「淸漆」表示。 各實例及比較例中所使用之原料的簡略符號及其對 應之化合物名稱下所示。 TPA :對苯二甲酸二氯化物 TMA :偏苯三酸酸酐氯化物 PMDA :焦苯六甲酸二酸酐 CBDA :環丁烷四羧酸二酸酐 BDA : 丁烷四羧酸二酸酐 · DPM : 4,4’-二氨二苯基甲烷 4CB1B : 1,1_雙(4- ((4-氨基苯基)甲基)苯基)-4- 丁基環己烷 5CCBOB : 1,1_雙(4- (4-氨基苯氧基)苯基)-4- (4_ 戊基環己基)環己烷 5CCB1P : 5- (- (4- (4-戊基環己基)環己基)苯基) 甲基-1,3-二氨基苯 6BOB : 2,2-雙(4- (4-氨基苯氧基)苯基)-己烷 5CCDPM : 1- ( 4-戊基環己基)·4· ( 5_氨基苄基-2-氨 基苯基)環己烷 NMP : Ν-甲基-2-吡喀烷酮 BC : 丁基溶纖劑 [實例1] (聚醯胺-亞醯胺之合成) 在具有溫度計、攪拌機、冷凝器、原料投入口及氮 74 5 91—— 9825 pifl 氣導入口之300ml的四口燒瓶中,加入DPM ( 5.001g)、 4ChBlB ( 6.828g)、及脫水 NMP ( lOO.Og),並於乾燥氮 氣流之下攪拌溶解。將溶液冷卻至攝氏5度,再添加TMA (&171g),並於攝氏25度下反應4小時。之後,添加吡 啶(15.34g),更於攝氏25度下反應15小時,以合成得 到黏稠的聚醯胺-醯胺酸溶液。接著,於其中依序添加脫 水NMP ( 64.66g)及無水醋酸(27.74g),再於攝氏50 度下反應3小時。之後,將所得到之反應溶液投入大量 的甲醇中,再過濾得到已析出之高分子。將所得之高分 子再度溶解於NMP中之後,利用純水進行再沈澱並過濾 之’之後經減壓乾燥後得到16.5g的聚醯胺-亞醯胺。此 聚醯胺-亞醯胺係作爲PAI-1。 除了改變羧酸類及二氨化合物之種類及組成之 外’其餘條件皆在相同之條件下進行操作,而合成得到 PAI-2〜PAI-8的聚醯胺-亞醯胺。所得之聚醯胺-亞醯胺之 原料組成係如表22所示。 表22聚醯胺-亞醯胺之原料組成(單位··莫爾% )In formula (24), T1, D1, and R1 have the same definitions as the symbols shown in formula (1), respectively. However, in comparison with the pre-substitution method, the aforementioned post-substitution method has better reactivity, and thus it is possible to obtain N-substituted polyamidoamine-iminomine having a higher molecular weight. Since a liquid crystal alignment film with better mechanical properties can be obtained by using this, the film is not damaged during the honing process for imparting liquid crystal alignment. In this way, the problem that the alignment of the liquid crystal is disturbed can be avoided. The preferred molecular weight of the N-substituted polyamidoamine-iminomine of the present invention is a weight average molecular weight (Mw) obtained by conversion of polystyrene such as gel permeation chromatography (GPC). It is 69 59 ^ 056 9825 pif 1 around 10,000 ~ 500,000. A more preferable molecular weight is 20000 ~ 200,000. The liquid crystal alignment agent lacquer of the present invention is a homogeneous solution composed of a composition containing the above-mentioned N-substituted polyamidamine-imide and a solvent. The liquid crystal alignment agent varnish may contain other polymers within a range that does not impair the effect of the present invention. Other polymers which can be used in combination with the N-substituted polyamidoamine-iminomine of the present invention are polyamidic acid, soluble polyamidoamine, polyamidoamine, and the like generally used in liquid crystal alignment agent lacquers. It is also possible to use other polyamidoamines. By using other polymers in combination, the characteristics of the liquid crystal # alignment agent can be further improved. In the liquid crystal alignment agent lacquer of the present invention, the preferred concentration of the polymer compound (N-substituted polyfluorene-amidine or a mixture of the substituted polyfluorene-imino and other polymers) is lacquer. The total weight is 0.1 to 40% by weight. When the liquid crystal alignment agent varnish is applied on the substrate, in order to adjust the film thickness, the varnish may be diluted with a solvent in advance if necessary. In order to make the solvent uniformly mixed in the varnish for easier dilution, it is necessary to ensure that the concentration of the polymer compound is within a range of not more than 40% by weight. When coating is performed by a spin coating method or a printing method, in order to maintain a good film thickness, the concentration of the local molecular compound is usually 10% by weight or less. When other coating methods such as a dip coating method are used, lower weights can be obtained by using 10% by weight. On the other hand, in order to prevent the film thickness of the liquid crystal film from doubling, the concentration of 1¾ molecular compound is at least G1% by weight. That is, in a general spin coating method or a printing method, the concentration of the polymer compound is more preferably 0.% by mass. The bone marrow of bribe g. 5 ~ i〇 weight%. However, with the lacquer coating method, a thinner concentration of 70 9825 pif 1 can also be used. In the liquid crystal alignment agent lacquer of the present invention, the solvent used to dissolve the N-substituted polyamide-imide is only required to be a liquid having the ability to dissolve the polymer compound, and there is no other special limitation. Therefore, when manufacturing polyamidoamines, polyamidoamines, polyamidoacids, soluble polyamidoamines, polyamidoamines, etc., or when using such polymers, it is preferable to use the commonly used solvents. Make appropriate selection according to the purpose of use. This solvent is a solvent having affinity for the above-mentioned polymers and is an aprotic polar organic solvent. Examples are N-methyl-2-orbitanone, Dimethylimidazolidinorie, N-methylcaprolactam, N-methylpropylamine, N, N-dimethylacetamide, dimethylsulfo Oxides, N, N-dimethylformamide, N, N-diethylformamide, diethylacetamide, r-butyllactone, and the like. Further, for the purpose of improving the coatability and the like, a mixed solvent obtained by adding other solvents to the above solvents may be used. Examples of other solvents used for this purpose are alkane lactate, 3-methyl-3-methoxy, tetralin, isophorone, ethylene glycol (mono) alkyl ethers (such as ethylene glycol ( A) butyl ether, etc.), diethylene glycol (a) alkyl ether (such as diethylene glycol (a) ethyl ether, etc.), ethylene glycol (a) alkyl acetate, ethylene glycol (a) Phenyl acetate, triethylene glycol (a) alkyl ether, propylene glycol (a) alkyl ether (such as propylene glycol (a) butyl ether, etc.), dipropylene glycol (a) alkyl ether (such as dipropylene glycol (a) Methyl ether, etc.), malonic acid dioxane (diethane malonate), a compound obtained by esterifying OH acetate with the aforementioned solvent, and the like. The liquid crystal alignment agent varnish of the present invention may contain various additives if necessary. For example, when it is desired to improve the coating property, 71 591056 9825 pif 1 and a surfactant suitable for this purpose may be added. When it is necessary to improve the antistatic property, an antistatic agent may be blended. When it is desired to improve the adhesion to the substrate, an organic silane coupling agent or a titanium-based coupling agent may be blended. The liquid crystal alignment agent varnish obtained as described above is more suitable as a material mainly composed of a liquid crystal alignment film for a TFT. In addition, since it can provide a moderate forward tilt angle, when forming a normal liquid crystal alignment film for a TN liquid crystal display element, a liquid crystal alignment film for a STN liquid crystal display element, a liquid crystal alignment film for an IPS liquid crystal display element, VA In the case of a liquid crystal alignment film for a liquid crystal display device, a liquid crystal alignment film for a OCB liquid crystal display device, a liquid crystal alignment film for a ferroelectric liquid crystal, or a liquid crystal alignment film for an anti-ferroelectric liquid crystal display device, etc., Department is useful. In addition, since the liquid crystal display element has good electrical characteristics, a protective film or an insulating film is also used. The liquid crystal display element of the present invention is produced by using a substrate on which a liquid crystal alignment film coated with the liquid crystal alignment agent of the present invention is formed. This substrate and a substrate on which a liquid crystal alignment film different from this substrate is formed are arranged so that the alignment films face each other, and liquid crystal is interposed therebetween to obtain a liquid crystal display element obtained by a conventional method. Alternatively, a liquid crystal display element may be manufactured using only this substrate. The liquid crystal alignment film is formed by a coating process of applying a liquid crystal alignment agent to a substrate, a subsequent drying process, and a heat treatment process necessary for dehydration and closed-loop reactions. Generally known coating methods are spin coating, printing, dip coating, and dropping. The aforementioned method is also applicable to the present invention. The general method of heating treatment necessary for drying, dehydration, and closed-loop reaction is a heating method in a heating furnace or an infrared heating furnace, or a heating method using 72 591056 9825 pif on a hot plate. The aforementioned method is also applicable to the present invention. The preferable temperature in the drying process is only required to be a temperature slightly lower than the range in which the solvent can be evaporated. The preferred temperature in the heat treatment process is 150 ° C to 300 ° C. The preferred liquid crystal composition used in the liquid crystal display element of the present invention is, for example, used in STN type liquid crystal display elements, such as Japanese Patent Laid-Open No. 8-157828, Japanese Patent Laid-Open No. 8-231960, and Japan The liquid crystal compositions disclosed in Patent Publication No. 9-241644 and Japanese Patent Publication No. 9-302346. In addition, for the TFT-type liquid crystal display element (TN type, IPS type, VA type, OCB type), for example, Japanese Patent Laid-Open No. 8-199168, Japanese Patent Laid-Open No. 9-235552, and Japan Patent Publication No. 9-241643, Japanese Patent Publication No. 10-204016, Japanese Patent Publication No. 10-204436, Japanese Patent Publication No. 10-231482, and Japanese Patent Publication No. 2000-087040 The disclosed liquid crystal composition. It is preferable to use a liquid crystal composition mainly composed of the composition disclosed above. Furthermore, a single optically active compound may be added to the liquid crystal composition. [Best method for implementing the present invention] Next, the present invention will be described in more detail with examples, but the present invention is not limited to the examples described. In the example, 'is an example of a case where N is substituted for polyamidoamine and polyamidoamine for the purpose of further improving the characteristics, but it is not limited thereto, and may be Without impairing the effect of the present invention, N is used instead of polyamidoamine-iminomine. 73 591056 9825 pif 1 In the following description, "liquid crystal alignment agent paint" is represented by "paint paint". The abbreviations of the raw materials used in the examples and comparative examples and their corresponding compound names are shown below. TPA: terephthalic acid dichloride TMA: trimellitic anhydride chloride PMDA: pyromellitic acid anhydride CBDA: cyclobutanetetracarboxylic acid anhydride BDA: butanetetracarboxylic acid anhydride DPM: 4, 4'-Diaminodiphenylmethane 4CB1B: 1,1_bis (4-((4-aminophenyl) methyl) phenyl) -4-butylcyclohexane 5CCBOB: 1,1_bis (4 -(4-aminophenoxy) phenyl) -4- (4-pentylcyclohexyl) cyclohexane 5CCB1P: 5-(-(4- (4-pentylcyclohexyl) cyclohexyl) phenyl) methyl -1,3-diaminobenzene 6BOB: 2,2-bis (4- (4-aminophenoxy) phenyl) -hexane 5CCDPM: 1- (4-pentylcyclohexyl) · 4 · (5_ Aminobenzyl-2-aminophenyl) cyclohexane NMP: N-methyl-2-pyrrolidone BC: Butyl cellosolve [Example 1] (Synthesis of polyamidoamine-iminomine) With a thermometer, A 300 ml four-necked flask with a mixer, condenser, raw material inlet and nitrogen 74 5 91-9825 pifl gas inlet was charged with DPM (5.001g), 4ChBlB (6.828g), and dehydrated NMP (100.Og), It was stirred and dissolved under a stream of dry nitrogen. The solution was cooled to 5 ° C, TMA (& 171g) was added, and the reaction was performed at 25 ° C for 4 hours. Then, pyridine (15.34 g) was added, and the reaction was carried out at 25 ° C for 15 hours to synthesize and obtain a viscose solution of polyamide-fluorine. Then, dehydrated NMP (64.66 g) and anhydrous acetic acid (27.74 g) were sequentially added thereto, and the reaction was performed at 50 ° C for 3 hours. Thereafter, the obtained reaction solution was poured into a large amount of methanol, and then filtered to obtain a polymer that had been precipitated. After the obtained polymer was dissolved in NMP again, it was reprecipitated with pure water and filtered, and after that, it was dried under reduced pressure to obtain 16.5 g of polyamidamine-moximine. This polyamidamine-amidamine system is referred to as PAI-1. Except changing the type and composition of carboxylic acids and diamine compounds, the other conditions were all operated under the same conditions, and the polyamidoamine-iminomine of PAI-2 ~ PAI-8 was synthesized. Table 22 shows the raw material composition of the obtained polyamidamine-imidate. Table 22 Raw material composition of Polyamidamine-Imidamine (unit ·· mole%)
No. 羧酸類 二氨化合物 TMA TPA BDA DPM 4CB1B 5CCBOB 5CCB1P 6BOB 5CCDPM PAI-1 50.0 32.5 17.5 PAI-2 25.0 25.0 32.5 17.5 PAI-3 25.0 25.0 32.5 17.5 PAI-4 25.0 25.0 32.5 17.5 PAI-5 50.0 32.5 17.5 PAI-6 50.0 32.5 17.5 PAI-7 50.0 32.5 17.5 PAI-8 50.0 32.5 17.5 [實例2] (N置換聚醯胺-亞醯胺之合成) 在具有溫度計、攪拌機、冷凝器、原料投入口及氮 75 591056 9825 pif 1 氣導入口之l〇〇ml的四口燒瓶中,加入實例1中所得之 PAI-1 ( 3.00g)及脫水NMP ( 47.00g),於攝氏25度下攪 拌溶解1小時。之後,於此溶液中添加氫化鈉(〇.651g), 並於攝氏25度下反應15小時,且更於攝氏50度下反應 3小時,再於此反應液中添加碘化甲烷( 2.402g),並進 一步反應15小時。利用所得之最終反應液,並藉由與前 述聚醯胺_亞醯胺(PAI-1)相同的再沈澱操作,即可得到 高分子,再對此高分子進行減壓乾燥,即可得到2.2g的 N置換聚醯胺-亞醯胺。此N置換聚醯胺L亞醯胺係作爲 NPAI-1。 除了替換原料聚醯胺-亞醯胺之種類或是以其他鹵 化物替換碘化甲烷之外’其餘之順序皆與NPAI-1之情形 完全相同,即可合成得到NPAI-2〜NPAI-12的N置換聚 醯胺-亞醯胺。所得之N置換聚醯胺-亞醯胺之置換基及 重量平均分子量係如表23所示。 其中,表23中之NPAI-9〜NPAI-12係分別以溴化乙 烷、溴化庚烷、溴化苄基、及溴化蒽基甲烷置換碘化甲 烷而合成得到N置換聚醯胺-亞醯胺的資料。 76 591056 9825 pif 1 表23 N置換聚醯胺-亞醯胺No. Carboxylic acid diamine compound TMA TPA BDA DPM 4CB1B 5CCBOB 5CCB1P 6BOB 5CCDPM PAI-1 50.0 32.5 17.5 PAI-2 25.0 25.0 32.5 17.5 PAI-3 25.0 25.0 32.5 17.5 PAI-4 25.0 25.0 32.5 17.5 PAI-5 50.0 32.5 17.5 PAI -6 50.0 32.5 17.5 PAI-7 50.0 32.5 17.5 PAI-8 50.0 32.5 17.5 [Example 2] (Synthesis of N-substituted polyamide-imide) In a thermometer, mixer, condenser, raw material input port and nitrogen 75 591056 A 100 ml four-necked flask with 9825 pif 1 gas inlet was charged with PAI-1 (3.00 g) and dehydrated NMP (47.00 g) obtained in Example 1, and stirred and dissolved at 25 ° C for 1 hour. Thereafter, sodium hydride (0.565 g) was added to the solution, and the reaction was performed at 25 ° C for 15 hours, and further, the reaction was performed at 50 ° C for 3 hours, and then methyl iodide (2.402 g) was added to the reaction solution And further reacted for 15 hours. Using the obtained final reaction solution, and by the same reprecipitation operation as the aforementioned polyamidoamine_amidoamine (PAI-1), a polymer can be obtained, and then the polymer is dried under reduced pressure to obtain 2.2 g of N replaces polyamidamine-imidate. This N-substituted polyamidamine L imidate system is referred to as NPAI-1. Except for the replacement of the raw material polyamidoamine-iminomine or the replacement of methane iodide with other halides, the rest of the sequence is exactly the same as that of NPAI-1, and NPAI-2 ~ NPAI-12 can be synthesized. N replaces polyamidamine-imidate. Table 23 shows the substitution groups and weight average molecular weights of the obtained N-substituted polyamidoamines and imidates. Among them, NPAI-9 to NPAI-12 in Table 23 are substituted with ethane bromide, heptane, benzyl bromide, and anthracene bromide to replace methyl iodide to synthesize N substituted polyfluorene- Information on imine. 76 591056 9825 pif 1 Table 23 N-substituted polyamidoamines
No. 原料 聚醯胺-亞醯胺 置換基 重量平均分子量 NPAI-1 PAI-1 甲基 59000 NPAI-2 PAI-2 甲基 72500 NPAI-3 PAI-3 甲基 45000 NPAI-4 PAI-4 甲基 57000 NPAI-5 PAI-5 甲基 66000 NPAI-6 PAI-6 甲基 52000 NPAI-7 PAI-7 甲基 53000 NPAI-8 PAI-8 甲基 48500 NPAI-9 PAI-1 乙基 60000 NPAI-10 PAI-1 庚基 59000 NPAI-11 PAI-1 T基 60000 NPAI-12 PAI-1 蒽基甲基 62000No. Raw material polyamidoamine-iminomine substitution weight average molecular weight NPAI-1 PAI-1 methyl 59000 NPAI-2 PAI-2 methyl 72500 NPAI-3 PAI-3 methyl 45000 NPAI-4 PAI-4 methyl 57000 NPAI-5 PAI-5 methyl 66000 NPAI-6 PAI-6 methyl 52000 NPAI-7 PAI-7 methyl 53000 NPAI-8 PAI-8 methyl 48500 NPAI-9 PAI-1 ethyl 60000 NPAI-10 PAI -1 heptyl 59000 NPAI-11 PAI-1 T-based 60,000 NPAI-12 PAI-1 anthracene methyl 62000
[合成例1] (聚醯胺酸之合成) 在具有溫度計、攪拌機、冷凝器、原料投入口及氮 氣導入口之500ml的四口燒瓶中,加入DPM (4.891g) 及脫水NMP ( 90.0g),並於乾燥氮氣流之下攪拌溶解。 將溶液之溫度保持於攝氏5度,再依序添加PMDA ( 2.690g)及CBDA(2.419g),並於攝氏25度下反應30 小時。之後,於此反應液中添加BC ( 100.0g),即可得 到高分子濃度爲5.0重量%的聚醯胺酸溶液(200g)。此聚 醯胺酸溶液係作爲PA酸-1。所得之聚醯胺酸的重量平均 分子量係爲75000左右。 [合成例2] (聚醯胺之合成) 在具有溫度計、攪拌機、冷凝器、原料投入口及氮 氣導入口之500ml的四口燒瓶中,加入TPA ( 3.216g)、 77 591056 9825 pifl DPM(1.919g)及4CB1B ( 4.866g),再於其中加入脫水 NMP(8.63g)及吡啶(9.33g)而得均勻溶液。於此溶液中依 序添加亞磷酸三苯(12.01g)、氯化鋰(4g)、及氯化鈣(I2g) 之後,於攝氏100度之下反應2小時。利用所得之反應 溶液,並藉由與前述聚醯胺-亞醯胺(PAM)相同的再沈 澱操作,即可得到高分子,再對此高分子進行減壓乾燥, 即可得到7.9g的聚醯胺。此聚醯胺係作爲PA-i。所得之 聚醯胺的重量平均分子量係爲88000左右。 [合成例3] (N置換聚醯胺之合成) 在具有溫度計、攪拌機、冷凝器、原料投入口及氮 氣導入口之200ml的四口燒瓶中,加入合成例2所得之 PA-1 ( 5.026g)及脫水NMP(26.39g),並於室溫下攪拌溶 解。於此溶液中添加氫化鈉(0.934g)並反應40分鐘之後, 更進一步加入碘化甲烷(3.037g)並反應1小時。利用所得 之反應溶液,並藉由與前述聚醯胺-亞醯胺(PAI-1)相同 的再沈澱操作,即可得到高分子,再對此高分子進行減 壓乾燥,即可得到3.5g的N置換聚醯胺。此N置換聚醯 胺係作爲NPA-1。另外,所得之N置換聚醯胺的重量平 均分子量係爲52000左右。 [合成例4] (可溶性聚醯胺之合成) 在具有溫度計、攪拌機、冷凝器、原料投入口及氮 氣導入口之300ml的四口燒瓶中,加入DPM(5.125g)、 78 591056 9825 pif 1 4CBlB(6.997g)及脫水NMP ( lOO.Og),並於乾燥氮氣器 流下攪拌溶解。將此溶液冷卻至攝氏5度,並於添加 BDA(7.879g)之後,於攝氏25度下反應15小時而得到黏 稠的聚醯胺酸溶液。於此溶液中依序添加脫水 NMP(64.66g)及無水醋酸(27.74g)之後,於攝氏ioo度下 反應3小時。利用所得之反應溶液,並藉由與前述聚醯 胺-亞醯胺(PAI-1)相同的再沈澱操作,即可得到高分子, 再對此高分子進行減壓乾燥,即可得到16.0g的可溶性聚 醯胺。此可溶性聚醯胺係作爲PI-1。所得之聚醯胺的重 量平均分子量係爲49000左右。 [實例3-1] (淸漆之調合) 將實例2所得之NPAI-l(O.lOg)加入合成例所得之 PA酸-l(18.0g)中,並溶解之。將所得之溶液稀釋成 NMP-BC混合溶劑(重量比1/1),即可得到高分子濃度 爲3重量%的淸漆。對此淸漆中之聚醯胺酸而言,N置 換聚醯胺-亞醯胺NPAI之比例係爲1/9的重量比。 [實例3-2〜3-12及比較例1〜3] (淸漆之調合) 除了分別以實例2所得之NPAI-2〜12、合成例2所 得之PA-1、合成例3所得之NPA-1及合成例4所得之PM 代替NPAI-1之外,其餘皆與實例3-1完全相同,如此即 可調合出對應之各個高分子。而且,PA-1係對應比較例 79 9825 pifl 1,NPA-1係對應比較例2,PI-1係對應比較例3。 [實例4] (配向膜評估用胞之製作) (1)殘留電荷及電壓保持率評估用胞(電特性測定用 胞)的製作 在附著有透明電極ITO的玻璃基板上以旋轉塗佈之 方式塗佈含有實例3-1所得之NPAI-1的淸漆,並於攝氏 80度下預備燒結5分鐘左右之後,於攝氏250度下進行 30分鐘的加熱處理。將此基板之形成有配向膜之面置於 硏磨裝置上以硏磨進行配向處理。接著,於此基板之配 向膜面上散佈7//用的間隙材料,再與以完全相同之方式 所得之一個基板,以形成有配向膜之面朝內側之方式, 重疊在一起。而且,於此重疊之2片基板之周圍,以殘 留有液晶注入孔之形式形成由環氧樹脂硬化劑所構成之 封膠,如此即可製得間隙爲7/zm的自平行胞。於此胞中 注入下述之液晶組成物,再於液晶注入孔上塗佈光硬化 劑,之後,照射UV光以使其硬化而封閉注入口。接著, 於攝氏100度下進行30分鐘左右的加熱處理,以作爲殘 留電荷及電壓保持率評估用的胞。實例3-2〜3-12及比較 例1〜3所得之淸漆也以完全相同之方式製作殘留電荷及 電壓保持率評估用的胞。所使用之液晶組成物之組成係 如下所述。此組成物之NI點係爲攝氏100.0度,再者, 其折射率異方性値係爲0.093。 591056[Synthesis Example 1] (Synthesis of Polyamic Acid) In a 500-ml four-necked flask equipped with a thermometer, a stirrer, a condenser, a raw material input port, and a nitrogen introduction port, DPM (4.891 g) and dehydrated NMP (90.0 g) were added. And dissolved under stirring under a stream of dry nitrogen. Keep the temperature of the solution at 5 ° C, then add PMDA (2.690g) and CBDA (2.419g) in this order, and react at 25 ° C for 30 hours. Thereafter, BC (100.0 g) was added to the reaction solution to obtain a polyamine solution (200 g) having a polymer concentration of 5.0% by weight. This polyamic acid solution was used as PA acid-1. The weight average molecular weight of the obtained polyamic acid was about 75,000. [Synthesis Example 2] (Synthesis of Polyamide) In a 500-ml four-necked flask equipped with a thermometer, a stirrer, a condenser, a raw material input port, and a nitrogen introduction port, TPA (3.216 g), 77 591056 9825 pifl DPM (1.919 g) and 4CB1B (4.866 g), and then added dehydrated NMP (8.63 g) and pyridine (9.33 g) to obtain a uniform solution. To this solution were sequentially added triphenyl phosphite (12.01 g), lithium chloride (4 g), and calcium chloride (I 2 g), followed by a reaction at 100 ° C for 2 hours. Using the obtained reaction solution, the polymer can be obtained by the same reprecipitation operation as the aforementioned polyamido-iminomine (PAM), and the polymer can be dried under reduced pressure to obtain 7.9 g of the polymer. Lamine. This polyamine system is referred to as PA-i. The weight average molecular weight of the obtained polyamide was about 88,000. [Synthesis Example 3] (Synthesis of N-substituted polyamide) In a 200-ml four-necked flask equipped with a thermometer, a stirrer, a condenser, a raw material input port, and a nitrogen introduction port, PA-1 (5.026 g) obtained in Synthesis Example 2 was added. ) And dehydrated NMP (26.39 g), and dissolved by stirring at room temperature. After adding sodium hydride (0.934 g) to the solution and reacting for 40 minutes, methane iodide (3.037 g) was further added and reacted for 1 hour. Using the obtained reaction solution, the polymer can be obtained by the same reprecipitation operation as the aforementioned polyamidoamine-iminomine (PAI-1), and the polymer can be dried under reduced pressure to obtain 3.5 g. N displacement polyamidamine. This N-substituted polyamine system is referred to as NPA-1. The weight-average molecular weight of the obtained N-substituted polyamine was about 52,000. [Synthesis Example 4] (Synthesis of soluble polyamide) In a 300-ml four-necked flask equipped with a thermometer, a stirrer, a condenser, a raw material inlet, and a nitrogen inlet, DPM (5.125 g) and 78 591056 9825 pif 1 4CBlB were added. (6.997g) and dehydrated NMP (100.Og), and dissolved by stirring under a stream of dry nitrogen. This solution was cooled to 5 degrees Celsius, and after adding BDA (7.879 g), it was reacted at 25 degrees Celsius for 15 hours to obtain a thick polyamic acid solution. To this solution were sequentially added dehydrated NMP (64.66 g) and anhydrous acetic acid (27.74 g), followed by a reaction at 100 ° C for 3 hours. Using the obtained reaction solution, the polymer can be obtained by the same reprecipitation operation as the aforementioned polyamidoamine-iminomine (PAI-1), and then the polymer is dried under reduced pressure to obtain 16.0g. Of soluble polyamidamine. This soluble polyamidine system is referred to as PI-1. The weight average molecular weight of the obtained polyamide was about 49,000. [Example 3-1] (Blend of lacquer) The NPAI-1 (0.10 g) obtained in Example 2 was added to the PA acid-1 (18.0 g) obtained in the synthesis example, and dissolved. The resulting solution was diluted into an NMP-BC mixed solvent (weight ratio 1/1) to obtain a varnish having a polymer concentration of 3% by weight. For the polyamic acid in this varnish, the ratio of N-exchanged polyamidamine-iminomine NPAI is 1/9 by weight. [Examples 3-2 to 3-12 and Comparative Examples 1 to 3] (The blending of lacquer) Except for NPAI-2 to 12 obtained in Example 2, PA-1 obtained in Synthesis Example 2, and NPA obtained in Synthesis Example 3 Except that -1 and PM obtained in Synthesis Example 4 replace NPAI-1, the rest are exactly the same as in Example 3-1, so that the corresponding polymers can be blended. In addition, PA-1 corresponds to Comparative Example 79 9825 pifl 1, NPA-1 corresponds to Comparative Example 2, and PI-1 corresponds to Comparative Example 3. [Example 4] (Production of cell for evaluation of alignment film) (1) Production of cell for evaluation of residual charge and voltage retention (cell for measuring electrical characteristics) Production of spin coating on a glass substrate with transparent electrode ITO attached The varnish containing the NPAI-1 obtained in Example 3-1 was applied, and after preliminary sintering at 80 ° C for about 5 minutes, heat treatment was performed at 250 ° C for 30 minutes. The surface of the substrate on which the alignment film is formed is placed on a honing apparatus to perform an alignment process by honing. Then, a gap material for 7 // is spread on the alignment film surface of the substrate, and then a substrate obtained in the exact same manner is overlapped with the surface formed with the alignment film facing inward. In addition, a sealant made of an epoxy resin hardener is formed around the two overlapping substrates with a liquid crystal injection hole remaining, so that an autoparallel cell having a gap of 7 / zm can be obtained. The following liquid crystal composition was injected into the cell, and then a light curing agent was applied to the liquid crystal injection hole, and then UV light was irradiated to harden it to close the injection port. Next, a heat treatment was performed at 100 ° C for about 30 minutes to serve as a cell for evaluating the residual charge and the voltage retention rate. The varnishes obtained in Examples 3-2 to 3-12 and Comparative Examples 1 to 3 were prepared in the same manner as the cells for evaluating the residual charge and the voltage holding ratio. The composition of the liquid crystal composition used is as follows. The NI point of this composition is 100.0 degrees Celsius, and the refractive index anisotropy is 0.093. 591056
9825 pif 19825 pif 1
17wt. % 17wt. % 16wt. %17wt.% 17wt.% 16wt.%
lOwt. %lOwt.%
5wt. %5wt.%
lOwt. %lOwt.%
6wt. %6wt.%
6wt. % 13wt. % 81 591056 9825 pifl (2)前傾角測量用胞的製作 除了使用20//用之間隙材料置換用間隙材料之 外,其餘皆與電特性測量用胞之製作之情形相同的方式, 製作得到具有20//之胞厚的自平行胞’其中此胞係作爲前 傾角測量用胞。而且,製作此胞之際所使用之液晶組成物 係使用與製作電特性測量用胞之際所使用之液晶組成物相 同的液晶組成物。 4 [實例5] ^ (淸漆之評估) (1)評估方法 i) 殘留電荷之測纛 殘留電荷係以「三宅等人’信學技報EID91-U1,P19」 中所記載之方法測量遽滯電壓。而且,於液晶胞中施加 50mV、1kHz的交流電應’以測量重疊且頻率爲0·0036Ηζ 的直流三角波。 ii) 電壓保持率之測量6wt.% 13wt.% 81 591056 9825 pifl (2) Production of cells for forward leaning measurement is the same as that for the production of cells for electrical characteristics, except that the gap material is replaced by 20 // Way, an autoparallel cell with a cell thickness of 20 // is produced, wherein the cell line is used as a cell for measuring the anteversion angle. The liquid crystal composition used in the production of this cell is the same liquid crystal composition used in the production of the cell for measuring electrical characteristics. 4 [Example 5] ^ (Evaluation of lacquer) (1) Evaluation method i) Measurement of residual charge (Residual charge was measured by the method described in "Miyake et al.'S Gazette EID91-U1, P19") Hysteresis. Furthermore, an alternating current of 50 mV and 1 kHz was applied to the liquid crystal cell to measure a direct current triangular wave having a frequency of 0,0036Ηζ. ii) Measurement of voltage holding rate
電壓保持率係以「水嶋等人,第14次液晶討論會預 I 稿集,p78」中所記載之方法測量。其測量條件係爲閘寬69 //s、頻率爲60Hz、波長高度爲±4.5V、以及測量溫度爲攝 氏60度。 -The voltage holding ratio was measured by the method described in "Minamata et al., Proceedings of the 14th LCD Symposium, p78". The measurement conditions are a gate width of 69 // s, a frequency of 60 Hz, a wavelength height of ± 4.5 V, and a measurement temperature of 60 degrees Celsius. -
Hi)前傾角的測定 液晶的前傾角是利用旋轉晶體法測定的。 iv)液晶配向性的評估 液晶配向性係將測量前傾角之際的胞於偏光顯微鏡 82 591056 9825 pif 1 下進行觀察,並判定領域(d〇main)之有無。 V)塗佈性的評估 以旋轉塗佈法塗佈淸漆,並於攝氏8〇度下預條轉 分鐘左右,之後,以目視的方式觀察於攝氏250襃卞 加熱處理30分鐘之後的配向膜表面,並判定有無小涧 佈不均的情形。 ~ ~ (2)評估結果 對實例4所得之淸漆所分別對應之評估用液晶胞而 〇 言,係藉由上述方法進行評估,其結果如表24所示。 表24評估結果 液晶配向 劑淸漆 高分子 殘留電f (mV) 電壓保持 率(%) 前傾角 (度) 液晶配向 性 塗佈性 實例3-1 NPAI-1 6 98.4 3.0 良好 良好 實例3-2 NPAI-2 12 98.6 2.6 良好 實例3-3 NPAI-3 8 98.2 3.1 良好 良好 實例3-4 NPAI-4 3 98.2 3.2 良好 良好 實例3-5 NPAI-5 15 98.0 5.5 良好 良好 實例3-6 NPAI-6 26 98.4 8.4 良好 良好 實例3-7 NPAI-7 12 98.8 5.6 良好 良好 實例3-8 NPAI-8 18 98.2 7.7 良好 良好 實例3-9 NPAI-9 14 98.5 3.0 良好 良好 實例3-10 NPAI-10 8 98.6 2.2 良好 良好 實例3-11 NPAI-11 10 Γ 98.5 2.5 良好 良好 實例3-12 INPAI-12 8 98.5 2.5 良好 比較例1 卜 PA-1 卜133 95.2 3.2 良好 微不良 比較例2 广 NPA-1 15 98.4 2.2 微不良 良好 比較例3 PI-1 23 98.8 3.5 良好 不良 殘留電荷値愈低愈佳,電壓保持率之値則是愈高愈 佳。而且,由上述結果可知,使用本發明之N置換聚醯胺_ 亞醯胺的淸漆與使用比較例之聚醯胺、N置換聚醯胺及可 83 591056 9825 pif 1 溶性聚醯胺的淸漆相比較之下,在關於殘留電荷、電壓保 持率、等的電特性或前傾角、液晶配向性等的配向特性、 以及塗佈性等特性中,係爲具有較佳之總和平均的物質。 [產業上之利用可能性] 使用本發明之N置換聚醯胺-亞醯胺之優點係如下所 示。所得之液晶配向劑淸漆之塗佈性較佳。所得之液晶配 向膜係具有良好的配向性,且可以對其前傾角進行任意的 調節。而且,具有此液晶配向膜的液晶顯示元件不需經過 燒結,即具有較大之電壓保持率及較小的殘留電荷。本發 明之液晶配向劑淸漆特別是適用於TFT型液晶顯示元件 (TN型、IPS型、VA型、OCB型)中。由於可以對前傾 角進行任意的調節而得到較佳之電特性,因此也可以使用 來作爲用於STN型液晶、強介電性液晶或反強介電性液晶 等中的配向劑。再者,由本液晶配向劑淸漆所構成的薄膜 由於具有較佳之電特性,因此也可以用以作爲保護膜或絕 緣膜。 84Hi) Measurement of rake angle The rake angle of the liquid crystal is measured by a rotating crystal method. iv) Evaluation of liquid crystal alignment The liquid crystal alignment is observed under a polarization microscope 82 591056 9825 pif 1 when measuring the forward tilt angle, and the presence or absence of domain is determined. V) Evaluation of applicability Coating the lacquer with a spin-coating method, pre-rolling at 80 ° C for about a minute, and then visually observing the alignment film after heating at 250 ° C for 30 minutes. Surface, and determine whether there is uneven cloth. ~ ~ (2) Evaluation results The evaluation liquid crystal cells corresponding to the lacquer obtained in Example 4 were evaluated by the above method. The results are shown in Table 24. Table 24 Evaluation results Liquid crystal alignment agent lacquer polymer residual electricity f (mV) Voltage retention (%) Forward tilt angle (degrees) Liquid crystal alignment coating property Example 3-1 NPAI-1 6 98.4 3.0 Good Good Example 3-2 NPAI-2 12 98.6 2.6 Good example 3-3 NPAI-3 8 98.2 3.1 Good example 3-4 NPAI-4 3 98.2 3.2 Good example 3-5 NPAI-5 15 98.0 5.5 Good example 3-6 NPAI-6 26 98.4 8.4 Good Good Example 3-7 NPAI-7 12 98.8 5.6 Good Good Example 3-8 NPAI-8 18 98.2 7.7 Good Good Example 3-9 NPAI-9 14 98.5 3.0 Good Good Example 3-10 NPAI-10 8 98.6 2.2 Good Good Example 3-11 NPAI-11 10 Γ 98.5 2.5 Good Good Example 3-12 INPAI-12 8 98.5 2.5 Good Comparative Example 1 PA-1 133 95.2 3.2 Good Poor Comparative Example 2 Wide NPA-1 15 98.4 2.2 Slightly Bad Good Comparative Example 3 PI-1 23 98.8 3.5 Good Bad Residual Charge: The lower the better, the higher the voltage retention, the better. In addition, from the above results, it can be seen that the varnish using the N-substituted polyamidoamine-iminomine of the present invention and the polyamidoamine of the comparative example, the N-substituted polyamidoamine, and the fluorene of 83 591056 9825 pif 1 soluble polyamidoamine In comparison with lacquers, it is a substance having a better total and average among the electrical characteristics such as the residual electric charge, the voltage holding ratio, etc., or the orientation characteristics such as the tilt angle, the liquid crystal alignment, and the coating properties. [Industrial Applicability] The advantages of using the N-substituted polyamidoamine-iminomine of the present invention are as follows. The coating property of the obtained liquid crystal alignment agent lacquer is better. The obtained liquid crystal alignment film has good alignment, and its forward tilt angle can be arbitrarily adjusted. Moreover, the liquid crystal display element having the liquid crystal alignment film does not need to undergo sintering, that is, it has a large voltage holding ratio and a small residual charge. The liquid crystal alignment agent paint of the present invention is particularly suitable for use in a TFT type liquid crystal display element (TN type, IPS type, VA type, OCB type). Since the forward tilt angle can be arbitrarily adjusted to obtain better electrical characteristics, it can also be used as an alignment agent in STN-type liquid crystals, ferroelectric liquid crystals, or anti-ferroelectric liquid crystals. In addition, the thin film composed of the liquid crystal alignment agent varnish has good electrical characteristics, so it can also be used as a protective film or an insulating film. 84
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001267441A JP5245187B2 (en) | 2001-09-04 | 2001-09-04 | Polyamideimide, liquid crystal aligning agent varnish, and liquid crystal display element |
Publications (1)
Publication Number | Publication Date |
---|---|
TW591056B true TW591056B (en) | 2004-06-11 |
Family
ID=19093573
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW091117861A TW591056B (en) | 2001-09-04 | 2002-08-08 | Polyamide-imide, liquid crystal orientating ingredient varnish and liquid crystal display |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP5245187B2 (en) |
KR (1) | KR100545466B1 (en) |
TW (1) | TW591056B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102408564A (en) * | 2011-08-30 | 2012-04-11 | 广东生益科技股份有限公司 | Thermoplastic polyimide and preparation method of two-layer process adhesive-free double-side flexible copper clad plate using thermoplastic polyimide |
CN110734544A (en) * | 2018-07-19 | 2020-01-31 | 住友化学株式会社 | Polyamide-imide resin and optical film |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101096690B1 (en) * | 2005-06-10 | 2011-12-22 | 엘지디스플레이 주식회사 | Liquid Crystal Display Device |
WO2008078629A1 (en) * | 2006-12-27 | 2008-07-03 | Sharp Kabushiki Kaisha | Liquid crystal display device, method for production thereof, and alignment film |
KR101492657B1 (en) * | 2007-03-23 | 2015-02-12 | 닛산 가가쿠 고교 가부시키 가이샤 | Diamine compound, polyamic acid, polyimide and liquid crystal aligning agent |
TWI471655B (en) * | 2007-12-28 | 2015-02-01 | Nissan Chemical Ind Ltd | Liquid crystal alignment agent, liquid crystal alignment film and liquid crystal display element |
JP5365780B2 (en) * | 2008-03-18 | 2013-12-11 | Jsr株式会社 | Liquid crystal aligning agent and liquid crystal display element |
KR101188777B1 (en) * | 2008-04-28 | 2012-10-10 | 제이에스알 가부시끼가이샤 | Liquid crystal aligning agent and method for forming liquid crystal alignment films, and polymers contained in the liquid crystal aligning agent |
JP5874646B2 (en) * | 2010-12-28 | 2016-03-02 | 日産化学工業株式会社 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
JP5853631B2 (en) | 2011-01-12 | 2016-02-09 | Jsr株式会社 | Liquid crystal display element |
KR101938923B1 (en) * | 2011-11-01 | 2019-04-10 | 닛산 가가쿠 가부시키가이샤 | Liquid crystal aligning agent, liquid crystal alignment film, and liquid crystal display element |
US11274206B2 (en) | 2017-01-20 | 2022-03-15 | Sumitomo Chemical Company, Limited | Polyamideimide resin and optical member including polyamideimide resin |
JP7084710B2 (en) * | 2017-01-20 | 2022-06-15 | 住友化学株式会社 | Polyamide-imide resin and an optical member containing the polyamide-imide resin. |
KR102023130B1 (en) * | 2017-11-09 | 2019-09-19 | 스미또모 가가꾸 가부시키가이샤 | Optical film |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0848776A (en) * | 1994-08-05 | 1996-02-20 | Chisso Corp | New polyimide-amide having liquid crystal group as side chain |
US6685997B1 (en) * | 1999-04-09 | 2004-02-03 | Chisso Corporation | Varnish composition and liquid-crystal display element |
JP4232284B2 (en) * | 1999-08-24 | 2009-03-04 | チッソ株式会社 | Polyamide compound and liquid crystal aligning agent containing the same |
JP4487343B2 (en) * | 1999-09-29 | 2010-06-23 | チッソ株式会社 | Diamino compound, resin composition using the same, liquid crystal alignment film, and liquid crystal display element |
JP2002162630A (en) * | 2000-11-29 | 2002-06-07 | Chisso Corp | Diamine compound and polymer material using the same, liquid crystal alignment layer using polymer material and liquid crystal display element equipped with alignment layer |
-
2001
- 2001-09-04 JP JP2001267441A patent/JP5245187B2/en not_active Expired - Lifetime
-
2002
- 2002-08-08 TW TW091117861A patent/TW591056B/en not_active IP Right Cessation
- 2002-09-04 KR KR1020020053141A patent/KR100545466B1/en not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102408564A (en) * | 2011-08-30 | 2012-04-11 | 广东生益科技股份有限公司 | Thermoplastic polyimide and preparation method of two-layer process adhesive-free double-side flexible copper clad plate using thermoplastic polyimide |
CN110734544A (en) * | 2018-07-19 | 2020-01-31 | 住友化学株式会社 | Polyamide-imide resin and optical film |
Also Published As
Publication number | Publication date |
---|---|
KR100545466B1 (en) | 2006-01-24 |
KR20030020850A (en) | 2003-03-10 |
JP5245187B2 (en) | 2013-07-24 |
JP2003073474A (en) | 2003-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3978754B2 (en) | Polyamic acid composition, liquid crystal alignment film, and liquid crystal display element | |
TW591056B (en) | Polyamide-imide, liquid crystal orientating ingredient varnish and liquid crystal display | |
KR100521070B1 (en) | Diamino compound, polymer using the compound, liquid crystal aligning film using the polymer and liquid crystal display element | |
JP7234924B2 (en) | Manufacturing method of zero plane anchoring film and liquid crystal display element | |
JP4591803B2 (en) | Varnish composition and liquid crystal display element | |
JP4192670B2 (en) | Liquid crystal aligning agent varnish, alignment film using the varnish, and liquid crystal display element having the alignment film | |
TW201206993A (en) | Liquid crystal alignment agent containing end-modified polyamic acid ester, and liquid crystal alignment film | |
JP6558068B2 (en) | Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element | |
CN104059675B (en) | Aligning agent for liquid crystal, liquid crystal orientation film, liquid crystal display cells, polymer and compound | |
JP2019139254A (en) | Manufacturing method of liquid crystal alignment film and manufacturing method of liquid crystal element | |
JP6447209B2 (en) | Polymer composition, liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, and method for producing liquid crystal display element | |
JP4228614B2 (en) | Phenylenediamine with ester bond | |
JP4140252B2 (en) | Phenylenediamine having a siloxane moiety, a liquid crystal alignment material including a polymer using the same, and a liquid crystal display element including the liquid crystal alignment material | |
JP4232284B2 (en) | Polyamide compound and liquid crystal aligning agent containing the same | |
JP4687859B2 (en) | Varnish composition and liquid crystal display element | |
JP4306317B2 (en) | Liquid crystal alignment film forming varnish, liquid crystal alignment film, and liquid crystal display element | |
JP2001097969A (en) | Diamino compound and resin composition using the same, liquid crystal orientation membrane, liquid crystal display device | |
JP4992893B2 (en) | Acid anhydride having asymmetric structure, liquid crystal alignment film, and liquid crystal display device | |
JP4569221B2 (en) | Tetracarboxylic dianhydrides, polymers made from them, varnishes using these, alignment films, and liquid crystal display elements | |
JP4415566B2 (en) | Acid anhydride having asymmetric structure, liquid crystal alignment film, and liquid crystal display device | |
TW202340433A (en) | Weak-anchoring liquid crystal alignment agent, and liquid cyrstal display element |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Annulment or lapse of patent due to non-payment of fees |